
<html lang="en"     class="pb-page"  data-request-id="caa05fa1-3631-4831-8df8-909f77e2174c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2010.53.issue-7;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm901858n;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Radiosynthesis and Bioimaging of the Tuberculosis Chemotherapeutics Isoniazid, Rifampicin and Pyrazinamide in Baboons" /></meta><meta name="dc.Creator" content="Li  Liu" /></meta><meta name="dc.Creator" content="Youwen  Xu" /></meta><meta name="dc.Creator" content="Colleen  Shea" /></meta><meta name="dc.Creator" content="Joanna S.  Fowler" /></meta><meta name="dc.Creator" content="Jacob M.  Hooker" /></meta><meta name="dc.Creator" content="Peter J.  Tonge" /></meta><meta name="dc.Description" content="The front-line tuberculosis (TB) chemotherapeutics isoniazid (INH), rifampicin (RIF), and pyrazinamide (PZA) have been labeled with carbon-11 and the biodistribution of each labeled drug has been d..." /></meta><meta name="Description" content="The front-line tuberculosis (TB) chemotherapeutics isoniazid (INH), rifampicin (RIF), and pyrazinamide (PZA) have been labeled with carbon-11 and the biodistribution of each labeled drug has been d..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 8, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901858n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901858n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901858n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901858n" /></link>
        
    
    

<title>Radiosynthesis and Bioimaging of the Tuberculosis Chemotherapeutics Isoniazid, Rifampicin and Pyrazinamide in Baboons | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901858n" /></meta><meta property="og:title" content="Radiosynthesis and Bioimaging of the Tuberculosis Chemotherapeutics Isoniazid, Rifampicin and Pyrazinamide in Baboons" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0006.jpeg" /></meta><meta property="og:description" content="The front-line tuberculosis (TB) chemotherapeutics isoniazid (INH), rifampicin (RIF), and pyrazinamide (PZA) have been labeled with carbon-11 and the biodistribution of each labeled drug has been determined in baboons using positron emission tomography (PET). Each radiosynthesis and formulation has been accomplished in 1 h, using [11C]CH3I to label RIF and [11C]HCN to label INH and PZA. Following iv administration, INH, PZA, RIF, and/or their radiolabeled metabolites clear rapidly from many tissues; however, INH, PZA, and/or their radiolabeled metabolites accumulate in the bladder while RIF and/or its radiolabeled metabolites accumulates in the liver and gall bladder, consistent with the known routes of excretion of the drugs. In addition, the biodistribution data demonstrate that the ability of the three drugs and their radiolabeled metabolites to cross the blood−brain barrier decreases in the order PZA &gt; INH &gt; RIF, although in all cases the estimated drug concentrations are greater than the minimum inhibitory concentration (MIC) values for inhibiting bacterial growth of Mycobacterium tuberculosis (MTB). The pharmacokinetic (PK) and drug distribution data have important implications for treatment of disseminated TB in the brain and pave the way for imaging the distribution of the pathogen in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901858n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901858n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901858n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901858n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901858n&amp;href=/doi/10.1021/jm901858n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2882-2891</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm9019068" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901877j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Radiosynthesis and Bioimaging of the Tuberculosis Chemotherapeutics Isoniazid, Rifampicin and Pyrazinamide in Baboons</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Liu">Li Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Youwen++Xu">Youwen Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Colleen++Shea">Colleen Shea</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joanna+S.++Fowler">Joanna S. Fowler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacob+M.++Hooker">Jacob M. Hooker</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Tonge">Peter J. Tonge</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Institute for Chemical Biology & Drug Discovery, Department of Chemistry, Stony Brook University, Stony Brook, New York 11794-3400</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Medical Department, Brookhaven National Laboratory, Upton, New York 11973-5000</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. For P.J.T.: phone, (631) 632 7907; fax, (631) 632 7960; E-mail, <a href="/cdn-cgi/l/email-protection#4c3c2938293e623823222b290c3f3922353f2e62292839"><span class="__cf_email__" data-cfemail="3141544554431f455e5f56547142445f4842531f545544">[email protected]</span></a>. For J.M.H.: phone, (617) 726 6596; fax, (617) 726 7422; E-mail, <a href="/cdn-cgi/l/email-protection#751d1a1a1e1007351b18075b18121d5b1d1407031407115b101100"><span class="__cf_email__" data-cfemail="bfd7d0d0d4dacdffd1d2cd91d2d8d791d7decdc9decddb91dadbca">[email protected]</span></a></div><div class="corresp-fn" id="fn1">∥Present address: Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, Massachusetts 02129.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901858n&amp;href=/doi/10.1021%2Fjm901858n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2882–2891</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 8, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 December 2009</li><li><span class="item_label"><b>Published</b> online</span>8 March 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 April 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901858n" title="DOI URL">https://doi.org/10.1021/jm901858n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2882%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLi%2BLiu%252C%2BYouwen%2BXu%252C%2BColleen%2BShea%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D7%26contentID%3Djm901858n%26title%3DRadiosynthesis%2Band%2BBioimaging%2Bof%2Bthe%2BTuberculosis%2BChemotherapeutics%2BIsoniazid%252C%2BRifampicin%2Band%2BPyrazinamide%2Bin%2BBaboons%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2891%26publicationDate%3DApril%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901858n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1938</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">44</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901858n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Radiosynthesis and Bioimaging of the Tuberculosis Chemotherapeutics Isoniazid, Rifampicin and Pyrazinamide in Baboons&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Youwen&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Colleen&quot;,&quot;last_name&quot;:&quot;Shea&quot;},{&quot;first_name&quot;:&quot;Joanna&quot;,&quot;last_name&quot;:&quot;S. Fowler&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;M. Hooker&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Tonge&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;2882-2891&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901858n&quot;},&quot;abstract&quot;:&quot;The front-line tuberculosis (TB) chemotherapeutics isoniazid (INH), rifampicin (RIF), and pyrazinamide (PZA) have been labeled with carbon-11 and the biodistribution of each labeled drug has been determined in baboons using positron emission tomography (PET). Each radiosynthesis and formulation has been accomplished in 1 h, using [11C]CH3I to label RIF and [11C]HCN to label INH and PZA. Following iv administration, INH, PZA, RIF, and/or their radiolabeled metabolites clear rapidly from many tissues; however, INH, PZA, and/or their radiolabeled metabolites accumulate in the bladder while RIF and/or its radiolabeled metabolites accumulates in the liver and gall bladder, consistent with the known routes of excretion of the drugs. In addition, the biodistribution data demonstrate that the ability of the three drugs and their radiolabeled metabolites to cross the blood−brain barrier decreases in the order PZA &gt; INH &gt; RIF, although in all cases the estimated drug concentrations are greater than the minimum inhibito&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901858n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901858n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901858n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901858n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901858n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901858n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901858n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901858n&amp;href=/doi/10.1021/jm901858n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901858n" /></input><a href="/doi/pdf/10.1021/jm901858n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901858n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901858n%26sid%3Dliteratum%253Aachs%26pmid%3D20205479%26genre%3Darticle%26aulast%3DLiu%26date%3D2010%26atitle%3DRadiosynthesis%2Band%2BBioimaging%2Bof%2Bthe%2BTuberculosis%2BChemotherapeutics%2BIsoniazid%252C%2BRifampicin%2Band%2BPyrazinamide%2Bin%2BBaboons%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D7%26spage%3D2882%26epage%3D2891%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291663" title="Positron emission tomography">Positron emission tomography</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The front-line tuberculosis (TB) chemotherapeutics isoniazid (INH), rifampicin (RIF), and pyrazinamide (PZA) have been labeled with carbon-11 and the biodistribution of each labeled drug has been determined in baboons using positron emission tomography (PET). Each radiosynthesis and formulation has been accomplished in 1 h, using [<sup>11</sup>C]CH<sub>3</sub>I to label RIF and [<sup>11</sup>C]HCN to label INH and PZA. Following iv administration, INH, PZA, RIF, and/or their radiolabeled metabolites clear rapidly from many tissues; however, INH, PZA, and/or their radiolabeled metabolites accumulate in the bladder while RIF and/or its radiolabeled metabolites accumulates in the liver and gall bladder, consistent with the known routes of excretion of the drugs. In addition, the biodistribution data demonstrate that the ability of the three drugs and their radiolabeled metabolites to cross the blood−brain barrier decreases in the order PZA > INH > RIF, although in all cases the estimated drug concentrations are greater than the minimum inhibitory concentration (MIC) values for inhibiting bacterial growth of <i>Mycobacterium tuberculosis</i> (MTB). The pharmacokinetic (PK) and drug distribution data have important implications for treatment of disseminated TB in the brain and pave the way for imaging the distribution of the pathogen in vivo.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The dose and duration of treatment of antibiotics is normally established using plasma pharmacokinetic (PK<a class="ref internalNav" href="#fn9" aria-label="a">a</a><div class="NLM_fn" id="fn9">a<p class="last">Abbreviations: TB, tuberculosis; INH, isoniazid; RIF, rifampicin; PZA, pyrazinamide; MIC, minimum inhibitory concentration; PK, pharmacokinetic; FDA, Food and Drug Administration; PET, positron emission tomography; MD, microdialysis; MRS, magnetic resonance spectroscopy; MTB, <i>Mycobacterium tuberculosis</i>; WHO, World Health Organization; EMB, ethambutol; CNS, central nervous system; CSF, cerebrospinal fluid; PPB, plasma protein binding; TAC, time−activity curve; AUC, area under the curve; ROI, region-of-interest; FBP, filtered back projection; %ID/cc, % of injected dose per cubic centimeter; HPLC, high performance liquid chromatography; RCY, radiochemical yield; DCY, decay-corrected yield.</p></div>) data together with information on drug efficacy once treatment has been initiated. Although plasma drug concentration is an important guide for establishing treatment protocols, recent studies indicate that the distribution of antibiotics in tissues is a more critical determinant and predictive factor for their activity.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> This is because most drugs exert their bactericidal effects at the site of infection rather than in the plasma and because drug equilibration between plasma and infection site cannot always be achieved.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Failure to reach optimal drug concentration at the site of infection may result in therapeutic failure and trigger bacterial resistance.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Therefore, the Food and Drug Administration (FDA) now requires clinical studies of tissue drug distribution at uninfected and infected sites.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Positron emission tomography (PET), which images drugs and other molecules labeled with positron-emitting isotopes, provides a method of acquiring quantitative information on the dynamics of drug absorption, distribution, and elimination in a living animal or human. Together with advances in the development of methods for labeling drug molecules and other organic compounds with carbon-11 (half-life: 20.4 min), PET is emerging as a powerful alternative to ex vivo distribution studies using laboratory animals which sample a single time point per animal. Indeed, PET can map three-dimensional tissue distribution over time noninvasively.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> It is also complementary to clinical microdialysis (MD) and magnetic resonance spectroscopy (MRS) in terms of acquiring information on the tissue distribution of different chemical species.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In addition, the methodology developed for imaging drug distribution in laboratory animals using PET can be readily translated to humans.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">More than two million deaths every year are attributed to infection with <i>Mycobacterium tuberculosis</i> (MTB) and the World Health Organization (WHO) has estimated that one-third of the world’s population is infected with this pathogen.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> While many bacterial infections are treated using a 1−2 week course of monotherapy, the treatment of tuberculosis (TB) requires the use of multiple antibiotics over a 6−9 month period, dramatically increasing the risk of noncompliance and enhancing the emergence of resistance.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The current treatment regime for drug-sensitive TB involves the use of isoniazid (INH), rifampicin (RIF), pyrazinamide (PZA), and ethambutol (EMB) or streptomycin for two months, followed by four months of continued dosing with INH and RIF. This regime has been used for decades and is primarily based on PK studies in serum combined with historical data on the efficacy of treatment.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> TB infection most commonly occurs through inhalation of live bacteria, and thus the primary site of infection in humans are the lungs. However, MTB can also disseminate via the bloodstream and infect other organs in the body. In particular, MTB infection of the brain (central nervous system TB, CNS TB) can occur. CNS TB is presented in many forms including tuberculous meningitis, cerebral tuberculomas without meningitis, and spinal TB.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> CNS TB is particularly difficult to manage because the pathogenesis, diagnosis, and treatment of this form of TB infection has not been as intensively studied as pulmonary TB, and there is little data to guide treatment options.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Current treatment for CNS TB normally follows the same format as that used for treating pulmonary TB and involves an intensive phase of treatment followed by a continuation phase.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Thus, both INH and RIF are included in the treatment based on their potent activity against pulmonary TB infection and, in the case of INH, the significant levels of this drug that can be detected in the cerebrospinal fluid (CSF). In addition, although high concentrations of PZA can be detected in the CSF, the importance of this drug for treating CNS TB is largely unknown.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Although measurement of CSF drug concentration through lumbar puncture is a good indication of drug availability in brain, it would be advantageous to be able to measure brain drug distribution noninvasively and more accurately because a ventriculo-lumbar concentration gradient is often observed and the distribution of drugs in each compartment of the CNS is not homogeneous.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Here we present a PET imaging study of carbon-11 labeled RIF, INH, and PZA in baboons in order to provide more direct insight into the PK and biodistribution of drugs commonly used to treat TB. These studies in healthy baboons are a prelude to imaging experiments in infected animals and humans and should ultimately be useful in evaluating new TB treatment regimes, especially for disseminated forms of the disease such as CNS TB where the ability to evaluate drug availability at the site of infection may be limited.</div><div class="NLM_p last">Using PET, we find that all three drugs and/or their radiolabeled metabolites are cleared rapidly from the lungs. In addition, their accumulations are consistent with the mechanism of excretion of each drug. We also find that the organ distribution of each drug differs by 1−1000 fold from the plasma drug distribution. All of the three injected drugs reached higher concentrations in the lung than the plasma over the time course of the experiment. In addition, we find that the ability of the drugs to penetrate the blood−brain barrier decreases in the order PZA > INH > RIF. Estimates based on the weight of the baboon, a standard drug dose and the assumption that the positron signal derives primarily from the intact drug indicates that the concentrations of RIF, INH, and PZA in the lungs are at least 10, 10, and 1−3 times higher, respectively, than the minimum inhibitory concentration (MIC) values for these drugs against MTB. Estimates of drug concentrations in the brain using the same assumptions outlined above suggest that the concentrations of RIF and INH are 3−4 and >10 times higher than their MIC values, while the concentration of PZA is similar to or slightly higher than its MIC. These data have important implications for the treatment of TB and set the scene for additional studies in humans.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10347" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10347" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Radiosynthesis of [<sup>11</sup>C]RIF</h3><div class="NLM_p">The radiolabeling of the RIF piperazine moiety with [<sup>11</sup>C]CH<sub>3</sub>I was accomplished by using potassium carbonate and a combination of DMSO and MeCN (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Although the conditions for labeling a piperazine with [<sup>11</sup>C]CH<sub>3</sub>I have been published before,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> we were concerned that other nucleophilic sites could also be alkylated (e.g., <i>O</i>-methylation of the phenolic oxygens). Consequently, we explored a range of non-nucleophilic organic and inorganic bases in combination with polar aprotic solvents in order to identify conditions that would give the required rate, radiochemical yield, and regioselectivity (i.e., <i>N</i>-methylation). These studies resulted in the use of potassium carbonate as the base and a combination of DMSO and MeCN as the solvent (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The [<sup>11</sup>C]RIF was subsequently purified by high performance liquid chromatography (HPLC) using a semipreparative Phenomenex Luna C-18 column (250 × 10, 5 μm), and 100 mg of ascorbic acid was added to the product solution prior to concentration in vacuo in order to prevent oxidation. In the optimized reaction scheme, the average decay-corrected yield (DCY), calculated from [<sup>11</sup>C]CH<sub>3</sub>I, was 15−25% in a total synthesis time of 50 min. Analytical HPLC and TLC demonstrated that the radiolabeled product was over 99% radiochemically pure, with a specific activity of 580 mCi/μmol at the time of delivery to the animal.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Radiosynthesis of [<sup>11</sup>C]RIF</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Radiosynthesis of [<sup>11</sup>C]INH</h3><div class="NLM_p">The synthesis of [<sup>11</sup>C]INH was accomplished in three steps beginning from [<sup>11</sup>C]HCN. The first step involved treating iodopyridine (<b>2</b>) with [<sup>11</sup>C]HCN in a DMSO reaction mixture catalyzed by tetrakis(triphenylphosphine)palladium(0) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) for 5 min to form [<sup>11</sup>C]cyanopyridine (<b>3</b>). This method was adapted from previously reported radiolabeling of an aromatic ring with [<sup>11</sup>C]HCN,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and gave 90% radiochemical yield (RCY) as determined by HPLC. The subsequent hydrazine hydrolysis of the cyanide was accomplished in two steps, which involved a nucleophilic attack by hydrazine and subsequent hydrolysis of the imine by water. This procedure was a modification of a published method,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> which used NaY zeolite as the catalyst to hydrolyze the aromatic cyano group without adding acetic acid to drive the reaction. Initial studies indicated that the hydrolysis step was too slow to be useful with carbon-11 (approximately 60 min at 180 °C). However, because mass spectrometry revealed the formation of intermediate (<b>4</b>) together with the complete consumption of <b>3</b> within the first 5 min of the reaction, acetic acid was added to promote hydrolysis of the intermediate. Using this two-step procedure, the combined hydrazine addition and hydrolysis time of <b>3</b> was reduced to 10 min. The final product was formed with an average 45−50% DCY (calculated from [<sup>11</sup>C]HCN) in a total synthesis time of 50 min. Isonicotinamide was the only major byproduct, but with optimization of the ratio between hydrazine, water, and acetic acid (3:3:1), formation of this adduct could be reduced to less than 15% of the desired product. [<sup>11</sup>C]INH was purified by semipreparative HPLC, and the amount of hydrazine in the sample, that initially coeluted with [<sup>11</sup>C]INH, was reduced by evacuation of the sample on the rotary evaporator for 10 min. The average amount of hydrazine present in the injected solution was 8.2 μg/mL (∼10.0 μg/injection) as determined by an analytical assay, which was adapted from a previous report.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Analytical HPLC and TLC were used to demonstrate that the radiolabeled product was over 99% radiochemically pure, with a specific activity of 140−165 mCi/μmol at the time of delivery.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Radiosynthesis of [<sup>11</sup>C]INH</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Radiosynthesis of [<sup>11</sup>C]PZA</h3><div class="NLM_p">The radiosynthesis of [<sup>11</sup>C]PZA is shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Initially, [<sup>11</sup>C]cyanopyrazine (<b>6</b>) was generated with a 90% RCY in 5 min from 2-iodopyrazine (<b>5</b>) and [<sup>11</sup>C]HCN using tetrakis(triphenylphosphine)palladium(0) as the catalyst under the same reaction conditions as those used for [<sup>11</sup>C]INH.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Subsequent hydrolysis of the cyano group was accomplished in an additional 5 min by treating <b>6</b> with hydrogen peroxide under basic conditions. The overall DCY was 50−55% (calculated from [<sup>11</sup>C]HCN) in a total synthesis time of 45 min. An unidentified volatile compound coeluted with the [<sup>11</sup>C]PZA product during HPLC purification, however, this was removed during concentration of the product in vacuo. Analytical HPLC and TLC demonstrated that the radiolabeled product was over 99% radiochemically pure, with a specific activity of 120−150 mCi/μmol at the time of delivery.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Radiosynthesis of [<sup>11</sup>C]PZA</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> LogD and Plasma Protein Binding (PPB)</h3><div class="NLM_p">The lipophilicity (logD) and PPB of each drug was determined using the radiolabel to report on drug concentration. The results are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and are similar to literature values reported elsewhere.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. LogD and PPB Determination</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th align="left">LogD</th><th align="char" char=".">PPB,<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> %</th></tr></thead><tbody><tr valign="top"><td align="left">RIF</td><td align="left">1.67</td><td align="char" char=".">27.32</td></tr><tr valign="top"><td align="left">INH</td><td align="left">nd<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td align="char" char=".">94.63</td></tr><tr valign="top"><td align="left">PZA</td><td align="left">−0.41</td><td align="char" char=".">91.32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Value expressed as % of free fraction in plasma.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Octanol−water partitioning was highly variable.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Brain PET Imaging in Anesthetized Baboons</h3><div class="NLM_p">PET imaging studies were performed with [<sup>11</sup>C]RIF, [<sup>11</sup>C]INH, and [<sup>11</sup>C]PZA to determine brain penetration and distribution. Time−activity curves (TACs) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a) were generated from the image data, which was acquired for 90 min following iv administration of each radiolabeled drug. Area under the curves (AUCs) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b) were produced by integrating TACs as a function of time and dose corrected coronal images (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>c) were generated by sum from 15 to 90 min. Regions-of-interest (ROIs) were drawn manually.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Blood−brain barrier penetration, brain tissue bioavailability, and TACs for [<sup>11</sup>C]PZA, [<sup>11</sup>C]INH, and [<sup>11</sup>C]RIF. (a) TACs generated from the image acquired after iv administration of each drug in baboons by manually drawing the ROIs. (b) Whole-brain regions of interest were used to generate TACs for each labeled drug. The resulting curves were integrated as a function of time to produce AUC plots. (c) Dose corrected coronal images summed over frames 24−35 (15−90 min). The NIH color scale was used to represent relative radioactivity concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These PET studies are the first in which dynamic TB drug concentrations have been measured in whole brain tissue in a living animal. Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> clearly demonstrates that the ability of the drugs and their radiolabeled metabolites to penetrate the blood−brain barrier decreases in the order PZA > INH > RIF. The [<sup>11</sup>C]RIF TAC, AUC, and image (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) showed that RIF and/or its radiolabeled metabolites poorly penetrate the blood−brain barrier in healthy baboons, consistent with previous studies in which the concentration of iv delivered RIF in human CSF was measured. Our studies demonstrate a higher RIF concentration in brain tissue than that observed in the CSF.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The concentration of injected [<sup>11</sup>C]RIF in the whole brain area was monitored over the 90 min scanning period with a C<sub>30 min</sub> = 0.000642%ID/cc (1.09 μg/mL), C<sub>60 min</sub> = 0.000536%ID/cc (0.912 μg/mL), and C<sub>90 min</sub> = 0.000710%ID/cc (1.21 μg/mL). In parentheses we have estimated the expected concentration of RIF in the baboon brain based on the weight of the baboon (17 kg), the recommended daily dose for a human adult (10 mg/kg) and the assumption that the positron signal derives primarily from the intact drug. Thus, for a 17 kg baboon the injected dose is 170 mg and, for example, at 30 min the concentration in the brain is estimated to be 0.000642% of 170 mg in each cubic centimeter which is 1.09 μg/mL. The anticipated concentration of RIF in the baboon brain is therefore 3−4 times above the MTB MIC for this compound, supporting the use of RIF for treating CNS TB infections.<a onclick="showRef(event, 'ref9 ref18'); return false;" href="javascript:void(0);" class="ref ref9 ref18">(9, 18)</a> The concentrations of RIF observed in our study are similar to the value of 0.87 μg/g determined in monkeys 6 h after iv administration of [<sup>14</sup>C]RIF,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> which suggests that the observed level of RIF could persist for several hours in brain tissue. In addition, although studies in mice revealed a much higher RIF brain tissue concentration of 10.25 μg/mL 3−7 h after ip administration,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> the latter measurements were made with a 100 mg/kg dose of RIF and thus are likely similar to the concentrations reported from our PET study if our estimates were based on a 100 mg/kg dose. Finally, Thomas and co-workers resected human brain tissue around tumors and determined a RIF concentration of 0.29 μg/mL following iv infusion of 600 mg of RIF in 500 mL saline over 3 h.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Thus, the concentrations of RIF determined by PET imaging the distribution of [<sup>11</sup>C]RIF in healthy baboons are similar to those observed in mice and monkeys, while the ∼3.5-fold difference between our values and that determined by resecting brain tissue could be due to the limited sampling region in the latter experiments. Although the studies with [<sup>14</sup>C]RIF do provide information on drug distribution, this is only at a single time point, whereas the PET imaging experiments provide dynamic data from 0 to 90 min. Importantly, the PET studies are noninvasive and thus can be readily applied to determining RIF concentration and distribution in humans.</div><div class="NLM_p">The [<sup>11</sup>C]INH TAC, AUC, and image (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) showed a higher initial brain penetration and tissue accumulation when compared to RIF, consistent with CSF analysis in humans.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> The concentration of injected [<sup>11</sup>C]INH in the whole brain area was monitored after iv administration (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a) and gave <i>C</i><sub>30 min</sub> = 0.00299%ID/cc (2.54 μg/mL), <i>C</i><sub>60 min</sub> = 0.00248%ID/cc (2.11 μg/mL), and <i>C</i><sub>90 min</sub> = 0.00206%ID/cc (1.75 μg/mL). Again, concentrations in μg/mL are estimated based on the weight of the baboon, the recommended daily dose for a human adult which is 5 mg/kg, and the assumption that the positron signal derives primarily from the intact drug. Thus, the calculated INH concentration is more than 10 times above the MIC of this compound against MTB and hence INH should be a suitable therapy for CNS TB infection as recommended,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> with the caveat that INH must be used with another drug because INH-resistant mutants emerge quickly during monotherapy.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Concentrations estimated from our [<sup>11</sup>C]INH study are similar to those determined in mice using [<sup>14</sup>C]INH in which a 10 mg/kg sc dose gave concentrations of 4.4 and 3.2 μg/g at 30 and 60 min, respectively.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> However, studies in cats in which [<sup>14</sup>C]INH was administered ip revealed much lower penetration of INH into the brain, with a calculated INH concentration of only 0.02 μg/g.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> The lower brain concentration of INH determined in cats compared to our baboon study could reflect interspecies differences and/or the different routes of administration that were used. Finally, although the observed CSF concentrations in humans from two experiments are contradictory (1.9 μg/mL with 8.5 mg/kg oral dose at 2 h<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and 0.31 μg/mL with 108.7 mg oral dose at 1 h<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>), it is clear that the INH concentration in brain tissue is equal to, or greater than, the concentration in the CSF.</div><div class="NLM_p last">The [<sup>11</sup>C]PZA TAC, AUC, and image indicated excellent penetration of PZA into healthy brain tissue in vivo (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). This result is consistent with CSF analysis in humans in which the PZA concentration in the CSF exceeded that in the serum.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> For example, in the brain, the <i>C</i><sub>60 min</sub> was 0.00463%ID/cc while in the plasma the <i>C</i><sub>60 min</sub> was 0.00272%ID/cc. The concentration of [<sup>11</sup>C]PZA in the whole brain area decreased following iv administration, with <i>C</i><sub>30 min</sub> = 0.00619%ID/cc (21.05 μg/mL), <i>C</i><sub>60 min</sub> = 0.00463%ID/cc (15.74 μg/mL), and <i>C</i><sub>90 min</sub> = 0.00403%ID/cc (13.70 μg/mL). As above, concentrations in μg/mL are estimated based on the weight of the baboon, the recommended daily dose for a human adult which is 20 mg/kg and the assumption that the positron signal derives primarily from the intact drug. We believe that this is the first study of PZA distribution in the primate brain. Studies with rats conducted by Wu and co-workers using MD gave similar brain tissue concentrations using a similar dose administered iv,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> while in patients with inflamed meninges, the CSF concentration of PZA was 50 μg/mL following a single 3 g oral dose.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The calculated PZA concentration at different time points from our baboon study is similar to or slightly greater than the MIC value for this drug against MTB.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Torso PET Imaging in Anesthetized Baboons</h3><div class="NLM_p">PET imaging studies were performed with [<sup>11</sup>C]RIF, [<sup>11</sup>C]INH, and [<sup>11</sup>C]PZA to determine their peripheral organ distribution. The TACs (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) were generated from the image acquired after iv administration of each drug to baboons by manually drawing the ROIs.</div><div class="NLM_p">[<sup>11</sup>C]RIF administered iv had moderate distribution in the heart, lung, and kidneys and was concentrated in the liver and gallbladder (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The concentration of RIF in μg/mL at 15, 30, 60, and 90 min has been estimated based on the weight of the baboon, the recommended dose of RIF, and assumption that the positron signal derives primarily from the intact drug (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The anticipated concentration of RIF in the lungs is more than 10 times above the MTB MIC for this compound and hence RIF should be a suitable therapy for TB infections as recommended by the American Thoracic Society.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In most organs, the concentration of injected RIF exceeds that in plasma over the study period except for the cortex of the kidney at 60 min. Although Nitti et al. have reported a PK study of RIF administered iv from 15 min to 12 h,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> these results are difficult to compare with our own because in their case the drug was infused over a 3 h period. In addition, Furesz and co-workers used samples obtained by biopsy to determine the concentration of orally administered RIF in the organs and body fluids of patients with diseases that are presumed not to affect the absorption and elimination of RIF.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Although their data do not show concentrations before 90 min, the relative abundance of RIF in each organ and body fluid is quite similar to our own measurements and demonstrates that in most cases the concentration of drug in the organs exceeds that in the serum. In their study, the bile concentration after a 150 mg oral dose is up to 538.5 μg/mL at 3−5 h, while the concentration in the liver is between 22 and 35 μg/mL, which is several fold smaller than our estimated liver concentration. This result may suggest that RIF is cleared quickly from the liver between 1.5 and 3 h post administration. Our data can also be compared with the tissue distribution of RIF in monkeys performed 6 h after iv administration of [<sup>14</sup>C]RIF. In the latter experiment, the liver still had the highest concentration (60.41 μg/g), while the heart, lung, and kidney retained some drug (10.11, 8.32, and 14.69 μg/g, respectively).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Finally, a semiquantitative evaluation of whole body RIF distribution in mice using iv injected [<sup>14</sup>C]RIF suggested a similar drug distribution compared to our own studies except that the difference between the liver and other organs was not as large.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. TACs for [<sup>11</sup>C]RIF in the (a) heart, lungs, liver, kidneys, and (b) gallbladder. Peripheral organ distribution following torso PET imaging of [<sup>11</sup>C]RIF administered iv to anesthetized baboons. TACs were generated from the image acquired after iv administration of each drug in baboons by manually drawing the ROIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Distribution of [<sup>11</sup>C]RIF Administered iv to Baboons<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="left">min after administration</th><th align="char">heart</th><th align="char">lung</th><th align="char">liver</th><th align="center">kidney cortex</th><th align="center">kidney medulla</th><th align="char">gallbladder</th><th align="char">plasma</th></tr></thead><tbody><tr valign="top"><td rowspan="2" align="left">15</td><td align="left">0.0043</td><td align="left">0.003</td><td align="left">0.1523</td><td align="left">0.0093</td><td align="left">0.0214</td><td align="left">0.0714</td><td align="left">0.00165</td></tr><tr valign="top"><td align="left">(7.28)</td><td align="left">(5.03)</td><td align="left">(258.98)</td><td align="left">(15.79)</td><td align="left">(36.39)</td><td align="left">(121.40)</td><td align="left">(2.81)</td></tr><tr valign="top"><td rowspan="2" align="left">30</td><td align="left">0.0031</td><td align="left">0.0017</td><td align="left">0.1624</td><td align="left">0.0037</td><td align="left">0.0068</td><td align="left">0.3449</td><td align="left">0.00088</td></tr><tr valign="top"><td align="left">(5.28)</td><td align="left">(2.83)</td><td align="left">(276.12)</td><td align="left">(6.34)</td><td align="left">(11.63)</td><td align="left">(586.34)</td><td align="left">(1.50)</td></tr><tr valign="top"><td rowspan="2" align="left">60</td><td align="left">0.0011</td><td align="left">0.0015</td><td align="left">0.1694</td><td align="left">0.0003</td><td align="left">0.004</td><td align="left">0.5784</td><td align="left">0.00067</td></tr><tr valign="top"><td align="left">(1.93)</td><td align="left">(2.53)</td><td align="left">(288.05)</td><td align="left">(0.43)</td><td align="left">(6.73)</td><td align="left">(983.24)</td><td align="left">(1.14)</td></tr><tr valign="top"><td rowspan="2" align="left">90</td><td align="left">0.004</td><td align="left">0.0040<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td align="left">0.1763</td><td align="left">0.0048</td><td align="left">0.0056</td><td align="left">0.5941</td><td align="left">0.00068</td></tr><tr valign="top"><td align="left">(6.80)</td><td align="left">(6.78)</td><td align="left">(299.73)</td><td align="left">(8.19)</td><td align="left">(9.44)</td><td align="left">(1009.99)</td><td align="left">(1.16)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Values given are [%ID/cc] while the values in parentheses are concentration of drug in μg/mL calculated assuming a 10 mg/kg dose and a 17 kg baboon.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Value taken from data collected at ∼80 min because the value at 90 min was a negative number.</p></div></div></div><div class="NLM_p">The tissue distribution of injected [<sup>11</sup>C]INH is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> where it is clear that INH and/or its radiolabeled metabolites rapidly penetrates the heart, lung, liver, and kidney. Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> gives the estimated concentration of INH in μg/mL at 15, 30, 60, and 90 min following iv administration based on the recommended dose of INH, the weight of the baboon, and assumption that the positron signal derives primarily from the intact drug. The calculated INH concentration is more than 10 times the MIC of this compound against MTB, and hence INH should be a suitable therapy for TB infection as recommended.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Barclay and co-workers have shown that the concentration of INH in a surgically removed normal human lung is 1.79 μg/g at about 3 h after iv administration of 108.7 mg INH using [<sup>14</sup>C]INH as the tracer.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In addition, Roth and co-workers have studied the distribution of INH in mice using [<sup>14</sup>C]INH injected sc and have shown similar drug distributions at 0.5 and 1 h compared to our baboon study assuming that 10 mg/kg drug is administered.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Other studies in mice with iv administration show drug concentrations in the liver, lung, and kidney that are several fold higher than the amounts estimated using PET imaging,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> while Roohi et al. used a technetium-99m derivative of INH to determine the drug biodistribution in Sprague−Dawley rats giving similar drug concentrations in heart and lung but more than 10-fold higher concentrations in the liver and kidney compared to the other studies.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Again, interspecies variation could play an important role in any differences observed between our study and those conducted in rodents, with the additional caveat that the study in rats involved the use of INH that had been modified with technetium-99m.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. TACs for [<sup>11</sup>C]INH in the heart, lungs, liver, and kidneys. Peripheral organ distribution following torso PET imaging of [<sup>11</sup>C]INH administered iv to anesthetized baboons. TACs were generated from the image acquired after iv administration of each drug in baboons by manually drawing the ROIs. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Distribution of [<sup>11</sup>C]INH Administered iv to Baboons<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="left">min after administration</th><th align="char">heart</th><th align="char">lung</th><th align="char">liver</th><th align="center">kidney cortex</th><th align="center">kidney medulla</th><th align="char">plasma</th></tr></thead><tbody><tr valign="top"><td rowspan="2" align="left">15</td><td align="left">0.0103</td><td align="left">0.0091</td><td align="left">0.0147</td><td align="left">0.0177</td><td align="left">0.0223</td><td align="left">0.00442</td></tr><tr valign="top"><td align="left">(8.72)</td><td align="left">(7.72)</td><td align="left">(12.50)</td><td align="left">(15.06)</td><td align="left">(18.94)</td><td align="left">(3.76)</td></tr><tr valign="top"><td rowspan="2" align="left">30</td><td align="left">0.0072</td><td align="left">0.0072</td><td align="left">0.0114</td><td align="left">0.0109</td><td align="left">0.0181</td><td align="left">0.00348</td></tr><tr valign="top"><td align="left">(6.13)</td><td align="left">(6.09)</td><td align="left">(9.71)</td><td align="left">(9.26)</td><td align="left">(15.43)</td><td align="left">(2.96)</td></tr><tr valign="top"><td rowspan="2" align="left">60</td><td align="left">0.0044</td><td align="left">0.0052</td><td align="left">0.0090</td><td align="left">0.0091</td><td align="left">0.0193</td><td align="left">0.00241</td></tr><tr valign="top"><td align="left">(3.74)</td><td align="left">(4.42)</td><td align="left">(7.64)</td><td align="left">(7.72)</td><td align="left">(16.37)</td><td align="left">(2.05)</td></tr><tr valign="top"><td rowspan="2" align="left">90</td><td align="left">0.0049</td><td align="left">0.0049</td><td align="left">0.0081</td><td align="left">0.0100</td><td align="left">0.0173</td><td align="left">0.0019</td></tr><tr valign="top"><td align="left">(4.15)</td><td align="left">(4.19)</td><td align="left">(6.91)</td><td align="left">(8.54)</td><td align="left">(14.69)</td><td align="left">(1.62)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values given are [%ID/cc] while the values in parentheses are concentration of drug in μg/mL calculated assuming a 5 mg/kg dose and 17 kg baboon.</p></div></div></div><div class="NLM_p">The tissue distribution of [<sup>11</sup>C]PZA administered iv is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. The concentration of PZA in μg/mL at 15, 30, 60, and 90 min has been estimated based on the weight of the baboon, the recommended dose of PZA, and the assumption that the positron signal derives primarily from the intact drug (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The calculated PZA concentration is 1−3 fold higher than the MIC of this compound against MTB. [<sup>11</sup>C]PZA and/or its radiolabeled metabolites rapidly penetrated the heart, lungs, liver, and kidneys, and in all cases the tissue concentration of PZA exceeded the concentration in serum with the exception of the kidney cortex. The calculated plasma concentration agreed closely with the published value determined in rabbits with iv administration,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> while the known plasma concentration in humans following oral administration of PZA is about twice that determined in our baboon study.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The organ distribution in rabbits has also been examined by dissection and gave a lower concentration of PZA in the lungs, kidneys, and liver compared to that determined in baboons.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Because the blood concentration is quite similar in the two studies, the difference in organ distribution could result from differences in drug permeability in the two species. The ability of PZA to cross the blood−brain barrier in rabbits is also quite different because PZA was not observed in the rabbit brain<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> in contrast to our studies and other literature reports.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The concentrations of PZA in baboons determined in the present work are broadly similar to the plasma concentration of PZA determined by MD and HPLC-MS in rats<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and in humans 1 h after oral administration of 27 mg/kg PZA.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. TACs for [<sup>11</sup>C]PZA in the heart, lungs, liver, and kidneys. Peripheral organ distribution following torso PET imaging of [<sup>11</sup>C]PZA administered iv to anesthetized baboons. TACs were generated from the image acquired after iv administration of each drug in baboons by manually drawing the ROIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Distribution of [<sup>11</sup>C]PZA Administered iv to Baboons<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="left">min after administration</th><th align="left">heart</th><th align="left">lung</th><th align="left">liver</th><th align="left">kidney cortex</th><th align="left">kidney medulla</th><th align="left">plasma</th></tr></thead><tbody><tr valign="top"><td rowspan="2" align="left">15</td><td align="left">0.0199</td><td align="left">0.0103</td><td align="left">0.0106</td><td align="left">0.0060</td><td align="left">0.1815</td><td align="left">0.00648</td></tr><tr valign="top"><td align="left">(67.76)</td><td align="left">(35.03)</td><td align="left">(36.14)</td><td align="left">(20.52)</td><td align="left">(617.02)</td><td align="left">(22.03)</td></tr><tr valign="top"><td rowspan="2" align="left">30</td><td align="left">0.0181</td><td align="left">0.0078</td><td align="left">0.0079</td><td align="left">0.0049</td><td align="left">0.1395</td><td align="left">0.00429</td></tr><tr valign="top"><td align="left">(61.50)</td><td align="left">(26.48)</td><td align="left">(26.96)</td><td align="left">(16.59)</td><td align="left">(474.39)</td><td align="left">(14.59)</td></tr><tr valign="top"><td rowspan="2" align="left">60</td><td align="left">0.0169</td><td align="left">0.0065</td><td align="left">0.0065</td><td align="left">0.0037</td><td align="left">0.1009</td><td align="left">0.00331</td></tr><tr valign="top"><td align="left">(57.59)</td><td align="left">(22.17)</td><td align="left">(21.98)</td><td align="left">(12.55)</td><td align="left">(343.00)</td><td align="left">(11.25)</td></tr><tr valign="top"><td rowspan="2" align="left">90</td><td align="left">0.0175</td><td align="left">0.0055</td><td align="left">0.0056</td><td align="left">0.0029</td><td align="left">0.0675</td><td align="left">0.00266</td></tr><tr valign="top"><td align="left">(59.49)</td><td align="left">(18.58)</td><td align="left">(19.19)</td><td align="left">(9.93)</td><td align="left">(229.44)</td><td align="left">(9.04)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Values given are [%ID/cc] while the values in parentheses are concentration of drug in μg/mL calculated assuming a 20 mg/kg dose and a 17 kg baboon.</p></div></div></div><div class="NLM_p last">The imaging experiments reported in the present work were conducted using drug administered iv and represent the fate of the drugs once they reach the blood. This is an important point given that the normal route of administration for INH, PZA, and RIF is po. In addition, only micro doses of drugs were used, and we are aware that drug distribution can change as a function of administered dose if one or more processes that affect distribution become saturated. However, on the basis of the mechanism of action of these drugs together with our experience from other drug PK studies, we believe that saturable processes are likely to play only a minor role in modulating distribution. These studies, which were conducted using healthy baboons, thus clearly highlight the utility of using PET imaging to determine drug PK parameters and drug biodistribution noninvasively in vivo and are a prelude to imaging experiments in infected animals and humans. Ultimately, this approach should be useful for determining better TB treatment regimes, especially for disseminated forms of the disease such as CNS TB where assessing drug availability at the site of infection may be difficult. It is also hypothesized that these labeled drugs may be eventually useful for determining the location of bacterial populations in vivo because these drugs are expected to accumulate within the bacteria either by conversion to metabolites that are unable to rapidly leave the cell or by binding with long residence times to their drug targets. Both PZA and INH are prodrugs for which activating enzymes are present in the mycobacterium,<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> while the INH-NAD adduct, which is the active form of INH, has a residence time of 60 min on the MTB enoyl-ACP reductase InhA.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In addition, RIF is also thought to have a significant residence time on the mycobacterial RNA polymerase based on studies with the <i>Escherichia coli</i> homologue which provided a residence time of ∼17 min.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Importantly, the rapid clearance of all drugs and/or their radiolabeled metabolites from the lungs provides a clear window for imaging populations of TB bacteria because this is the primary site of TB infection.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27826" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27826" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The front-line TB chemotherapeutics INH, RIF, and PZA have been labeled with carbon-11 and the biodistribution of the labeled drugs has been imaged in baboons in vivo. These PET imaging studies provide an opportunity to review the bioavailability of known drugs both in the brain and peripheral organs, which could potentially improve their use and help to determine the effective dose because these methods can be easily translated to healthy volunteers and patients. Radiosynthesis and formulation of each drug has been accomplished in 1 h, using [<sup>11</sup>C]CH<sub>3</sub>I to label RIF and [<sup>11</sup>C]HCN to label INH and PZA. Following iv administration, the labeled drugs have been imaged in baboons using PET. INH, PZA, RIF, and/or their radiolabeled metabolites clear rapidly from many tissues, however INH, PZA and/or their radiolabeled metabolites accumulate in the bladder while RIF and/or its radiolabeled metabolites accumulate in the liver and gall bladder, consistent with the routes of excretion of the drugs. In addition, estimates based on the weight of the baboon, a standard drug dose, and the assumption that the positron signal derives primarily from the intact drug indicates that the concentrations of RIF, INH, and PZA in the lungs are at least 10, 10, and 1−3 times higher, respectively, than the MIC values for these drugs against MTB. Furthermore, we find that the ability of the drugs and their radiolabeled metabolites to penetrate the blood−brain barrier decreases in the order PZA > INH > RIF. Estimates of drug concentrations in the brain using the same assumptions outlined above suggest that the concentrations of RIF and INH are 3−4 and >10 times higher than their MIC values, respectively, while PZA is similar to or slightly higher than the MIC. The PK and drug distribution data have important implications for treatment of disseminated TB in the brain and set the scene for imaging the distribution of the pathogen in vivo.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64566" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64566" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General</h3><div class="NLM_p">[<sup>11</sup>C]CH<sub>3</sub>I was generated from [<sup>11</sup>C]CO<sub>2</sub> using a PETtrace MeI Microlab (GE Medical System, Milwaukee, WI,). Briefly, [<sup>11</sup>C]CO<sub>2</sub> was obtained from proton bombardment of a N<sub>2</sub>/O<sub>2</sub> target (<sup>14</sup>N(<i>p</i>,α)<sup>11</sup>C) using an EBCO TR 19 cyclotron (Advanced Cyclotron System Inc., Richmond, Canada). [<sup>11</sup>C]CO<sub>2</sub> was heated with H<sub>2</sub> on nickel to produce [<sup>11</sup>C]CH<sub>4</sub>, and the latter was converted to [<sup>11</sup>C]CH<sub>3</sub>I by iodination, which was released into a stream of argon.</div><div class="NLM_p">[<sup>11</sup>C]HCN was generated from [<sup>11</sup>C]CO<sub>2</sub> using a homemade unit. Briefly, [<sup>11</sup>C]CO<sub>2</sub> was obtained and converted to [<sup>11</sup>C]CH<sub>4</sub> using the same conditions as those used for [<sup>11</sup>C]CH<sub>3</sub>I production. Reaction of [<sup>11</sup>C]CH<sub>4</sub> and NH<sub>3</sub> catalyzed by platinum produced [<sup>11</sup>C]HCN, which was carried by a stream of argon.</div><div class="NLM_p last">Chemical and radiochemical purity was determined by an analytical HPLC system equipped with both UV and radioactivity detectors. The purities of the intermediate and final products were >95%, and the specific solvent gradients used for each compound are given below.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis of Demethyl RIF(<b>1</b>) (RIF Precursor)</h3><div class="NLM_p">1-Nitrosopiperazine.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Piperazine 0.86 g (10 mmol) in 6N HCl (6 mL) was cooled to −10 °C and a solution of NaNO<sub>2</sub> (0.69 g, 10 mmol) in H<sub>2</sub>O (12 mL) was added slowly over 1 h. At a temperature below 0 °C, the pH was adjusted to 10 using NaOH, and then the mixture was extracted using chloroform, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent removed by evaporation. The crude product was purified by column chromatography using silica gel and 8% MeOH/CH<sub>2</sub>Cl<sub>2</sub> as the mobile phase. The product was a yellow oil, and the yield was 72%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 4.15−4.18 (m, 2H), 3.74−3.77 (m, 2H), 3.00−3.03 (m, 2H), 2.75−2.79 (m, 2H), 1.83 (s, 1H). ESI-MS calcd for [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 116, found 116.</div><div class="NLM_p last">Demethyl RIF (<b>1</b>).<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> 1-Nitrosopiperazine 230 mg (2 mmol) was dissolved in 2 mL of THF and was then added slowly to a suspension of LiAlH<sub>4</sub> (216 mg, 6 mmol) in 10 mL of THF under N<sub>2</sub> at 0 °C. The mixture was stirred for 5 min and then heated to reflux for 3 h. The cooled reaction mixture was quenched by MeOH until no further gas evolved, concentrated in vacuo, and filtered. The resulting filter cake was washed with MeOH, and the combined filtrate was evaporated to dryness, yielding crude 1-aminopiperazine as a solid. <i>p</i>-Toluenesulfonic acid (5 mg), 10 mL of dry THF, and 140 mg of 3-formyl-rifamycin (0.2 mmol) were then added with molecular sieves to the crude 1-aminopiperazine. The reaction mixture was stirred at room temperature overnight, filtered, and concentrated in vacuo. The crude product was purified by column chromatography with silica gel using 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub> as the mobile phase. The product was a red solid and the yield was 78%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ: 13.15 (s, 1H), 12.01 (s, 1H), 8.30 (s, 1H), 6.57 (dd, <i>J</i> = 15.6, 11.4 Hz, 1H), 6.38 (d, <i>J</i> = 11.4 Hz, 1H), 6.20 (d, <i>J</i> = 12.6 Hz, 1H), 5.93 (dd, <i>J</i> = 15.6 Hz, 4.8 1H), 5.10 (dd, <i>J</i> = 12.6, 6.6 Hz, 1H), 4.94 (d, <i>J</i> = 10.8 Hz, 1H), 3.77 (d, <i>J</i> = 9.0 Hz, 1H), 3.47 (d, <i>J</i> = 6.6 Hz, 1H), 3.11−3.14 (m, 2H), 3.05−3.06 (m, 2H), 3.04 (s, 3H), 3.01−3.03 (m, 2H), 2.97−3.01 (m, 2H), 2.97−3.06 (m, 1H), 2.33−2.41 (m, 1H), 2.22 (s, 3H), 2.08 (s, 3H), 2.06 (s, 3H), 1.79 (s, 3H), 1.69−1.72 (m, 1H), 1.51−1.56 (m, 1H), 1.33−1.38 (m, 1H), 1.01 (d, <i>J</i> = 7.2 Hz, 3H), 0.88 (d, <i>J</i> = 7.2 Hz, 3H), 0.60 (d, <i>J</i> = 6.6 Hz, 3H), −0.30 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 195.12, 174.32, 171.91, 169.50, 169.36, 147.85, 142.60, 142.54, 138.68, 135.02, 134.19, 129.31, 123.18, 120.29, 118.50, 117.87, 112.89, 110.85, 108.74, 106.04, 104.44, 94.39, 77.20, 76.87, 76.77, 74.41, 70.62, 57.09, 53.43, 51.48, 44.82, 39.56, 38.59, 37.55, 33.43, 21.55, 20.80, 17.83, 10.96, 9.02, 8.57, 7.65. ESI-MS calcd for [M + H]<sup>+</sup><i>m</i>/<i>z</i> = 809, found 809. Chemical purity was determined by reverse-phase analytical HPLC using a Phenomenex, Luna C-18, 250 × 4.6, 5 μm column operated at 1 mL/min flow rate using a mobile phase of 32% MeCN/68% H<sub>2</sub>O.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Radiosynthesis of [<sup>11</sup>C]RIF</h3><div class="NLM_p last">The synthesis of [<sup>11</sup>C]RIF was performed using <b>1</b> as precursor. A solution of precursor (1.0 mg, 1.2 μmol) was dissolved in 0.1 mL of MeCN and 0.2 mL of DMSO with 0.2 mg of K<sub>2</sub>CO<sub>3</sub>. After [<sup>11</sup>C]CH<sub>3</sub>I was purged into the solution and trapped, the reaction vessel was sealed and heated at 110 °C for 10 min in an oil bath. The reaction mixture was diluted with 1 mL of aqueous ammonium formate (0.1M) prior to loading onto a semipreparative HPLC column. HPLC purification was performed using a reverse phase C-18 column (Phenomenex, Luna C-18 250 × 10, 5 μm), at a 5 mL/min flow rate with a mobile phase consisting of 35% MeCN/65% aqueous ammonium formate (0.1 M). The product was collected at the expected retention time (17 min), mixed with 100 mg ascorbic acid, and the solvent was removed by rotary evaporation. After dilution with 4 mL of saline, the solution was filtered through an Acrodisc 13 mm syringe filter equipped with a 0.2 μm Supor membrane (Pall Corporation, Ann Arbor, MI) into a sterile vial. Radiochemical purity was determined by reverse-phase analytical HPLC using a Phenomenex, Luna C-18, 250 × 4.6, 5 μm column operated at 1 mL/min flow rate using a mobile phase of 35% MeCN/65% 0.1 M aqueous ammonium formate. Subsequently, purity was verified using TLC (15% MeOH/85% CH<sub>2</sub>Cl<sub>2</sub>) by cospotting the labeled product with a standard.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Radiosynthesis of [<sup>11</sup>C]INH</h3><div class="NLM_p">The synthesis of [<sup>11</sup>C]INH was performed using <b>2</b> as the precursor. The precursor (1.0 mg), K<sub>222</sub> (0.2 mg), and tetrakis(triphenylphosphine)palladium(0) (2.0 mg) was placed in a vial with 0.2 mL of DMSO and heated until all the solid dissolved. This solution was then added to [<sup>11</sup>C]HCN that had been trapped in 0.1 mL of DMSO, and the reaction mixture was sealed and heated at 135 °C for 5 min. Water (0.3 mL), hydrazine monohydrate (0.3 mL), and NaY zeolite (20 mg) were then added, and after heating for 5 min at 135 °C, acetic acid (0.1 mL) was added. Following an additional 5 min at 135 °C, the reaction mixture was filtered through celite and the reaction vessel was washed with 0.5 mL of water prior to injection onto the semipreparative HPLC column. HPLC purification was performed using a reverse phase PFP column (Phenomenex, Luna PFP(2) 250 × 10, 5 μm) at a 5 mL/min flow rate with a gradient elution: 0−5 min, 100% water; 5−20 min from 100% water to 20% MeCN/80% water. The product was collected at the expected retention time (12 min), and the solvent together with the majority of hydrazine that coeluted was removed by ∼10 min rotary evaporation. After dilution with 4 mL of saline, the solution was filtered through an Acrodisc 13 mm syringe filter equipped with a 0.2 μm Supor membrane into a sterile vial for delivery. Radiochemical purity was determined by reverse-phase analytical HPLC using a Phenomenex, Luna PFP, 250 × 4.6, 5 μm column operated at 1 mL/min with a gradient of 0−20% MeCN in water over 20 min. Subsequently, purity was verified using TLC (25% MeOH/75% CH<sub>2</sub>Cl<sub>2</sub>) by cospotting the labeled product with a standard.</div><div class="NLM_p last">Quantification of hydrazine in the final formulated solution was determined by modification of a published procedure.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Briefly, an aliquot (20 μL) of [<sup>11</sup>C]INH in saline was added to a test tube containing 20 μL of H<sub>2</sub>SO<sub>4</sub> solution (0.1 M) and 20 μL of benzaldehyde in methanol (1 mL benzaldehyde/100 mL methanol). Then 40 μL of sodium borate solution (0.01 M) and 20 μL of methanol was added to the reaction mixture, and 25 μL of this new solution was analyzed using HPLC. The concentration of hydrazine was calculated based on the UV absorption at 313 nm of the hydrazone and by using a standard curve. A blank sample (INH standard without hydrazine) was also analyzed which confirmed that INH did not interfere with the detection of hydrazine.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Radiosynthesis of [<sup>11</sup>C]PZA</h3><div class="NLM_p last">The synthesis of [<sup>11</sup>C]PZA was performed using <b>5</b> as the precursor. The precursor (1.0 mg), K<sub>222</sub> (0.2 mg), and tetrakis (triphenylphosphine)palladium(0) (2.0 mg) were placed in a vial with 0.2 mL of DMSO and heated until all the solid dissolved. This solution was then added to [<sup>11</sup>C]HCN that had been trapped in 0.1 mL of DMSO, and the reaction mixture was sealed and heated at 135 °C for 5 min. K<sub>2</sub>CO<sub>3</sub> (0.2 mL, 0.1 M) and H<sub>2</sub>O<sub>2</sub> (0.1 mL, 30%) were then added, and after heating for 5 min at 135 °C, the reaction mixture was diluted with 0.3 mL of ammonium formate (0.025 M, 5% acetic acid) and filtered through celite. The reaction vessel was washed with 0.5 mL of ammonium formate solution prior to injection onto the semipreparative HPLC column. HPLC purification was performed using a reverse phase PFP column (Phenomenex, Luna PFP(2) 250 × 10, 5 μm) at a 5 mL/min flow rate with a mobile phase consisting of 2% MeCN/98% ammonium formate (0.025M, 5% acetic acid). The product was collected at the expected retention time (7 min), and the solvent was removed by rotary evaporation. After dilution with 4 mL of saline, the solution was filtered through an Acrodisc 13 mm syringe filter equipped with a 0.2 μm Supor membrane into a sterile vial for delivery. Radiochemical purity was determined by reverse-phase analytical HPLC using a Phenomenex, Luna PFP, 250 × 4.6, 5 μm column operated at 1 mL/min with 3% MeCN/97% 0.025 M aqueous ammonium formate as the mobile phase. Subsequently, purity was verified using TLC (25% MeOH/75% CH<sub>2</sub>Cl<sub>2</sub>) by cospotting the labeled product with a standard.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> PET Imaging and Data Processing</h3><div class="NLM_p">Four baboons were included in this study, and all animal experiments were approved by the Brookhaven Institutional Animal Care and Use Committee. Ketamine hydrochloride (10 mg/kg) was administered intramuscularly as an anesthetic agent, and anesthesia was further maintained with oxygen (800 mL/min), nitrous oxide (1500 mL/min), and isoflurane (Forane, 1−4%) during scanning. Two catheters were placed in a radial arm vein and the popliteal artery for [<sup>11</sup>C]-labeled drug injection and arterial sampling, respectively. Following [<sup>11</sup>C]-labeled drug injection, arterial blood was collected every 5 s for 2 min, then 2, 5, 10, 20, 30, 45, 60, and 90 min post injection. During the PET scanning, heart rate, respiration rate, body temperature, and pO<sub>2</sub> were monitored. A Siemens HR+ (Siemens high-resolution, whole-body PET scanner with 4.5 mm × 4.5 mm × 4.8 mm resolution at the center of field of view) was used to perform the dynamic PET scans for a total of 90 min with the following time frames in 3D mode: 1 × 10, 12 × 5, 1 × 20, 1 × 30, 8 × 60, 4 × 300, 8 × 450 s. Correction of attenuation was obtained by a transmission scan of a <sup>68</sup>Ge rod source prior to each PET scan. Six baboon studies were conducted with average injected doses for RIF, INH, and PZA of 1.54, 4.38, and 5.17 mCi, respectively. Images were reconstructed by filtered back projection (FBP) and analyzed using AMIDE software.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p last">A test tube containing 2.5 mL of octanol and 2.5 mL of phosphate buffer solution (pH 7.4) was mixed with ∼50 μL aliquot of formulated [<sup>11</sup>C]-labeled drug, vortexed for 2 min and then centrifuged for 2 min to ensure full separation of the aqueous and organic phases. Aliquots from the octanol layer (0.1 mL) and aqueous layer (1 mL) were removed for radioactive counting, while a separate 2 mL aliquot of the octanol layer was carefully transferred to a new test tube containing 0.5 mL of octanol and 2.5 mL of phosphate buffer (pH 7.4). The octanol phosphate mixture was vortexed and centrifuged, after which a second set of aliquots were obtained. This process was repeated until a total of six sets of samples had been generated. A well counter (Picker, Cleveland, OH) was then used to measure the radioactivity of each sample, and the logD values were calculated using the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/jm-2009-01858n_m001.gif" alt="" /></img></span></div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> PPB Determination</h3><div class="NLM_p last">A 10 μL aliquot of the formulated [<sup>11</sup>C]-labeled drug was mixed with a sample of baboon plasma (0.8 mL, collected from at least four different baboons and pooled) by gently inverting several times. The mixture was incubated for 10 min at room temperature, and then a 20 μL aliquot was taken to determine the total radioactivity in the plasma sample (<i>A</i><sub>T</sub>; <i>A</i><sub>T</sub> = <i>A</i><sub>bound</sub> + <i>A</i><sub>unbound</sub>). An additional 0.2 mL aliquot of plasma was placed in the upper level of a centrifree tube (Amicon, Inc., Beverly, MA), and then the tube was centrifuged for 10 min. After discarding the upper part of the Centrifree tube, a 20 μL aliquot from the bottom part of the tube was taken to determine the amount of radioactivity that passed through the membrane (<i>A</i><sub>unbound</sub>). PPB was calculated by the following equation: % unbound = <i>A</i><sub>unbound</sub> × 100/<i>A</i><sub>T</sub>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Metabolite Analysis</h3><div class="NLM_p last">Several aliquots (∼0.2 mL each) of baboon plasma were collected at various time points during the PET study. Each sample was counted and added to a solution of unlabeled standard (20 μL of a 1 mg/mL solution) in MeCN (0.3 mL). The resulting solution was vortexed and centrifuged, and the supernatant was collected. After mixing with 0.3 mL water, the supernatant was analyzed by HPLC using the following conditions: RIF, Waters μbondapak C-18 3.9 mm × 300 mm column with eluent 70% MeCN/30% 0.1 M aqueous ammonium formate at 1.0 mL/min using UV (254 nm) and radiodetection; INH, Phenomenex spherisorb ODS(2) 4.6 mm × 300 mm, 5 μm column with eluent 2% MeCN/98% 0.02 M aqueous heptane sulfonic acid at 1.0 mL/min using UV (254 nm) and radiodetection; PZA, Phenomenex spherisorb ODS(2) 4.6 mm × 300 mm, 5 μm column with eluent 10% MeCN/90% 0.01 M aqueous potassium phosphate (pH 5.2) at 1.7 mL/min using UV (254 nm) and radiodetection. The percent of unmetabolized radiotracer was determined as the ratio between the fraction of radioactivity coeluting with the unlabeled standard and the total radioactivity from the HPLC column.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob M. Hooker</span> - <span class="hlFld-Affiliation affiliation">Medical Department, Brookhaven National Laboratory, Upton, New York 11973-5000</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1c6c7968796e326873727b795c6f6972656f7e327978693c74737377796e5c72716e32717b7432747d6e6a7d6e7832797869"><span class="__cf_email__" data-cfemail="0575607160772b716a6b62604576706b7c76672b606170">[email protected]</span> <span class="__cf_email__" data-cfemail="28404747434d5a6846455a06454f400640495a5e495a4c064d4c5d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Tonge</span> - <span class="hlFld-Affiliation affiliation">Institute for Chemical Biology & Drug Discovery, Department of Chemistry, Stony Brook University, Stony Brook, New York 11794-3400</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f28297869780dc869d9c9597b281879c8b8190dc979687d29a9d9d999780b29c9f80dc9f959adc9a938084938096dc979687"><span class="__cf_email__" data-cfemail="d1a1b4a5b4a3ffa5bebfb6b491a2a4bfa8a2b3ffb4b5a4">[email protected]</span> <span class="__cf_email__" data-cfemail="bbd3d4d4d0dec9fbd5d6c995d6dcd395d3dac9cddac9df95dedfce">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Liu</span> - <span class="hlFld-Affiliation affiliation">Institute for Chemical Biology & Drug Discovery, Department of Chemistry, Stony Brook University, Stony Brook, New York 11794-3400</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youwen Xu</span> - <span class="hlFld-Affiliation affiliation">Medical Department, Brookhaven National Laboratory, Upton, New York 11973-5000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colleen Shea</span> - <span class="hlFld-Affiliation affiliation">Medical Department, Brookhaven National Laboratory, Upton, New York 11973-5000</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanna S. Fowler</span> - <span class="hlFld-Affiliation affiliation">Medical Department, Brookhaven National Laboratory, Upton, New York 11973-5000</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm901858n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by NIH grant AI084189 to P.J.T. In addition, the work at  Brookhaven National Laboratory was performed under contract DE-AC02-98CH10886 with the U.S. Department of Energy, and with infrastructure support from its Office of Biological and Environmental Research. We are grateful to Dr. Michael Schueller for cyclotron operation, David Alexoff for technical assistance with data processing, and the PET radiotracer and imaging team at BNL (Lisa Muench, Pauline Carter, Payton King, and Don Warner) for carrying out primate imaging experiments.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Muller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dela Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derendorf, H.</span><span> </span><span class="NLM_article-title">Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1441</span><span class="NLM_x">–</span> <span class="NLM_lpage">1453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1441-1453&author=M.+Mullerauthor=A.+dela+Penaauthor=H.+Derendorf&title=Issues+in+pharmacokinetics+and+pharmacodynamics+of+anti-infective+agents%3A+distribution+in+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DM.%26aulast%3Ddela%2BPena%26aufirst%3DA.%26aulast%3DDerendorf%26aufirst%3DH.%26atitle%3DIssues%2520in%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520anti-infective%2520agents%253A%2520distribution%2520in%2520tissue%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1441%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Langer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M.</span><span> </span><span class="NLM_article-title">Methods to assess tissue-specific distribution and metabolism of drugs</span> <span class="citation_source-journal">Curr. Drug. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.2174%2F1389200043335379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=15578942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWhurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=463-481&author=O.+Langerauthor=M.+Muller&title=Methods+to+assess+tissue-specific+distribution+and+metabolism+of+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Methods to assess tissue-specific distribution and metabolism of drugs</span></div><div class="casAuthors">Langer, Oliver; Mueller, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">463-481</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Most drugs exert their effects not within the blood plasma compartment, but in defined target tissues into which drugs have to distribute from the central compartment.  Unfortunately, a complete and lasting equilibration between blood and tissue cannot always be taken for granted.  Drug distribution processes may be characterized by a high intertissue- and intersubject variability and target site drug levels may substantially differ from corresponding plasma levels.  Suboptimal target site concns. may have important clin. implications, as it is a potential explanation for therapeutic failures.  Therefore, detn. of drug tissue penetration plays an important role in clin. drug development.  In recent years, the assessment of tissue concns. after administration of very low, sub-pharmacol. drug amts. (microdosing) has attracted major interest in early clin. drug development, which calls for the availability of highly sensitive anal. methods.  The present article will review the most important techniques that are currently available for studying drug disposition in humans.  These can be classified as semi-invasive (microdialysis, MD) and non-invasive (positron emission tomog., PET, and magnetic resonance spectroscopy, MRS).  The authors will discuss individual strengths and shortcomings of each method and provide some recent examples with particular focus on antiinfective and anticancer drugs.  Whereas MD and MRS also lend themselves to the assessment of tissue-specific drug metab., PET usually does not provide metabolic information.  For some drugs, such as the anticancer agents 5-fluorouracil and capecitabine, measurement of drug metabolites is particularly important as these represent the therapeutically active species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn1J5qD2c-IbVg90H21EOLACvtfcHk0li2WiQVKojM3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWhurnK&md5=ba1643d5a090ba7ecd0a7947c856cb82</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F1389200043335379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200043335379%26sid%3Dliteratum%253Aachs%26aulast%3DLanger%26aufirst%3DO.%26aulast%3DMuller%26aufirst%3DM.%26atitle%3DMethods%2520to%2520assess%2520tissue-specific%2520distribution%2520and%2520metabolism%2520of%2520drugs%26jtitle%3DCurr.%2520Drug.%2520Metab.%26date%3D2004%26volume%3D5%26spage%3D463%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Fischman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alpert, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, R. H.</span><span> </span><span class="NLM_article-title">The role of positron emission tomography in pharmacokinetic analysis</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">956</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.3109%2F03602539709002238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=9421680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK1cXhtlGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1997&pages=923-956&author=A.+J.+Fischmanauthor=N.+M.+Alpertauthor=J.+W.+Babichauthor=R.+H.+Rubin&title=The+role+of+positron+emission+tomography+in+pharmacokinetic+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of positron emission tomography in pharmacokinetic analysis</span></div><div class="casAuthors">Fischman, Alan J.; Alpert, Nathaniel M.; Babich, John W.; Rubin, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">923-956</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review with 77 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk-4bEzSDZH7Vg90H21EOLACvtfcHk0lh9bepAsNQQyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtlGkug%253D%253D&md5=275fffcf5e05b5c6e46d0bc84499c31e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3109%2F03602539709002238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602539709002238%26sid%3Dliteratum%253Aachs%26aulast%3DFischman%26aufirst%3DA.%2BJ.%26aulast%3DAlpert%26aufirst%3DN.%2BM.%26aulast%3DBabich%26aufirst%3DJ.%2BW.%26aulast%3DRubin%26aufirst%3DR.%2BH.%26atitle%3DThe%2520role%2520of%2520positron%2520emission%2520tomography%2520in%2520pharmacokinetic%2520analysis%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D1997%26volume%3D29%26spage%3D923%26epage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bloom, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. J.</span><span> </span><span class="NLM_article-title">Tuberculosis: commentary on a reemergent killer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1992&pages=1055-1064&author=B.+R.+Bloomauthor=C.+J.+Murray&title=Tuberculosis%3A+commentary+on+a+reemergent+killer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBloom%26aufirst%3DB.%2BR.%26aulast%3DMurray%26aufirst%3DC.%2BJ.%26atitle%3DTuberculosis%253A%2520commentary%2520on%2520a%2520reemergent%2520killer%26jtitle%3DScience%26date%3D1992%26volume%3D257%26spage%3D1055%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kochi, A.</span><span> </span><span class="NLM_article-title">The global tuberculosis situation and the new control strategy of the World Health Organization</span> <span class="citation_source-journal">Tubercle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1016%2F0041-3879%2891%2990017-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=1882440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADyaK3Mzlt1ylsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1991&pages=1-6&author=A.+Kochi&title=The+global+tuberculosis+situation+and+the+new+control+strategy+of+the+World+Health+Organization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The global tuberculosis situation and the new control strategy of the World Health Organization</span></div><div class="casAuthors">Kochi A</div><div class="citationInfo"><span class="NLM_cas:title">Tubercle</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>
        ISSN:<span class="NLM_cas:issn">0041-3879</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQA5m2VZZuC4VvAgqb2vdc5fW6udTcc2eaVqlfOtw8J97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3Mzlt1ylsA%253D%253D&md5=664a0be98ad235e8898256d65b8f788a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0041-3879%2891%2990017-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0041-3879%252891%252990017-M%26sid%3Dliteratum%253Aachs%26aulast%3DKochi%26aufirst%3DA.%26atitle%3DThe%2520global%2520tuberculosis%2520situation%2520and%2520the%2520new%2520control%2520strategy%2520of%2520the%2520World%2520Health%2520Organization%26jtitle%3DTubercle%26date%3D1991%26volume%3D72%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rattan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, N.</span><span> </span><span class="NLM_article-title">Multidrug-resistant <i>Mycobacterium tuberculosis</i>: molecular perspectives</span> <span class="citation_source-journal">Emerg. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.3201%2Feid0402.980207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=9621190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK1cXjvVemt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=195-209&author=A.+Rattanauthor=A.+Kaliaauthor=N.+Ahmad&title=Multidrug-resistant+Mycobacterium+tuberculosis%3A+molecular+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives</span></div><div class="casAuthors">Rattan, Ashok; Kalia, Awdhesh; Ahmad, Nishat</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Infectious Diseases</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-209</span>CODEN:
                <span class="NLM_cas:coden">EIDIFA</span>;
        ISSN:<span class="NLM_cas:issn">1080-6040</span>.
    
            (<span class="NLM_cas:orgname">National Center for Infectious Diseases, Centers for Disease Control and Prevention</span>)
        </div><div class="casAbstract">A review with 121 refs.  Multidrug-resistant strains of Mycobacterium tuberculosis seriously threaten tuberculosis (TB) control and prevention efforts.  Mol. studies of the mechanism of action of antitubercular drugs have elucidated the genetic basis of drug resistance in M. tuberculosis.  Drug resistance in M. tuberculosis is attributed primarily to the accumulation of mutations in the drug target genes; these mutations lead either to an altered target (e.g., RNA polymerase and catalase-peroxidase in rifampicin and isoniazid resistance, resp.) or to a change in titrn. of the drug (e.g., InhA in isoniazid resistance).  Development of specific mechanism-based inhibitors and techniques to rapidly detect multidrug resistance will require further studies addressing the drug and drug-target interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0AqTkDe_vyLVg90H21EOLACvtfcHk0lh9bepAsNQQyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvVemt7s%253D&md5=9f849fcf4a974028f9b8286a3bb98616</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3201%2Feid0402.980207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid0402.980207%26sid%3Dliteratum%253Aachs%26aulast%3DRattan%26aufirst%3DA.%26aulast%3DKalia%26aufirst%3DA.%26aulast%3DAhmad%26aufirst%3DN.%26atitle%3DMultidrug-resistant%2520Mycobacterium%2520tuberculosis%253A%2520molecular%2520perspectives%26jtitle%3DEmerg.%2520Infect.%2520Dis.%26date%3D1998%26volume%3D4%26spage%3D195%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Bass, J. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farer, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopewell, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruben, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snider, D. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, G.</span><span> </span><span class="NLM_article-title">Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8173779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADyaK2c3ivVSrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=1994&pages=1359-1374&author=J.+B.+Bassauthor=L.+S.+Farerauthor=P.+C.+Hopewellauthor=R.+O%27Brienauthor=R.+F.+Jacobsauthor=F.+Rubenauthor=D.+E.+Sniderauthor=G.+Thornton&title=Treatment+of+tuberculosis+and+tuberculosis+infection+in+adults+and+children.+American+Thoracic+Society+and+The+Centers+for+Disease+Control+and+Prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention</span></div><div class="casAuthors">Bass J B Jr; Farer L S; Hopewell P C; O'Brien R; Jacobs R F; Ruben F; Snider D E Jr; Thornton G</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1359-74</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Treatment of Tuberculosis. 1.  A 6-mo regimen consisting of isoniazid, rifampin, and pyrazinamide given for 2 mo followed by isoniazid and rifampin for 4 mo is the preferred treatment for patients with fully susceptible organisms who adhere to treatment.  Ethambutol (or streptomycin in children too young to be monitored for visual acuity) should be included in the initial regimen until the results of drug susceptibility studies are available, unless there is little possibility of drug resistance (i.e., there is less than 4% primary resistance to isoniazid in the community, and the patient has had no previous treatment with antituberculosis medications, is not from a country with a high prevalence of drug resistance, and has no known exposure to a drug-resistant case).  This four-drug, 6-mo regimen is effective even when the infecting organism is resistant to INH.  This recommendation applies to both HIV-infected and uninfected persons.  However, in the presence of HIV infection it is critically important to assess the clinical and bacteriologic response.  If there is evidence of a slow or suboptimal response, therapy should be prolonged as judged on a case by case basis. 2.  Alternatively, a 9-mo regimen of isoniazid and rifampin is acceptable for persons who cannot or should not take pyrazinamide.  Ethambutol (or streptomycin in children too young to be monitored for visual acuity) should also be included until the results of drug susceptibility studies are available, unless there is little possibility of drug resistance (see Section 1 above).  If INH resistance is demonstrated, rifampin and ethambutol should be continued for a minimum of 12 mo. 3.  Consideration should be given to treating all patients with directly observed therapy (DOT). 4.  Multiple-drug-resistant tuberculosis (i.e., resistance to at least isoniazid and rifampin) presents difficult treatment problems.  Treatment must be individualized and based on susceptibility studies.  In such cases, consultation with an expert in tuberculosis is recommended. 5.  Children should be managed in essentially the same ways as adults using appropriately adjusted doses of the drugs.  This document addresses specific important differences between the management of adults and children. 6.  Extrapulmonary tuberculosis should be managed according to the principles and with the drug regimens outlined for pulmonary tuberculosis, except for children who have miliary tuberculosis, bone/joint tuberculosis, or tuberculous meningitis who should receive a minimum of 12 mo of therapy.(ABSTRACT TRUNCATED AT 400 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0l93nkFZ-q1Zoq0fPSOTvfW6udTcc2eY-guRaNqPKTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3ivVSrsQ%253D%253D&md5=087f7c9125678f52f8d2d83d09c34fd4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBass%26aufirst%3DJ.%2BB.%26aulast%3DFarer%26aufirst%3DL.%2BS.%26aulast%3DHopewell%26aufirst%3DP.%2BC.%26aulast%3DO%2527Brien%26aufirst%3DR.%26aulast%3DJacobs%26aufirst%3DR.%2BF.%26aulast%3DRuben%26aufirst%3DF.%26aulast%3DSnider%26aufirst%3DD.%2BE.%26aulast%3DThornton%26aufirst%3DG.%26atitle%3DTreatment%2520of%2520tuberculosis%2520and%2520tuberculosis%2520infection%2520in%2520adults%2520and%2520children.%2520American%2520Thoracic%2520Society%2520and%2520The%2520Centers%2520for%2520Disease%2520Control%2520and%2520Prevention%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D1994%26volume%3D149%26spage%3D1359%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">American Thoracic Society</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Medical Section of the American Lung Association: Treatment of tuberculosis and tuberculosis infection in adults and children</span>.  <span class="citation_source-journal">Am. Rev. Respir. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span>− <span class="NLM_lpage">363</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=3527010" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1986&pages=355-363&author=American+Thoracic+Society&title=Medical+Section+of+the+American+Lung+Association%3A+Treatment+of+tuberculosis+and+tuberculosis+infection+in+adults+and+children"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DMedical%2520Section%2520of%2520the%2520American%2520Lung%2520Association%253A%2520Treatment%2520of%2520tuberculosis%2520and%2520tuberculosis%2520infection%2520in%2520adults%2520and%2520children%26jtitle%3DAm.%2520Rev.%2520Respir.%2520Dis.%26date%3D1986%26volume%3D134%26spage%3D355%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Thwaites, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemingway, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innes, J.</span><span> </span><span class="NLM_article-title">British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children</span> <span class="citation_source-journal">J. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1016%2Fj.jinf.2009.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=19643501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADC%252BD1Mnhslygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2009&pages=167-187&author=G.+Thwaitesauthor=M.+Fisherauthor=C.+Hemingwayauthor=G.+Scottauthor=T.+Solomonauthor=J.+Innes&title=British+Infection+Society+guidelines+for+the+diagnosis+and+treatment+of+tuberculosis+of+the+central+nervous+system+in+adults+and+children"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children</span></div><div class="casAuthors">Thwaites Guy; Fisher Martin; Hemingway Cheryl; Scott Geoff; Solomon Tom; Innes John</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infection</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SUMMARY AND KEY RECOMMENDATIONS: The aim of these guidelines is to describe a practical but evidence-based approach to the diagnosis and treatment of central nervous system tuberculosis in children and adults.  We have presented guidance on tuberculous meningitis (TBM), intra-cerebral tuberculoma without meningitis, and tuberculosis affecting the spinal cord.  Our key recommendations are as follows: 1.  TBM is a medical emergency.  Treatment delay is strongly associated with death and empirical anti-tuberculosis therapy should be started promptly in all patients in whom the diagnosis of TBM is suspected.  Do not wait for microbiological or molecular diagnostic confirmation. 2.  The diagnosis of TBM is best made with lumbar puncture and examination of the cerebrospinal fluid (CSF).  Suspect TBM if there is a CSF leucocytosis (predominantly lymphocytes), the CSF protein is raised, and the CSF:plasma glucose is <50%.  The diagnostic yield of CSF microscopy and culture for Mycobacterium tuberculosis increases with the volume of CSF submitted; repeat the lumbar puncture if the diagnosis remains uncertain. 3.  Imaging is essential for the diagnosis of cerebral tuberculoma and tuberculosis involving the spinal cord, although the radiological appearances do not confirm the diagnosis.  A tissue diagnosis (by histopathology and mycobacterial culture) should be attempted whenever possible, either by biopsy of the lesion itself, or through diagnostic sampling from extra-neural sites of disease e.g. lung, gastric fluid, lymph nodes, liver, bone marrow. 4.  Treatment for all forms of CNS tuberculosis should consist of 4 drugs (isoniazid, rifampicin, pyrazinamide, ethambutol) for 2 months followed by 2 drugs (isoniazid, rifampicin) for at least 10 months.  Adjunctive corticosteroids (either dexamethasone or prednisolone) should be given to all patients with TBM, regardless of disease severity. 5.  Children with CNS tuberculosis should ideally be managed by a paediatrician with familiarity and expertise in paediatric tuberculosis or otherwise with input from a paediatric infectious diseases unit.  The Children's HIV Association of UK and Ireland (CHIVA) provide further guidance on the management of HIV-infected children (www.chiva.org.uk). 6.  All patients with suspected or proven tuberculosis should be offered testing for HIV infection.  The principles of CNS tuberculosis diagnosis and treatment are the same for HIV infected and uninfected individuals, although HIV infection broadens the differential diagnosis and anti-retroviral treatment complicates management.  Tuberculosis in HIV infected patients should be managed either within specialist units by physicians with expertise in both HIV and tuberculosis, or in a combined approach between HIV and tuberculosis experts.  The co-administration of anti-retroviral and anti-tuberculosis drugs should follow guidance issued by the British HIV association (www.bhiva.org).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdAsg5jWJ-Tf9pSBfyDvp7fW6udTcc2eY-guRaNqPKTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mnhslygug%253D%253D&md5=562be8ce340708f97e1fb7768a59f7b6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jinf.2009.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinf.2009.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DThwaites%26aufirst%3DG.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DHemingway%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DG.%26aulast%3DSolomon%26aufirst%3DT.%26aulast%3DInnes%26aufirst%3DJ.%26atitle%3DBritish%2520Infection%2520Society%2520guidelines%2520for%2520the%2520diagnosis%2520and%2520treatment%2520of%2520tuberculosis%2520of%2520the%2520central%2520nervous%2520system%2520in%2520adults%2520and%2520children%26jtitle%3DJ.%2520Infect.%26date%3D2009%26volume%3D59%26spage%3D167%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Thwaites, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. H.</span><span> </span><span class="NLM_article-title">Tuberculous meningitis: many questions, too few answers</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=15721826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252Fpt1Cntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=160-170&author=G.+E.+Thwaitesauthor=T.+H.+Tran&title=Tuberculous+meningitis%3A+many+questions%2C+too+few+answers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculous meningitis: many questions, too few answers</span></div><div class="casAuthors">Thwaites Guy E; Tran Tinh Hien</div><div class="citationInfo"><span class="NLM_cas:title">Lancet neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">160-70</span>
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    </div><div class="casAbstract">Tuberculous meningitis (TM) is difficult to diagnose and treat; clinical features are non-specific, conventional bacteriology is widely regarded as insensitive, and assessment of newer diagnostic methods is not complete.  Treatment includes four drugs, which were developed more than 30 years ago, and prevents death or disability in less than half of patients.  Mycobacterium tuberculosis resistant to these drugs threatens a return to the prechemotherapeutic era in which all patients with TM died.  Research findings suggest that adjunctive treatment with corticosteroids improve survival but probably do not prevent severe disability, although how or why is not known.  There are many important unanswered questions about the pathophysiology, diagnosis, and treatment of TM.  Here we review the available evidence to answer some of these questions, particularly those on the diagnosis and treatment of TM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRcTUVBfA8UlsNIRw0GKUoEfW6udTcc2eY-guRaNqPKTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252Fpt1Cntw%253D%253D&md5=1089377020ed93b3a602bda7cbb625a2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThwaites%26aufirst%3DG.%2BE.%26aulast%3DTran%26aufirst%3DT.%2BH.%26atitle%3DTuberculous%2520meningitis%253A%2520many%2520questions%252C%2520too%2520few%2520answers%26jtitle%3DLancet%2520Neurol.%26date%3D2005%26volume%3D4%26spage%3D160%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Nau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorgel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prange, H. W.</span><span> </span><span class="NLM_article-title">Pharmacokinetic optimization of the treatment of bacterial central nervous system infections</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.2165%2F00003088-199835030-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=9784935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK1cXmsFOqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1998&pages=223-246&author=R.+Nauauthor=F.+Sorgelauthor=H.+W.+Prange&title=Pharmacokinetic+optimization+of+the+treatment+of+bacterial+central+nervous+system+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic optimization of the treatment of bacterial central nervous system infections</span></div><div class="casAuthors">Nau, Roland; Sorgel, Fritz; Prange, Hilmar W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-246</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 141 refs. Central nervous system (CNS) infections caused by bacteria with reduced sensitivity to antibacterials are an increasing worldwide challenge.  In successfully treating these infections several conditions should be considered. Antibacterials do not distribute homogeneously in the central nervous compartments [cerebrospinal fluid (CSF), extracellular space of the nervous tissue, intracellular space of the neurons, glial cells and leukocytes].  Even within the CSF, after i.v. administration, a ventriculolumbar concn. gradient is often obsd.  Valid parameters of drug entry into the CSF are the CSF/serum concn. ratio at steady state and the CSF/serum ratio of the area under the concn.-time curves (AUCCSF/AUCs).  Frequently, the elimination half-life (t1/2β) in the CSF is longer than the t1/2β in serum.  For most antibacterials, lipophilicity, mol. wt. and serum protein binding det. the drug entry into the CSF and brain tissue.  With an intact blood-CSF and blood-brain barrier, the entry of hydrophilic antibacterials (β-lactam antibacterials, glycopeptides) into the CNS compartments is poor and increases during meningeal inflammation.  More lipophilic compds. [metronidazole, quinolones, rifampicin (rifampin) and chloramphenicol] are less dependent on the function of the blood-CSF and blood-brain barrier.  Detn. of the minimal inhibitory concns. (MIC) of the causative organism is necessary for optimization of treatment.  For rapid sterilization of the CSF, drug concns. of ≥10-fold the MIC are required.  The min. CSF concn./MIC ratio ensuring successful therapy is unknown.  Strategies to achieve optimum antibacterial concns. in the presence of minor disturbances of the blood-CSF and blood-brain barrier include the increased use of low-toxicity antibacterials (e.g., β-lactam antibiotics), the use of moderately lipophilic compds., and the combination of i.v. and intraventricular administration.  Antibacterials which do not interfere with bacterial cell wall synthesis delay and/or decrease the liberation of proinflammatory bacterial products, delay or inhibit tumor necrosis factor release, and may reduce brain edema in exptl. meningitis.  Conclusive evidence of the redn. of neuronal damage by this approach, however, is lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoujxLLsN4K0bVg90H21EOLACvtfcHk0litn62gIV-JVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsFOqsrk%253D&md5=4caa1f73dbb2af3f000c290f391bf334</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2165%2F00003088-199835030-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199835030-00005%26sid%3Dliteratum%253Aachs%26aulast%3DNau%26aufirst%3DR.%26aulast%3DSorgel%26aufirst%3DF.%26aulast%3DPrange%26aufirst%3DH.%2BW.%26atitle%3DPharmacokinetic%2520optimization%2520of%2520the%2520treatment%2520of%2520bacterial%2520central%2520nervous%2520system%2520infections%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1998%26volume%3D35%26spage%3D223%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kniess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rode, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuest, F.</span><span> </span><span class="NLM_article-title">Practical experiences with the synthesis of [<sup>11</sup>C]CH<sub>3</sub>I through gas phase iodination reaction using a TRACERlabFX<sub>C</sub> synthesis module</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1016%2Fj.apradiso.2007.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=17683943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisl2jurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2008&pages=482-488&author=T.+Kniessauthor=K.+Rodeauthor=F.+Wuest&title=Practical+experiences+with+the+synthesis+of+%5B11C%5DCH3I+through+gas+phase+iodination+reaction+using+a+TRACERlabFXC+synthesis+module"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Practical experiences with the synthesis of [11C]CH3I through gas phase iodination reaction using a TRACERlabFXC synthesis module</span></div><div class="casAuthors">Kniess, Torsten; Rode, Katrin; Wuest, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">482-488</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The results of [11C]CH3I synthesis through hydrogen gas redn. of [11C]CO2 on different nickel catalysts (HARSHAW-nickel, SHIMALITE-nickel, nickel on silica/alumina, nickel nanosize 99.99%) followed by gas phase iodination using a TRACERlab FXC synthesis unit are reported.  Further reaction parameters such as furnace temps., flow rate of hydrogen gas and redn. time were optimized.  It was found that redn. of [11C]CO2 proceeded in 28-83% yield depending on the nickel catalyst and temp.  The gas phase iodination (methane conversion) gave 31-62% of [11C]CH3I depending on temp. and amt. of iodine in the iodine furnace. [11C]CH3I was used for heteroatom methylation reactions exemplified by a piperazine and a phenol.  The specific activity of the 11C-labeled products and was detd. after HPLC purifn. and solid-phase extn.  Compds. and were obtained in 8-14% radiochem. yield (decay-cor., based upon trapped [11C]CH4) within 30 min.  The specific activity was detd. to be in the range of 20-30 GBq/μmol at the end-of-synthesis.  Nickel catalyst nanosize was found to be superior compared with other Ni catalysts tested.  The relatively low specific activity may be mainly due to carbon contaminations originating from the long copper tubing (500 m) between the cyclotron and the radiochem. facility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFrj_rSyu5ybVg90H21EOLACvtfcHk0litn62gIV-JVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisl2jurg%253D&md5=bfa6dacc534a9da92ab6e8c9969f0e7c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2007.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2007.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DKniess%26aufirst%3DT.%26aulast%3DRode%26aufirst%3DK.%26aulast%3DWuest%26aufirst%3DF.%26atitle%3DPractical%2520experiences%2520with%2520the%2520synthesis%2520of%2520%255B11C%255DCH3I%2520through%2520gas%2520phase%2520iodination%2520reaction%2520using%2520a%2520TRACERlabFXC%2520synthesis%2520module%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2008%26volume%3D66%26spage%3D482%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Andersson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstroem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laanstroem, B.</span><span> </span><span class="NLM_article-title">Synthesis of <sup>11</sup>C-labelled benzamide compounds as potential tracers for poly(ADP-ribose) synthetase</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1016%2F0969-8043%2894%2990251-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8038764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK2cXlvF2ks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=707-714&author=I.+Anderssonauthor=M.+Bergstroemauthor=B.+Laanstroem&title=Synthesis+of+11C-labelled+benzamide+compounds+as+potential+tracers+for+poly%28ADP-ribose%29+synthetase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 11C-labeled benzamide compounds as potential tracers for poly(ADP-ribose) synthetase</span></div><div class="casAuthors">Andersson, Ivonne; Bergstroem, Mats; Laanstroem, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">707-14</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0883-2889</span>.
    </div><div class="casAbstract">Poly(ADP-ribose) synthetase catalyzes the synthesis of poly(ADP-ribose) from NAD+, thereby releasing the DNA from histones to a transcriptionally and reparationally active form.  To investigate if in vivo and in vitro studies of this enzyme are feasible to perform with PET, the poly(ADP-ribose) synthetase inhibitors benzamide, 3-aminobenzamide, 3-methoxybenzamide and nicotinamide were labeled with carbon-11 in the amide group.  Starting with the corresponding arom. halides and hydrogen [11C]cyanide, the substituted [11C]benzohitriles were prepd. using a palladium promoted reaction.  Conversion of the nitriles to [carboxy-11C]amides was achieved by reaction with sodium percarbonate.  A one-pot procedure for synthesis of the 11C-labeled arom. amides was developed.  The total synthesis time including reversed-phase HPLC purifn. was 25-35 min.  Decay-cor. radiochem. yield was 40-70% and the radiochem. purity >99%.  The specific radioactivity was in the order of 2-3 Ci/μmol.  Initial distribution and kinetic studies were performed in monkey using the tracer substance injected as a rapid bolus.  These studies demonstrated that the blood-clearance was fast for [carboxy-11C]nicotinamide but considerably slower for 3-amino[carboxy-11C]benzamide and 3-methoxy[carboxy-11C]benzamide.  The brain uptake was low for substances except 3-methoxy[carboxy-11C]benzamide which initially had a high brain uptake, followed by a rapid washout.  The 11C-labeled nicotinamide demonstrated a rapid fixation with high uptake values in the liver, kidney and lymph nodes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgyJnh3qqEb7Vg90H21EOLACvtfcHk0litn62gIV-JVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvF2ks7o%253D&md5=65baa59048ce59955fabdfd6c6c575d1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F0969-8043%2894%2990251-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8043%252894%252990251-8%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DI.%26aulast%3DBergstroem%26aufirst%3DM.%26aulast%3DLaanstroem%26aufirst%3DB.%26atitle%3DSynthesis%2520of%252011C-labelled%2520benzamide%2520compounds%2520as%2520potential%2520tracers%2520for%2520poly%2528ADP-ribose%2529%2520synthetase%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D1994%26volume%3D45%26spage%3D707%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Milic, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opsenica, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnadevic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solaja, B. A.</span><span> </span><span class="NLM_article-title">NaY zeolite: A useful catalyst for nitrile hydrolysis</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=118-126&author=D.+R.+Milicauthor=D.+M.+Opsenicaauthor=B.+Adnadevicauthor=B.+A.+Solaja&title=NaY+zeolite%3A+A+useful+catalyst+for+nitrile+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilic%26aufirst%3DD.%2BR.%26aulast%3DOpsenica%26aufirst%3DD.%2BM.%26aulast%3DAdnadevic%26aufirst%3DB.%26aulast%3DSolaja%26aufirst%3DB.%2BA.%26atitle%3DNaY%2520zeolite%253A%2520A%2520useful%2520catalyst%2520for%2520nitrile%2520hydrolysis%26jtitle%3DMolecules%26date%3D2000%26volume%3D5%26spage%3D118%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Elias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, W. F.</span><span> </span><span class="NLM_article-title">Hydrazine determination in sludge samples by high-performance liquid chromatography</span> <span class="citation_source-journal">J. Sep. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1002%2Fjssc.200500380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=16544889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1KnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=460-464&author=G.+Eliasauthor=W.+F.+Bauer&title=Hydrazine+determination+in+sludge+samples+by+high-performance+liquid+chromatography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrazine determination in sludge samples by high-performance liquid chromatography</span></div><div class="casAuthors">Elias, Gracy; Bauer, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Separation Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">460-464</span>CODEN:
                <span class="NLM_cas:coden">JSSCCJ</span>;
        ISSN:<span class="NLM_cas:issn">1615-9306</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A relatively simple and cost-effective method using HPLC with UV detection was developed to detect and quantify hydrazine in sludge samples.  The method was developed primarily for sludge samples, but it can also be applicable to soil and other environmental samples.  The hydrazines in the matrixes were derivatized to hydrazones with benzaldehyde.  The hydrazones were sepd. using HPLC with an RP C-18 column in an isocratic mode with MeOH-H2O (95:5 vol./vol.) and detected with UV detection at 313 nm.  The detection limit (25 μL injection) for the method is 0.02 μg/mL of hydrazine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6MFJs_8YxX7Vg90H21EOLACvtfcHk0lhMofFz6c8cow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1KnsLk%253D&md5=41deed0322cf3b5a8cb8e5b95cbf7635</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjssc.200500380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjssc.200500380%26sid%3Dliteratum%253Aachs%26aulast%3DElias%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DW.%2BF.%26atitle%3DHydrazine%2520determination%2520in%2520sludge%2520samples%2520by%2520high-performance%2520liquid%2520chromatography%26jtitle%3DJ.%2520Sep.%2520Sci.%26date%3D2006%26volume%3D29%26spage%3D460%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Woo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K.</span><span> </span><span class="NLM_article-title">In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and α-1-acid glycoprotein</span> <span class="citation_source-journal">Clin. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1016%2F0009-9120%2895%2902024-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8601328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK28Xis1Krurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1996&pages=175-177&author=J.+Wooauthor=W.+Cheungauthor=R.+Chanauthor=H.+S.+Chanauthor=A.+Chengauthor=K.+Chan&title=In+vitro+protein+binding+characteristics+of+isoniazid%2C+rifampicin%2C+and+pyrazinamide+to+whole+plasma%2C+albumin%2C+and+%CE%B1-1-acid+glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and α-1-acid glycoprotein</span></div><div class="casAuthors">Woo, J.; Cheung, W.; Chan, R.; Chan, H.S.; Cheng, A.; Chan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-7</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In this study, the authors examd. the degree of binding of isoniazid, rifampicin, and pyrazinamide to plasma, albumin and α-1-glycoprotein, and the effect of variations in protein concn. on the degree of binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSy4n49k3rRLVg90H21EOLACvtfcHk0lhMofFz6c8cow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xis1Krurk%253D&md5=98b1a5bcfd24635d324366d23046fdbd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2F0009-9120%2895%2902024-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-9120%252895%252902024-1%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DH.%2BS.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DK.%26atitle%3DIn%2520vitro%2520protein%2520binding%2520characteristics%2520of%2520isoniazid%252C%2520rifampicin%252C%2520and%2520pyrazinamide%2520to%2520whole%2520plasma%252C%2520albumin%252C%2520and%2520%25CE%25B1-1-acid%2520glycoprotein%26jtitle%3DClin.%2520Biochem.%26date%3D1996%26volume%3D29%26spage%3D175%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Nguyen, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillarme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudaz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veuthey, J. L.</span><span> </span><span class="NLM_article-title">Validation of an ultra-fast UPLC-UV method for the separation of antituberculosis tablets</span> <span class="citation_source-journal">J. Sep. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1050</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1002%2Fjssc.200700537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=18306434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVKhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=1050-1056&author=D.+T.+Nguyenauthor=D.+Guillarmeauthor=S.+Rudazauthor=J.+L.+Veuthey&title=Validation+of+an+ultra-fast+UPLC-UV+method+for+the+separation+of+antituberculosis+tablets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of an ultra-fast UPLC-UV method for the separation of antituberculosis tablets</span></div><div class="casAuthors">Nguyen, Dao T.-T.; Guillarme, Davy; Rudaz, Serge; Veuthey, Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Separation Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">1050-1056</span>CODEN:
                <span class="NLM_cas:coden">JSSCCJ</span>;
        ISSN:<span class="NLM_cas:issn">1615-9306</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A simple method using ultra performance LC (UPLC) coupled with UV detection was developed and validated for the detn. of antituberculosis drugs in combined dosage form, i.e. isoniazid (ISN), pyrazinamide (PYR), and rifampicin (RIF).  Drugs were sepd. on a short column (2.1 mm × 50 mm) packed with 1.7 μm particles, using an elution gradient procedure.  At 30°C, < 2 min was necessary for the complete sepn. of the 3 antituberculosis drugs, while the original USP method was performed in 15 min.  Further improvements were obtained with the combination of UPLC and high temp. (≤ 90°C), namely HT-UPLC, which allows the application of higher mobile phase flow rates.  Therefore, the sepn. of ISN, PYR, and RIF was performed in < 1 min.  After validation (selectivity, trueness, precision, and accuracy), both methods (UPLC and HT-UPLC) have proven suitable for the routine quality control anal. of antituberculosis drugs in combined dosage form.  Addnl., a large no. of samples per day can be analyzed due to the short anal. times.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTBoSNMvpqLLVg90H21EOLACvtfcHk0lhMofFz6c8cow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVKhs7s%253D&md5=c89b5767697d10a8c03571d6a17219f1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fjssc.200700537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjssc.200700537%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DD.%2BT.%26aulast%3DGuillarme%26aufirst%3DD.%26aulast%3DRudaz%26aufirst%3DS.%26aulast%3DVeuthey%26aufirst%3DJ.%2BL.%26atitle%3DValidation%2520of%2520an%2520ultra-fast%2520UPLC-UV%2520method%2520for%2520the%2520separation%2520of%2520antituberculosis%2520tablets%26jtitle%3DJ.%2520Sep.%2520Sci.%26date%3D2008%26volume%3D31%26spage%3D1050%26epage%3D1056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Nau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prange, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolenda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seydel, J. K.</span><span> </span><span class="NLM_article-title">Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1093%2Fjac%2F29.6.719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=1506352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADyaK38znt1GntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1992&pages=719-724&author=R.+Nauauthor=H.+W.+Prangeauthor=S.+Menckauthor=H.+Kolendaauthor=K.+Visserauthor=J.+K.+Seydel&title=Penetration+of+rifampicin+into+the+cerebrospinal+fluid+of+adults+with+uninflamed+meninges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges</span></div><div class="casAuthors">Nau R; Prange H W; Menck S; Kolenda H; Visser K; Seydel J K</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of antimicrobial chemotherapy</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-24</span>
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">The penetration of rifampicin into CSF was studied in seven patients who had undergone external ventriculostomy for occlusive hydrocephalus without major disturbance of the blood-CSF barrier.  After the first dose of rifampicin 600 mg i.v. over 3 h, blood and CSF concentrations were determined serially by HPLC.  Peak CSF concentrations obtained 0-8 h (median = 1 h) after the end of the infusion ranged from 0.57 to 1.24 mg/L (median = 0.73 mg/L).  Elimination from CSF was slower than from serum (T1/2 beta CSF: 9.1-21.0 h (median = 14.5 h, n = 5); T1/2 beta serum: 2.2-5.8 h (median = 3.6 h, n = 7)).  Based on the ratios of the areas under the concentration-time curves in CSF and serum, the overall penetration of rifampicin into CSF was 0.13-0.42 (median = 0.22).  These results demonstrate effective CSF penetration and favourable pharmacokinetics of rifampicin in the absence of meningeal inflammation.  They support the use of rifampicin as part of a combination therapy not only for tuberculosis of the central nervous system (CNS), but also for staphylococcal and listerial infections of the CNS in which there may be little meningeal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlfIHswCXjJUEksK8CslK8fW6udTcc2ea7LshZNJADkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38znt1GntA%253D%253D&md5=8fd53d2446185536fd0f0cd0f05d18f6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F29.6.719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F29.6.719%26sid%3Dliteratum%253Aachs%26aulast%3DNau%26aufirst%3DR.%26aulast%3DPrange%26aufirst%3DH.%2BW.%26aulast%3DMenck%26aufirst%3DS.%26aulast%3DKolenda%26aufirst%3DH.%26aulast%3DVisser%26aufirst%3DK.%26aulast%3DSeydel%26aufirst%3DJ.%2BK.%26atitle%3DPenetration%2520of%2520rifampicin%2520into%2520the%2520cerebrospinal%2520fluid%2520of%2520adults%2520with%2520uninflamed%2520meninges%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1992%26volume%3D29%26spage%3D719%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">McDougall, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grahame-Smith, D. G.</span><span> </span><span class="NLM_article-title">Penetration of C<sup>14</sup>-labelled rifampicin into primate peripheral nerve</span> <span class="citation_source-journal">Experientia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1069</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1975&pages=1068-1069&author=A.+C.+McDougallauthor=J.+A.+Roseauthor=D.+G.+Grahame-Smith&title=Penetration+of+C14-labelled+rifampicin+into+primate+peripheral+nerve"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcDougall%26aufirst%3DA.%2BC.%26aulast%3DRose%26aufirst%3DJ.%2BA.%26aulast%3DGrahame-Smith%26aufirst%3DD.%2BG.%26atitle%3DPenetration%2520of%2520C14-labelled%2520rifampicin%2520into%2520primate%2520peripheral%2520nerve%26jtitle%3DExperientia%26date%3D1975%26volume%3D31%26spage%3D1068%26epage%3D1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Mindermann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landolt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajacic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratzl, O.</span><span> </span><span class="NLM_article-title">Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">737</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1093%2Fjac%2F31.5.731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8335500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK3sXks1agur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1993&pages=731-737&author=T.+Mindermannauthor=H.+Landoltauthor=W.+Zimmerliauthor=Z.+Rajacicauthor=O.+Gratzl&title=Penetration+of+rifampicin+into+the+brain+tissue+and+cerebral+extracellular+space+of+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats</span></div><div class="casAuthors">Mindermann, Thomas; Landolt, Hans; Zimmerli, Werner; Rajacic, Zarko; Gratzl, Otmar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">731-7</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">Rifampicin is used to treat neurosurgical shunt infections because of its excellent in-vitro activity against staphylococci and its adequate penetration into the CSF.  However, nothing is known about rifampicin concns. in the cerebral extracellular space (CES).  The authors measured the penetration of rifampicin into the CES of anesthetized rats by microdialysis using low-flow and equil. methods.  Depending on the method, rifampicin concns. in the CES were 0.3-1% of the serum concn. or 3-8% of brain tissue concn., resp.  These exptl. data in animals suggest that the recommended dose of rifampicin in man might be inadequate for treatment of some brain infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIHLQcpKx2z7Vg90H21EOLACvtfcHk0licTz5U8J1_9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1agur8%253D&md5=2edbcc2307384e527e5f5c2c7952bab9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F31.5.731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F31.5.731%26sid%3Dliteratum%253Aachs%26aulast%3DMindermann%26aufirst%3DT.%26aulast%3DLandolt%26aufirst%3DH.%26aulast%3DZimmerli%26aufirst%3DW.%26aulast%3DRajacic%26aufirst%3DZ.%26aulast%3DGratzl%26aufirst%3DO.%26atitle%3DPenetration%2520of%2520rifampicin%2520into%2520the%2520brain%2520tissue%2520and%2520cerebral%2520extracellular%2520space%2520of%2520rats%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1993%26volume%3D31%26spage%3D731%26epage%3D737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mindermann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratzl, O.</span><span> </span><span class="NLM_article-title">Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2626</span><span class="NLM_x">–</span> <span class="NLM_lpage">2629</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=2626-2629&author=T.+Mindermannauthor=W.+Zimmerliauthor=O.+Gratzl&title=Rifampin+concentrations+in+various+compartments+of+the+human+brain%3A+a+novel+method+for+determining+drug+levels+in+the+cerebral+extracellular+space"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMindermann%26aufirst%3DT.%26aulast%3DZimmerli%26aufirst%3DW.%26aulast%3DGratzl%26aufirst%3DO.%26atitle%3DRifampin%2520concentrations%2520in%2520various%2520compartments%2520of%2520the%2520human%2520brain%253A%2520a%2520novel%2520method%2520for%2520determining%2520drug%2520levels%2520in%2520the%2520cerebral%2520extracellular%2520space%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1998%26volume%3D42%26spage%3D2626%26epage%3D2629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Barclay, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Roy, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthei, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, L. J.</span><span> </span><span class="NLM_article-title">Distribution and excretion of radioactive isoniazid in tuberculous patients</span> <span class="citation_source-journal">J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">1384</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=13034481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaG3sXkvVOhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1953&pages=1384-1388&author=W.+R.+Barclayauthor=R.+H.+Ebertauthor=G.+V.+Le+Royauthor=R.+W.+Mantheiauthor=L.+J.+Roth&title=Distribution+and+excretion+of+radioactive+isoniazid+in+tuberculous+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and excretion of radioactive isoniazid in tuberculous patients</span></div><div class="casAuthors">Barclay, W. R.; Ebert, R. H.; LeRoy, G. V.; Manthei, R. W.; Roth, L. J.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1384-8</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    </div><div class="casAbstract">C14-Isoniazid (isonicotinic acid hydrazide) was used to study the distribution and excretion of this bacteriostatic agent in tuberculous patients.  Peak levels were reached in blood and plasma within 1 hr. after intramuscular injection and fell rapidly during the next 8 hrs., but detectable amts. were still present 3-7 days after a single injection.  The drug is freely diffusible into tissues, and the highest concns. were found in lung and skin.  The drug diffuses freely into dense caseous lesions in both lung and lymph nodes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog8Vax7fsyGbVg90H21EOLACvtfcHk0licTz5U8J1_9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXkvVOhsQ%253D%253D&md5=2739c78a0a683c250b6ce8f57d5145ec</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarclay%26aufirst%3DW.%2BR.%26aulast%3DEbert%26aufirst%3DR.%2BH.%26aulast%3DLe%2BRoy%26aufirst%3DG.%2BV.%26aulast%3DManthei%26aufirst%3DR.%2BW.%26aulast%3DRoth%26aufirst%3DL.%2BJ.%26atitle%3DDistribution%2520and%2520excretion%2520of%2520radioactive%2520isoniazid%2520in%2520tuberculous%2520patients%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D1953%26volume%3D151%26spage%3D1384%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Barling, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkon, J. B.</span><span> </span><span class="NLM_article-title">The penetration of antibiotics into cerebrospinal fluid and brain tissue</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1093%2Fjac%2F4.3.203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=353023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaE1cXkslSlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1978&pages=203-227&author=R.+W.+Barlingauthor=J.+B.+Selkon&title=The+penetration+of+antibiotics+into+cerebrospinal+fluid+and+brain+tissue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The penetration of antibiotics into cerebrospinal fluid and brain tissue</span></div><div class="casAuthors">Barling, R. W. A.; Selkon, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-27</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">A review with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTqbQ0NuAeA7Vg90H21EOLACvtfcHk0licTz5U8J1_9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXkslSlsrc%253D&md5=52ba0b85f9be881a6a38c702368cda47</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F4.3.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F4.3.203%26sid%3Dliteratum%253Aachs%26aulast%3DBarling%26aufirst%3DR.%2BW.%26aulast%3DSelkon%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520penetration%2520of%2520antibiotics%2520into%2520cerebrospinal%2520fluid%2520and%2520brain%2520tissue%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1978%26volume%3D4%26spage%3D203%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Rouse, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. L.</span><span> </span><span class="NLM_article-title">Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2472</span><span class="NLM_x">–</span> <span class="NLM_lpage">2477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1995&pages=2472-2477&author=D.+A.+Rouseauthor=Z.+Liauthor=G.+H.+Baiauthor=S.+L.+Morris&title=Characterization+of+the+katG+and+inhA+genes+of+isoniazid-resistant+clinical+isolates+of+Mycobacterium+tuberculosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRouse%26aufirst%3DD.%2BA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBai%26aufirst%3DG.%2BH.%26aulast%3DMorris%26aufirst%3DS.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520katG%2520and%2520inhA%2520genes%2520of%2520isoniazid-resistant%2520clinical%2520isolates%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1995%26volume%3D39%26spage%3D2472%26epage%3D2477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Roth, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthel, R. W.</span><span> </span><span class="NLM_article-title">The distribution of C<sup>14</sup> labeled isonicotinic acid hydrazide in normal mice</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">566</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=13027371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaG3sXhs1Khsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1952&pages=566-569&author=L.+J.+Rothauthor=R.+W.+Manthel&title=The+distribution+of+C14+labeled+isonicotinic+acid+hydrazide+in+normal+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The distribution of carbon14-labeled isonicotinic acid hydrazide in normal mice</span></div><div class="casAuthors">Roth, L. J.; Manthei, R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">566-9</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    </div><div class="casAbstract">After subcutaneous injection of carboxyl C14-labeled isonicotinic hydrazide (I) in mice the drug is localized chiefly in the liver, skin, lungs, brain, and kidneys.  The lung tissue contains considerable amts. of activity after the blood level has fallen to trace amts.  Both I and its major metabolite isonicotinic acid are found in the brain tissue.  The skin may serve as an important storage depot for I.  Excretion of I is chiefly in the urine.  Less than 1% is converted to CO2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaPydx34E7CbVg90H21EOLACvtfcHk0ljd7zPXzLAcNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXhs1Khsg%253D%253D&md5=496407f5c3c55db733a095450f47c0c5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DL.%2BJ.%26aulast%3DManthel%26aufirst%3DR.%2BW.%26atitle%3DThe%2520distribution%2520of%2520C14%2520labeled%2520isonicotinic%2520acid%2520hydrazide%2520in%2520normal%2520mice%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1952%26volume%3D81%26spage%3D566%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Barlow, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoolar, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, L. J.</span><span> </span><span class="NLM_article-title">Distribution of carbon-14 labeled isoniazid in brain</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">820</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1957&pages=820-824&author=C.+F.+Barlowauthor=J.+C.+Schoolarauthor=L.+J.+Roth&title=Distribution+of+carbon-14+labeled+isoniazid+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarlow%26aufirst%3DC.%2BF.%26aulast%3DSchoolar%26aufirst%3DJ.%2BC.%26aulast%3DRoth%26aufirst%3DL.%2BJ.%26atitle%3DDistribution%2520of%2520carbon-14%2520labeled%2520isoniazid%2520in%2520brain%26jtitle%3DNeurology%26date%3D1957%26volume%3D7%26spage%3D820%26epage%3D824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Schoolar, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlow, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, L. J.</span><span> </span><span class="NLM_article-title">Autoradiography of carbon-14 labeled isoniazid in brain</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=13297797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaG28XksF2jsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1956&pages=347-349&author=J.+C.+Schoolarauthor=C.+F.+Barlowauthor=L.+J.+Roth&title=Autoradiography+of+carbon-14+labeled+isoniazid+in+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Autoradiography of carbon-14 labeled isoniazid in brain</span></div><div class="casAuthors">Schoolar, Joseph C.; Barlow, Charles F.; Roth, Lloyd J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">347-9</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    </div><div class="casAbstract">Gross autoradiograms of cat brain slices contg. C14-labeled isoniazid, together with supportive data from radioactive assay, are presented to show the differential localization of isoniazid in brain tissues.  The technique is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk40ZUvucL17Vg90H21EOLACvtfcHk0ljd7zPXzLAcNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG28XksF2jsw%253D%253D&md5=4b3df642f7e90cb94ff2f08d85a3031d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoolar%26aufirst%3DJ.%2BC.%26aulast%3DBarlow%26aufirst%3DC.%2BF.%26aulast%3DRoth%26aufirst%3DL.%2BJ.%26atitle%3DAutoradiography%2520of%2520carbon-14%2520labeled%2520isoniazid%2520in%2520brain%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1956%26volume%3D91%26spage%3D347%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ellard, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, B. W.</span><span> </span><span class="NLM_article-title">Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis</span> <span class="citation_source-journal">Am. Rev. Respir. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1164%2Fajrccm%2F148.3.650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8368635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADyaK3sznvVWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1993&pages=650-655&author=G.+A.+Ellardauthor=M.+J.+Humphriesauthor=B.+W.+Allen&title=Cerebrospinal+fluid+drug+concentrations+and+the+treatment+of+tuberculous+meningitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis</span></div><div class="casAuthors">Ellard G A; Humphries M J; Allen B W</div><div class="citationInfo"><span class="NLM_cas:title">The American review of respiratory disease</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">650-5</span>
        ISSN:<span class="NLM_cas:issn">0003-0805</span>.
    </div><div class="casAbstract">Tuberculous meningitis is a very serious form of tuberculosis.  In the absence of randomized controlled trials of alternative treatment regimens, its management depends on employing potent drugs that penetrate well into the cerebrospinal fluid (CSF).  The penetration of isoniazid, rifampin, and streptomycin into the CSF of 27 Chinese patients was studied using fluorimetric and microbiologic procedures.  Isoniazid rapidly diffused into the CSF, peak concentrations in excess of 3 mg/L, or over 30 times its minimal inhibitory concentration (MIC) against Mycobacterium tuberculosis being attained within 4 hr.  In contrast, rifampin and streptomycin penetrated very slowly across the meninges, and CSF levels only slightly in excess of their MICs against M. tuberculosis were achieved.  The penetration of the drugs into the CSF correlated poorly with differences in their partitioning between octanol/water and cyclohexane/water but could be predicted using a simple model based on their renal clearance rates and plasma protein binding.  It is recommended that patients with tuberculous meningitis should be treated for at least 9 months with a combination of isoniazid, rifampin, and pyrazinamide, which may be supplemented in the first 2 mo with streptomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfiYpMTPePUNNTrvPZP1IpfW6udTcc2eYB46vHFfBOQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3sznvVWquw%253D%253D&md5=4705021b0d042ac346c3384bda1f6035</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1164%2Fajrccm%2F148.3.650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm%252F148.3.650%26sid%3Dliteratum%253Aachs%26aulast%3DEllard%26aufirst%3DG.%2BA.%26aulast%3DHumphries%26aufirst%3DM.%2BJ.%26aulast%3DAllen%26aufirst%3DB.%2BW.%26atitle%3DCerebrospinal%2520fluid%2520drug%2520concentrations%2520and%2520the%2520treatment%2520of%2520tuberculous%2520meningitis%26jtitle%3DAm.%2520Rev.%2520Respir.%2520Dis.%26date%3D1993%26volume%3D148%26spage%3D650%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Forgan-Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellard, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, D. A.</span><span> </span><span class="NLM_article-title">Pyrazinamide and other drugs in tuberculous meningitis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1973&pages=374&author=R.+Forgan-Smithauthor=G.+A.+Ellardauthor=D.+Newtonauthor=D.+A.+Mitchison&title=Pyrazinamide+and+other+drugs+in+tuberculous+meningitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForgan-Smith%26aufirst%3DR.%26aulast%3DEllard%26aufirst%3DG.%2BA.%26aulast%3DNewton%26aufirst%3DD.%26aulast%3DMitchison%26aufirst%3DD.%2BA.%26atitle%3DPyrazinamide%2520and%2520other%2520drugs%2520in%2520tuberculous%2520meningitis%26jtitle%3DLancet%26date%3D1973%26volume%3D2%26spage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Wu, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, H.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, T.-H.</span><span> </span><span class="NLM_article-title">Determination and pharmacokinetic profile of pyrazinamide in rat blood, brain and bile using microdialysis coupled with high-performance liquid chromatography and verified by tandem mass spectrometry</span> <span class="citation_source-journal">Anal. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">522</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=522&publication_year=2004&pages=231-239&author=J.-W.+Wuauthor=H.-H.+Shihauthor=S.-C.+Wangauthor=T.-H.+Tsai&title=Determination+and+pharmacokinetic+profile+of+pyrazinamide+in+rat+blood%2C+brain+and+bile+using+microdialysis+coupled+with+high-performance+liquid+chromatography+and+verified+by+tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-W.%26aulast%3DShih%26aufirst%3DH.-H.%26aulast%3DWang%26aufirst%3DS.-C.%26aulast%3DTsai%26aufirst%3DT.-H.%26atitle%3DDetermination%2520and%2520pharmacokinetic%2520profile%2520of%2520pyrazinamide%2520in%2520rat%2520blood%252C%2520brain%2520and%2520bile%2520using%2520microdialysis%2520coupled%2520with%2520high-performance%2520liquid%2520chromatography%2520and%2520verified%2520by%2520tandem%2520mass%2520spectrometry%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2004%26volume%3D522%26spage%3D231%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Nitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virgilio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricolo, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuliano, A.</span><span> </span><span class="NLM_article-title">Pharmacokinetic study of intravenous rifampicin</span> <span class="citation_source-journal">Chemotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1977&pages=1-6&author=V.+Nittiauthor=R.+Virgilioauthor=M.+R.+Patricoloauthor=A.+Iuliano&title=Pharmacokinetic+study+of+intravenous+rifampicin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNitti%26aufirst%3DV.%26aulast%3DVirgilio%26aufirst%3DR.%26aulast%3DPatricolo%26aufirst%3DM.%2BR.%26aulast%3DIuliano%26aufirst%3DA.%26atitle%3DPharmacokinetic%2520study%2520of%2520intravenous%2520rifampicin%26jtitle%3DChemotherapy%26date%3D1977%26volume%3D23%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Furesz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallanza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mapelli, E.</span><span> </span><span class="NLM_article-title">Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=5631581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaF2sXkvV2ms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1967&pages=534-537&author=S.+Fureszauthor=R.+Scottiauthor=R.+Pallanzaauthor=E.+Mapelli&title=Rifampicin%3A+a+new+rifamycin.+3.+Absorption%2C+distribution%2C+and+elimination+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Rifamycins.  LIII.  Rifampicin.  A new rifamycin.  3.  Absorption, distribution, and elimination in man</span></div><div class="casAuthors">Furesz, S.; Scotti, R.; Pallanza, Rosa; Mapelli, E.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">534-7</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">cf. preceding abstrs.  Rifampicin (I) was well absorbed by humans after oral administration, therapeutically active concns. being maintained in the blood for 8 hrs. after administration of 150 mg.  When the dose was increased to 450 mg., serum I was detected for 24 hrs., and with 900 mg. I, blood levels were very high and long lasting.  Elimination of I was slow and took place mainly via the bile, although bactericidal concns. were present in the urine.  The new antibiotic had a high distribution vol. (1.619 ml./g. after a 25-mg. dose), and direct detn. of the antibiotic in the different organs confirmed that I diffused well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzSTAjqSdWIbVg90H21EOLACvtfcHk0lisJPMBQPkSYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXkvV2ms7c%253D&md5=27fa6079567ab3f60deec5ded972ce19</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuresz%26aufirst%3DS.%26aulast%3DScotti%26aufirst%3DR.%26aulast%3DPallanza%26aufirst%3DR.%26aulast%3DMapelli%26aufirst%3DE.%26atitle%3DRifampicin%253A%2520a%2520new%2520rifamycin.%25203.%2520Absorption%252C%2520distribution%252C%2520and%2520elimination%2520in%2520man%26jtitle%3DArzneim.%2520Forsch.%26date%3D1967%26volume%3D17%26spage%3D534%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Boman, G.</span><span> </span><span class="NLM_article-title">Tissue distribution of <sup>14</sup>C-rifampicin II. Accumulation in melanin-containing structures</span> <span class="citation_source-journal">Acta Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1111%2Fj.1600-0773.1975.tb00794.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=1173525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaE2MXkt1ahs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1975&pages=267-283&author=G.+Boman&title=Tissue+distribution+of+14C-rifampicin+II.+Accumulation+in+melanin-containing+structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution of carbon-14-labeled-rifampicin.  II.  Accumulation in melanin-containing structures</span></div><div class="casAuthors">Boman, Gunnar</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica et Toxicologica</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-83</span>CODEN:
                <span class="NLM_cas:coden">APTOA6</span>;
        ISSN:<span class="NLM_cas:issn">0001-6683</span>.
    </div><div class="casAbstract">The tissue distribution of 14Crifampicin [13292-46-1] was investigated by whole body autoradiog. in brown mice surviving up to 30 days after a single i.v. injection.  In contrast to the findings in albino mice a long-term retention was obsd. in the uveal tract, the inner ear and the skin.  Similar results were obtained in pigmented rats.  Sections of organs from a human fetus incubated in 14C-rifampicin showed selective accumulation in the pigment epithelium of the eye.  Quant. detns. of radioactivity were performed of the blood, liver, lung, kidney and eye of mice up to 4 days after a single i.v. injection of 14C-rifampicin.  A 15-fold difference was found between the pigmented and the albino eye after 4 days.  The findings were interpreted as evidence for a melanin affinity of rifampicin and discussed in relation to its possible ocular and otol. side effects, which seem to be mostly unverified and very infrequent even during long-term therapy.  However, the accumulation of transplacentally transferred drug in the eye and the inner ear provides a further reason for restricting its use during pregnancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNwGb65N0n5rVg90H21EOLACvtfcHk0lisJPMBQPkSYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXkt1ahs74%253D&md5=b45ba0e1bc4cdb77ef963c0191f6ea8d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1975.tb00794.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1975.tb00794.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoman%26aufirst%3DG.%26atitle%3DTissue%2520distribution%2520of%252014C-rifampicin%2520II.%2520Accumulation%2520in%2520melanin-containing%2520structures%26jtitle%3DActa%2520Pharmacol.%2520Toxicol.%26date%3D1975%26volume%3D36%26spage%3D267%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Verma, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span> </span><span class="NLM_article-title">Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3195</span><span class="NLM_x">–</span> <span class="NLM_lpage">3201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3195-3201&author=R.+K.+Vermaauthor=J.+Kaurauthor=K.+Kumarauthor=A.+B.+Yadavauthor=A.+Misra&title=Intracellular+time+course%2C+pharmacokinetics%2C+and+biodistribution+of+isoniazid+and+rifabutin+following+pulmonary+delivery+of+inhalable+microparticles+to+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DR.%2BK.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DYadav%26aufirst%3DA.%2BB.%26aulast%3DMisra%26aufirst%3DA.%26atitle%3DIntracellular%2520time%2520course%252C%2520pharmacokinetics%252C%2520and%2520biodistribution%2520of%2520isoniazid%2520and%2520rifabutin%2520following%2520pulmonary%2520delivery%2520of%2520inhalable%2520microparticles%2520to%2520mice%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3195%26epage%3D3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Roohi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mushtaq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jehangir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, S. A.</span><span> </span><span class="NLM_article-title">Direct labeling of isoniazid with technetium-99m for diagnosis of tuberculosis</span> <span class="citation_source-journal">Radiochim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1524%2Fract.2006.94.3.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslOmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=147-152&author=S.+Roohiauthor=A.+Mushtaqauthor=M.+Jehangirauthor=S.+A.+Malik&title=Direct+labeling+of+isoniazid+with+technetium-99m+for+diagnosis+of+tuberculosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Direct labeling of isoniazid with technetium-99m for diagnosis of tuberculosis</span></div><div class="casAuthors">Roohi, Samina; Mushtaq, A.; Jehangir, M.; Malik, Salman A.</div><div class="citationInfo"><span class="NLM_cas:title">Radiochimica Acta</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">147-152</span>CODEN:
                <span class="NLM_cas:coden">RAACAP</span>;
        ISSN:<span class="NLM_cas:issn">0033-8230</span>.
    
            (<span class="NLM_cas:orgname">Oldenbourg Wissenschaftsverlag GmbH</span>)
        </div><div class="casAbstract">Isonicotinic acid hydrazide (isoniazid) is one of the most effective agents in tuberculosis therapy.  Hence it was chosen as ligand for 99mTc labeling and imaging in the developed animal model with a gamma camera.  Direct labeling of isoniazid with technetium-99m was studied.  Factors affecting the radiolabeling efficiency such as amt. of reducing agent, pH and time of the reaction were studied.  Biodistribution of the labeled compd. was performed in Sprague-Dawley rats.  The localization kinetics of the radiolabeled complex was also studied in the developed animal model by injecting 100-125 MBq 99mTc-isoniazid i.v. in the ear of rabbit and the images were taken with a gamma camera.  Optimum conditions gave > 98% labeling efficiency of 99mTc-isoniazid.  Biodistribution studies in rats revealed that the max. uptake was in kidneys (15%, 8% and 2.5% at 0.5, 4 and 24 h, resp.), indicating renal excretion of the 99mTc-isoniazid.  High accumulation was obtained in liver (10%, 11% and 4% at 0.5, 4 and 24 h, resp.) and significant radioactivity was also seen in the intestines (8%, 6% and 1% at 0.5, 4 and 24 h, resp.), indicating hepatobiliary excretion of the complex.  Less than 2% uptake in stomach until 24 h confirmed good in vivo stability of the complex.  99mTc-isoniazid initially accumulated in infective lesions of S. aureus in rabbits due to hyper-vascularity, but because of its non specificity for S. aureus the residency of 99mTc-isoniazid was low and it showed rapid wash out from the lesion, whereas residency of tubercular lesion was high and it remained in the tubercular lesion in the delayed images also.  The results suggest that 99mTc-isoniazid is a specific agent for localization of tubercular lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_IVkud-n2yLVg90H21EOLACvtfcHk0lg9_yPV6wMXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslOmurw%253D&md5=b83c120dc91c97b9185793a0a6c42483</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1524%2Fract.2006.94.3.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1524%252Fract.2006.94.3.147%26sid%3Dliteratum%253Aachs%26aulast%3DRoohi%26aufirst%3DS.%26aulast%3DMushtaq%26aufirst%3DA.%26aulast%3DJehangir%26aufirst%3DM.%26aulast%3DMalik%26aufirst%3DS.%2BA.%26atitle%3DDirect%2520labeling%2520of%2520isoniazid%2520with%2520technetium-99m%2520for%2520diagnosis%2520of%2520tuberculosis%26jtitle%3DRadiochim.%2520Acta%26date%3D2006%26volume%3D94%26spage%3D147%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Stottmeier, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beam, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubica, G. P.</span><span> </span><span class="NLM_article-title">The absorption and excretion of pyrazinamide. I. Preliminary study in laboratory animals and in man</span> <span class="citation_source-journal">Am. Rev. Respir. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=5657154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADyaF1c3os1OmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1968&pages=70-74&author=K.+D.+Stottmeierauthor=R.+E.+Beamauthor=G.+P.+Kubica&title=The+absorption+and+excretion+of+pyrazinamide.+I.+Preliminary+study+in+laboratory+animals+and+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The absorption and excretion of pyrazinamide. I. Preliminary study in laboratory animals and in man</span></div><div class="casAuthors">Stottmeier K D; Beam R E; Kubica G P</div><div class="citationInfo"><span class="NLM_cas:title">The American review of respiratory disease</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-4</span>
        ISSN:<span class="NLM_cas:issn">0003-0805</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQskxNTbfL5CFm8bhe6roZYfW6udTcc2eaCGqlmBbBoG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF1c3os1OmsA%253D%253D&md5=d97eb5604f6e151d045719f1ea224a50</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStottmeier%26aufirst%3DK.%2BD.%26aulast%3DBeam%26aufirst%3DR.%2BE.%26aulast%3DKubica%26aufirst%3DG.%2BP.%26atitle%3DThe%2520absorption%2520and%2520excretion%2520of%2520pyrazinamide.%2520I.%2520Preliminary%2520study%2520in%2520laboratory%2520animals%2520and%2520in%2520man%26jtitle%3DAm.%2520Rev.%2520Respir.%2520Dis.%26date%3D1968%26volume%3D98%26spage%3D70%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Peloquin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaresko, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keung, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulpitt, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelliffe, R. W.</span><span> </span><span class="NLM_article-title">Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2670</span><span class="NLM_x">–</span> <span class="NLM_lpage">2679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1997&pages=2670-2679&author=C.+A.+Peloquinauthor=G.+S.+Jareskoauthor=C.+L.+Yongauthor=A.+C.+Keungauthor=A.+E.+Bulpittauthor=R.+W.+Jelliffe&title=Population+pharmacokinetic+modeling+of+isoniazid%2C+rifampin%2C+and+pyrazinamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeloquin%26aufirst%3DC.%2BA.%26aulast%3DJaresko%26aufirst%3DG.%2BS.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DKeung%26aufirst%3DA.%2BC.%26aulast%3DBulpitt%26aufirst%3DA.%2BE.%26aulast%3DJelliffe%26aufirst%3DR.%2BW.%26atitle%3DPopulation%2520pharmacokinetic%2520modeling%2520of%2520isoniazid%252C%2520rifampin%252C%2520and%2520pyrazinamide%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1997%26volume%3D41%26spage%3D2670%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Lacroix, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nouveau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyonnaud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duwoos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafont, O.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1989&pages=395-400&author=C.+Lacroixauthor=T.+P.+Hoangauthor=J.+Nouveauauthor=C.+Guyonnaudauthor=G.+Laineauthor=H.+Duwoosauthor=O.+Lafont&title=Pharmacokinetics+of+pyrazinamide+and+its+metabolites+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLacroix%26aufirst%3DC.%26aulast%3DHoang%26aufirst%3DT.%2BP.%26aulast%3DNouveau%26aufirst%3DJ.%26aulast%3DGuyonnaud%26aufirst%3DC.%26aulast%3DLaine%26aufirst%3DG.%26aulast%3DDuwoos%26aufirst%3DH.%26aulast%3DLafont%26aufirst%3DO.%26atitle%3DPharmacokinetics%2520of%2520pyrazinamide%2520and%2520its%2520metabolites%2520in%2520healthy%2520subjects%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1989%26volume%3D36%26spage%3D395%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heym, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S.</span><span> </span><span class="NLM_article-title">The catalase-peroxidase gene and isoniazid resistance of <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1992&pages=591-593&author=Y.+Zhangauthor=B.+Heymauthor=B.+Allenauthor=D.+Youngauthor=S.+Cole&title=The+catalase-peroxidase+gene+and+isoniazid+resistance+of+Mycobacterium+tuberculosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHeym%26aufirst%3DB.%26aulast%3DAllen%26aufirst%3DB.%26aulast%3DYoung%26aufirst%3DD.%26aulast%3DCole%26aufirst%3DS.%26atitle%3DThe%2520catalase-peroxidase%2520gene%2520and%2520isoniazid%2520resistance%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D591%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Blanchard, J. S.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of drug resistance in <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1146%2Fannurev.bi.65.070196.001243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8811179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK28XktFamtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1996&pages=215-239&author=J.+S.+Blanchard&title=Molecular+mechanisms+of+drug+resistance+in+Mycobacterium+tuberculosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of drug resistance in Mycobacterium tuberculosis</span></div><div class="casAuthors">Blanchard, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">215-239</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 127 refs.  In spite of forty years of effective chemotherapy for tuberculosis, the mol. mechanisms of antibacterial compds. in Mycobacterium tuberculosis have only recently been revealed.  Broad spectrum antibacterials, including streptomycin, rifampicin, and fluoroquinolones, have been demonstrated to act on the same targets in M. tuberculosis as they do in Escherichia coli.  Resistance to these agents results from single mutagenic events that lead to amino acid substitutions in their target proteins.  The mechanisms of action of the unique antitubercular drugs, including isoniazid, ethambutol, and pyrazinamide, have also recently been defined.  Resistance to isoniazid can be caused either by mutations in the katG-encoded catalase-peroxidase, the enzyme responsible for drug activation, or by the mol. target, the inhA-encoded long chain enoyl-ACP reductase.  Ethambutol appears to block specifically the biosynthesis of the arabinogalactan component of the mycobacterial cell envelope, and pyrazinamide has no known target.  With the resurgence of tuberculosis and the appearance of strains which are multiply resistant to the above compds., present tuberculosis chemotherapies are threatened.  New approaches to the treatment of multidrug-resistant tuberculosis are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBC4hQKmc42rVg90H21EOLACvtfcHk0ljiR1ruUzXpWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktFamtLw%253D&md5=8154424e4e4d3c06a4388d561eb9adae</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bi.65.070196.001243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bi.65.070196.001243%26sid%3Dliteratum%253Aachs%26aulast%3DBlanchard%26aufirst%3DJ.%2BS.%26atitle%3DMolecular%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520Mycobacterium%2520tuberculosis%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1996%26volume%3D65%26spage%3D215%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Rawat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonge, P. J.</span><span> </span><span class="NLM_article-title">The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the <i>Mycobacterium tuberculosis</i> enoyl reductase: adduct affinity and drug resistance</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">13881</span><span class="NLM_x">–</span> <span class="NLM_lpage">13886</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1073%2Fpnas.2235848100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=14623976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFGisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13881-13886&author=R.+Rawatauthor=A.+Whittyauthor=P.+J.+Tonge&title=The+isoniazid-NAD+adduct+is+a+slow%2C+tight-binding+inhibitor+of+InhA%2C+the+Mycobacterium+tuberculosis+enoyl+reductase%3A+adduct+affinity+and+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance</span></div><div class="casAuthors">Rawat, Richa; Whitty, Adrian; Tonge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13881-13886</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Isoniazid (INH), a frontline antitubercular drug, inhibits InhA, the enoyl reductase from Mycobacterium tuberculosis, by forming a covalent adduct with the NAD cofactor.  Here, we report that the INH-NAD adduct is a slow, tight-binding competitive inhibitor of InhA.  Demonstration that the adduct binds to WT InhA by a two-step enzyme inhibition mechanism, with initial weak binding (K-1 = 16 ± 11 nM) followed by slow conversion to a final inhibited complex (EI*) with overall Ki = 0.75 ± 0.08 nM, reconciles existing contradictory values for the inhibitory potency of INH-NAD for InhA.  The first order rate const. for conversion of the initial EI complex to EI* (k2 = 0.13 ± 0.01 min-1) is similar to the max. rate const. obsd. for InhA inhibition in reaction mixts. contg. InhA, INH, NADH, and the INH-activating enzyme KatG (catalase/peroxidase from M. tuberculosis), consistent with an inhibition mechanism in which the adduct forms in soln. rather than on the enzyme.  Importantly, three mutations that correlate with INH resistance, 121V, 147T, and S94A, have little impact on the inhibition consts.  Thus, drug resistance does not result simply from a redn. in affinity of INH-NAD for pure InhA.  Instead, we hypothesize that protein-protein interactions within the type II dissocd. fatty acid biosynthesis pathway (FASII) complex are crit. to the mechanism of INH action.  Finally, for M161V, an InhA mutation that correlates with resistance to the common biocide triclosan in Mycobacterium smegmatis, binding to form the initial EI complex is significantly weakened, explaining why this mutant inactivates more slowly than WT InhA when incubated with INH, NADH, and KatG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ASTFMC3T_rVg90H21EOLACvtfcHk0ljiR1ruUzXpWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFGisLo%253D&md5=dbacbee13fb8ab6c677df78554ae1fdf</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2235848100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2235848100%26sid%3Dliteratum%253Aachs%26aulast%3DRawat%26aufirst%3DR.%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520isoniazid-NAD%2520adduct%2520is%2520a%2520slow%252C%2520tight-binding%2520inhibitor%2520of%2520InhA%252C%2520the%2520Mycobacterium%2520tuberculosis%2520enoyl%2520reductase%253A%2520adduct%2520affinity%2520and%2520drug%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D13881%26epage%3D13886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Yarbrough, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. W.</span><span> </span><span class="NLM_article-title">Molecular mechanism of the rifampicin−RNA polymerase interaction</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2669</span><span class="NLM_x">–</span> <span class="NLM_lpage">2676</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00657a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1976&pages=2669-2676&author=L.+R.+Yarbroughauthor=F.+Y.+Wuauthor=C.+W.+Wu&title=Molecular+mechanism+of+the+rifampicin%E2%88%92RNA+polymerase+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi00657a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00657a029%26sid%3Dliteratum%253Aachs%26aulast%3DYarbrough%26aufirst%3DL.%2BR.%26aulast%3DWu%26aufirst%3DF.%2BY.%26aulast%3DWu%26aufirst%3DC.%2BW.%26atitle%3DMolecular%2520mechanism%2520of%2520the%2520rifampicin%25E2%2588%2592RNA%2520polymerase%2520interaction%26jtitle%3DBiochemistry%26date%3D1976%26volume%3D15%26spage%3D2669%26epage%3D2676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1624</span><span class="NLM_x">–</span> <span class="NLM_lpage">1630</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1624-1630&author=J.+Maoauthor=Y.+Wangauthor=B.+Wanauthor=A.+P.+Kozikowskiauthor=S.+G.+Franzblau&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+mefloquine-based+ligands+as+novel+antituberculosis+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520mefloquine-based%2520ligands%2520as%2520novel%2520antituberculosis%2520agents%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1624%26epage%3D1630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Glamkowski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitano, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, D. L.</span><span> </span><span class="NLM_article-title">Synthesis of 3-(4-acylaminopiperazin-1-ylalkyl)indoles as potential antihypertensive agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1489</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00221a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=1485-1489&author=E.+J.+Glamkowskiauthor=P.+A.+Reitanoauthor=D.+L.+Woodward&title=Synthesis+of+3-%284-acylaminopiperazin-1-ylalkyl%29indoles+as+potential+antihypertensive+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm00221a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00221a024%26sid%3Dliteratum%253Aachs%26aulast%3DGlamkowski%26aufirst%3DE.%2BJ.%26aulast%3DReitano%26aufirst%3DP.%2BA.%26aulast%3DWoodward%26aufirst%3DD.%2BL.%26atitle%3DSynthesis%2520of%25203-%25284-acylaminopiperazin-1-ylalkyl%2529indoles%2520as%2520potential%2520antihypertensive%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D1485%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Loening, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. S.</span><span> </span><span class="NLM_article-title">AMIDE: a free software tool for multimodality medical image analysis</span> <span class="citation_source-journal">Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1162%2F153535003322556877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=14649056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADC%252BD3srmtF2jsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=131-137&author=A.+M.+Loeningauthor=S.+S.+Gambhir&title=AMIDE%3A+a+free+software+tool+for+multimodality+medical+image+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">AMIDE: a free software tool for multimodality medical image analysis</span></div><div class="casAuthors">Loening Andreas Markus; Gambhir Sanjiv Sam</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-7</span>
        ISSN:<span class="NLM_cas:issn">1535-3508</span>.
    </div><div class="casAbstract">Amide's a Medical Image Data Examiner (AMIDE) has been developed as a user-friendly, open-source software tool for displaying and analyzing multimodality volumetric medical images.  Central to the package's abilities to simultaneously display multiple data sets (e.g., PET, CT, MRI) and regions of interest is the on-demand data reslicing implemented within the program.  Data sets can be freely shifted, rotated, viewed, and analyzed with the program automatically handling interpolation as needed from the original data.  Validation has been performed by comparing the output of AMIDE with that of several existing software packages.  AMIDE runs on UNIX, Macintosh OS X, and Microsoft Windows platforms, and it is freely available with source code under the terms of the GNU General Public License.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcToCSSNUtq4wiCEBeYuoi7AfW6udTcc2eZ3SZVYnGlL77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srmtF2jsw%253D%253D&md5=edf65edb4cc1fd4160544df7138b66c0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1162%2F153535003322556877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1162%252F153535003322556877%26sid%3Dliteratum%253Aachs%26aulast%3DLoening%26aufirst%3DA.%2BM.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26atitle%3DAMIDE%253A%2520a%2520free%2520software%2520tool%2520for%2520multimodality%2520medical%2520image%2520analysis%26jtitle%3DMol.%2520Imaging%26date%3D2003%26volume%3D2%26spage%3D131%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 44 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Cristina Fernández-Paz, Sara Rojas, Pablo Salcedo-Abraira, Teresa Simón-Yarza, Carmen Remuñán-López, <span class="NLM_string-name hlFld-ContribAuthor">Patricia Horcajada</span>. </span><span class="cited-content_cbyCitation_article-title">Metal–Organic Framework Microsphere Formulation for Pulmonary Administration. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2020,</strong> <em>12 </em>
                                    (23)
                                     , 25676-25682. <a href="https://doi.org/10.1021/acsami.0c07356" title="DOI URL">https://doi.org/10.1021/acsami.0c07356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.0c07356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.0c07356%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DMetal%2525E2%252580%252593Organic%252BFramework%252BMicrosphere%252BFormulation%252Bfor%252BPulmonary%252BAdministration%26aulast%3DFern%25C3%25A1ndez-Paz%26aufirst%3DCristina%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D04052020%26date%3D28052020%26date%3D04052020%26volume%3D12%26issue%3D23%26spage%3D25676%26epage%3D25682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Filipa Mota, Alvaro A. Ordonez, George Firth, Camilo A. Ruiz-Bedoya, Michelle T. Ma, <span class="NLM_string-name hlFld-ContribAuthor">Sanjay K. Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Radiotracer Development for Bacterial Imaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1964-1977. <a href="https://doi.org/10.1021/acs.jmedchem.9b01623" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01623%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRadiotracer%252BDevelopment%252Bfor%252BBacterial%252BImaging%26aulast%3DMota%26aufirst%3DFilipa%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30092019%26date%3D21022020%26date%3D12022020%26volume%3D63%26issue%3D5%26spage%3D1964%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bingyin  Jiang</span>, <span class="hlFld-ContribAuthor ">Wendy L.  Hom</span>, <span class="hlFld-ContribAuthor ">Xianyin  Chen</span>, <span class="hlFld-ContribAuthor ">Pengqing  Yu</span>, <span class="hlFld-ContribAuthor ">Laura C.  Pavelka</span>, <span class="hlFld-ContribAuthor ">Kim  Kisslinger</span>, <span class="hlFld-ContribAuthor ">John B.  Parise</span>, <span class="hlFld-ContribAuthor ">Surita R.  Bhatia</span>, and <span class="hlFld-ContribAuthor ">Robert B.  Grubbs</span>  . </span><span class="cited-content_cbyCitation_article-title">Magnetic Hydrogels from Alkyne/Cobalt Carbonyl-Functionalized ABA Triblock Copolymers. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2016,</strong> <em>138 </em>
                                    (13)
                                     , 4616-4625. <a href="https://doi.org/10.1021/jacs.6b01271" title="DOI URL">https://doi.org/10.1021/jacs.6b01271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.6b01271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.6b01271%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DMagnetic%252BHydrogels%252Bfrom%252BAlkyne%25252FCobalt%252BCarbonyl-Functionalized%252BABA%252BTriblock%252BCopolymers%26aulast%3DJiang%26aufirst%3DBingyin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03022016%26date%3D24032016%26date%3D06042016%26date%3D09032016%26volume%3D138%26issue%3D13%26spage%3D4616%26epage%3D4625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Courtney C.  Aldrich</span>, <span class="hlFld-ContribAuthor ">Robert S.  Wallis</span>, <span class="hlFld-ContribAuthor ">Rory P.  Remmel</span>, <span class="hlFld-ContribAuthor ">Pooja  Hegde</span>, <span class="hlFld-ContribAuthor ">Christina L.  Stallings</span>. </span><span class="cited-content_cbyCitation_article-title">Antitubercular Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-110. <a href="https://doi.org/10.1002/0471266949.bmc298" title="DOI URL">https://doi.org/10.1002/0471266949.bmc298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc298%26sid%3Dliteratum%253Aachs%26atitle%3DAntitubercular%252BAgents%26aulast%3DAldrich%26aufirst%3DCourtney%2BC.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D110%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faye  Lanni</span>, <span class="hlFld-ContribAuthor ">Neil  Burton</span>, <span class="hlFld-ContribAuthor ">Debbie  Harris</span>, <span class="hlFld-ContribAuthor ">Susan  Fotheringham</span>, <span class="hlFld-ContribAuthor ">Simon  Clark</span>, <span class="hlFld-ContribAuthor ">Oliver  Skinner</span>, <span class="hlFld-ContribAuthor ">Nathan  Wiblin</span>, <span class="hlFld-ContribAuthor ">Mike  Dennis</span>, <span class="hlFld-ContribAuthor ">Stuart  Armstrong</span>, <span class="hlFld-ContribAuthor ">Geraint  Davies</span>, <span class="hlFld-ContribAuthor ">Ann  Williams</span>, . </span><span class="cited-content_cbyCitation_article-title">The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     , e0245922. <a href="https://doi.org/10.1371/journal.pone.0245922" title="DOI URL">https://doi.org/10.1371/journal.pone.0245922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0245922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0245922%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DThe%252Bpotential%252Bof%252Bmicrodialysis%252Bto%252Bestimate%252Brifampicin%252Bconcentrations%252Bin%252Bthe%252Blung%252Bof%252Bguinea%252Bpigs%26aulast%3DLanni%26aufirst%3DFaye%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D1%26spage%3De0245922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen  Thompson</span>, <span class="hlFld-ContribAuthor ">Steven  Kealey</span>, <span class="hlFld-ContribAuthor ">Selena Milicevic  Sephton</span>, <span class="hlFld-ContribAuthor ">Franklin I.  Aigbirhio</span>. </span><span class="cited-content_cbyCitation_article-title">Radiochemistry with Carbon‐11. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 143-249. <a href="https://doi.org/10.1002/9781119500575.ch7" title="DOI URL">https://doi.org/10.1002/9781119500575.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119500575.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119500575.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DRadiochemistry%252Bwith%252BCarbon%2525E2%252580%25259011%26aulast%3DThompson%26aufirst%3DStephen%26date%3D2020%26date%3D2021%26spage%3D143%26epage%3D249%26pub%3DWiley%26atitle%3DHandbook%252Bof%252BRadiopharmaceuticals%26aulast%3DScott%26aufirst%3DPeter%26date%3D2020%26date%3D2021%26volume%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lloyd  Tanner</span>, <span class="hlFld-ContribAuthor ">Richard K.  Haynes</span>, <span class="hlFld-ContribAuthor ">Lubbe  Wiesner</span>. </span><span class="cited-content_cbyCitation_article-title">Accumulation of TB-Active Compounds in Murine Organs Relevant to Infection by Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00724" title="DOI URL">https://doi.org/10.3389/fphar.2020.00724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00724%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DAccumulation%252Bof%252BTB-Active%252BCompounds%252Bin%252BMurine%252BOrgans%252BRelevant%252Bto%252BInfection%252Bby%252BMycobacterium%252Btuberculosis%26aulast%3DTanner%26aufirst%3DLloyd%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alvaro A.  Ordonez</span>, <span class="hlFld-ContribAuthor ">Hechuan  Wang</span>, <span class="hlFld-ContribAuthor ">Gesham  Magombedze</span>, <span class="hlFld-ContribAuthor ">Camilo A.  Ruiz-Bedoya</span>, <span class="hlFld-ContribAuthor ">Shashikant  Srivastava</span>, <span class="hlFld-ContribAuthor ">Allen  Chen</span>, <span class="hlFld-ContribAuthor ">Elizabeth W.  Tucker</span>, <span class="hlFld-ContribAuthor ">Michael E.  Urbanowski</span>, <span class="hlFld-ContribAuthor ">Lisa  Pieterse</span>, <span class="hlFld-ContribAuthor ">E.  Fabian Cardozo</span>, <span class="hlFld-ContribAuthor ">Martin A.  Lodge</span>, <span class="hlFld-ContribAuthor ">Maunank R.  Shah</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Holt</span>, <span class="hlFld-ContribAuthor ">William B.  Mathews</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Jogarao V. S.  Gobburu</span>, <span class="hlFld-ContribAuthor ">Charles A.  Peloquin</span>, <span class="hlFld-ContribAuthor ">Steven P.  Rowe</span>, <span class="hlFld-ContribAuthor ">Tawanda  Gumbo</span>, <span class="hlFld-ContribAuthor ">Vijay D.  Ivaturi</span>, <span class="hlFld-ContribAuthor ">Sanjay K.  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions. </span><span class="cited-content_cbyCitation_journal-name">Nature Medicine</span><span> <strong>2020,</strong> <em>26 </em>
                                    (4)
                                     , 529-534. <a href="https://doi.org/10.1038/s41591-020-0770-2" title="DOI URL">https://doi.org/10.1038/s41591-020-0770-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41591-020-0770-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41591-020-0770-2%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Medicine%26atitle%3DDynamic%252Bimaging%252Bin%252Bpatients%252Bwith%252Btuberculosis%252Breveals%252Bheterogeneous%252Bdrug%252Bexposures%252Bin%252Bpulmonary%252Blesions%26aulast%3DOrdonez%26aufirst%3DAlvaro%2BA.%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D4%26spage%3D529%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ismaheel O.  Lawal</span>, <span class="hlFld-ContribAuthor ">Mike M.  Sathekge</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging Tuberculosis and AIDS Associated Infections. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 237-257. <a href="https://doi.org/10.1007/978-3-030-25494-0_15" title="DOI URL">https://doi.org/10.1007/978-3-030-25494-0_15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-25494-0_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-25494-0_15%26sid%3Dliteratum%253Aachs%26atitle%3DImaging%252BTuberculosis%252Band%252BAIDS%252BAssociated%252BInfections%26aulast%3DLawal%26aufirst%3DIsmaheel%2BO.%26date%3D2020%26date%3D2019%26spage%3D237%26epage%3D257%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNuclear%252BMedicine%252Bin%252BInfectious%252BDiseases%26aulast%3DSignore%26aufirst%3DAlberto%26date%3D2020%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Ebenhan</span>, <span class="hlFld-ContribAuthor ">Mariza  Vorster</span>. </span><span class="cited-content_cbyCitation_article-title">Non-FDG PET Tracers for TB Imaging. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 145-155. <a href="https://doi.org/10.1007/978-3-030-47009-8_12" title="DOI URL">https://doi.org/10.1007/978-3-030-47009-8_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-47009-8_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-47009-8_12%26sid%3Dliteratum%253Aachs%26atitle%3DNon-FDG%252BPET%252BTracers%252Bfor%252BTB%252BImaging%26aulast%3DEbenhan%26aufirst%3DT.%26date%3D2020%26date%3D2020%26spage%3D145%26epage%3D155%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%25252FCT%252Bin%252BTuberculosis%26aulast%3DSobic%2BSaranovic%26aufirst%3DDragana%26date%3D2020%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanjay  Gambhir</span>, <span class="hlFld-ContribAuthor ">Kasturi  Rangan</span>, <span class="hlFld-ContribAuthor ">Manish  Ora</span>. </span><span class="cited-content_cbyCitation_article-title">Role of PET-CT in Central Nervous System Tuberculosis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 101-117. <a href="https://doi.org/10.1007/978-3-030-47009-8_9" title="DOI URL">https://doi.org/10.1007/978-3-030-47009-8_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-47009-8_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-47009-8_9%26sid%3Dliteratum%253Aachs%26atitle%3DRole%252Bof%252BPET-CT%252Bin%252BCentral%252BNervous%252BSystem%252BTuberculosis%26aulast%3DGambhir%26aufirst%3DSanjay%26date%3D2020%26date%3D2020%26spage%3D101%26epage%3D117%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%25252FCT%252Bin%252BTuberculosis%26aulast%3DSobic%2BSaranovic%26aufirst%3DDragana%26date%3D2020%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuiyu  Lu</span>, <span class="hlFld-ContribAuthor ">Fabrice G.  Siméon</span>, <span class="hlFld-ContribAuthor ">Sanjay  Telu</span>, <span class="hlFld-ContribAuthor ">Lisheng  Cai</span>, <span class="hlFld-ContribAuthor ">Victor W.  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry of labeling heterocycles with carbon-11 or fluorine-18 for biomedical imaging. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 241-384. <a href="https://doi.org/10.1016/bs.aihch.2019.11.005" title="DOI URL">https://doi.org/10.1016/bs.aihch.2019.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2019.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2019.11.005%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bchemistry%252Bof%252Blabeling%252Bheterocycles%252Bwith%252Bcarbon-11%252Bor%252Bfluorine-18%252Bfor%252Bbiomedical%252Bimaging%26aulast%3DLu%26aufirst%3DShuiyu%26date%3D2020%26spage%3D241%26epage%3D384%26pub%3DElsevier%26date%3D2020%26volume%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Camilo A.  Ruiz-Bedoya</span>, <span class="hlFld-ContribAuthor ">Oren  Gordon</span>, <span class="hlFld-ContribAuthor ">Filipa  Mota</span>, <span class="hlFld-ContribAuthor ">Sudhanshu  Abhishek</span>, <span class="hlFld-ContribAuthor ">Elizabeth W.  Tucker</span>, <span class="hlFld-ContribAuthor ">Alvaro A.  Ordonez</span>, <span class="hlFld-ContribAuthor ">Sanjay K.  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Imaging of Diabetic Foot Infections: New Tools for Old Questions. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (23)
                                     , 5984. <a href="https://doi.org/10.3390/ijms20235984" title="DOI URL">https://doi.org/10.3390/ijms20235984</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20235984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20235984%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMolecular%252BImaging%252Bof%252BDiabetic%252BFoot%252BInfections%25253A%252BNew%252BTools%252Bfor%252BOld%252BQuestions%26aulast%3DRuiz-Bedoya%26aufirst%3DCamilo%2BA.%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D23%26spage%3D5984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth W.  Tucker</span>, <span class="hlFld-ContribAuthor ">Beatriz  Guglieri-Lopez</span>, <span class="hlFld-ContribAuthor ">Alvaro A.  Ordonez</span>, <span class="hlFld-ContribAuthor ">Brittaney  Ritchie</span>, <span class="hlFld-ContribAuthor ">Mariah H.  Klunk</span>, <span class="hlFld-ContribAuthor ">Richa  Sharma</span>, <span class="hlFld-ContribAuthor ">Yong S.  Chang</span>, <span class="hlFld-ContribAuthor ">Julian  Sanchez-Bautista</span>, <span class="hlFld-ContribAuthor ">Sarah  Frey</span>, <span class="hlFld-ContribAuthor ">Martin A.  Lodge</span>, <span class="hlFld-ContribAuthor ">Steven P.  Rowe</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Holt</span>, <span class="hlFld-ContribAuthor ">Jogarao V. S.  Gobburu</span>, <span class="hlFld-ContribAuthor ">Charles A.  Peloquin</span>, <span class="hlFld-ContribAuthor ">William B.  Mathews</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Carlos A.  Pardo</span>, <span class="hlFld-ContribAuthor ">Sujatha  Kannan</span>, <span class="hlFld-ContribAuthor ">Vijay D.  Ivaturi</span>, <span class="hlFld-ContribAuthor ">Sanjay K.  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Noninvasive
              11
              C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2018,</strong> <em>10 </em>
                                    (470)
                                     , eaau0965. <a href="https://doi.org/10.1126/scitranslmed.aau0965" title="DOI URL">https://doi.org/10.1126/scitranslmed.aau0965</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aau0965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aau0965%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DNoninvasive%252B11%252BC-rifampin%252Bpositron%252Bemission%252Btomography%252Breveals%252Bdrug%252Bbiodistribution%252Bin%252Btuberculous%252Bmeningitis%26aulast%3DTucker%26aufirst%3DElizabeth%2BW.%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D470%26spage%3Deaau0965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephanus T.  Malherbe</span>, <span class="hlFld-ContribAuthor ">Léanie  Kleynhans</span>, <span class="hlFld-ContribAuthor ">Gerhard  Walzl</span>. </span><span class="cited-content_cbyCitation_article-title">The potential of imaging tools as correlates of infection and disease for new TB vaccine development. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Immunology</span><span> <strong>2018,</strong> <em>39 </em>, 73-80. <a href="https://doi.org/10.1016/j.smim.2018.06.001" title="DOI URL">https://doi.org/10.1016/j.smim.2018.06.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.smim.2018.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.smim.2018.06.001%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Immunology%26atitle%3DThe%252Bpotential%252Bof%252Bimaging%252Btools%252Bas%252Bcorrelates%252Bof%252Binfection%252Band%252Bdisease%252Bfor%252Bnew%252BTB%252Bvaccine%252Bdevelopment%26aulast%3DMalherbe%26aufirst%3DStephanus%2BT.%26date%3D2018%26volume%3D39%26spage%3D73%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adeola  Shobo</span>, <span class="hlFld-ContribAuthor ">Annapurna  Pamreddy</span>, <span class="hlFld-ContribAuthor ">Hendrik G  Kruger</span>, <span class="hlFld-ContribAuthor ">Maya M  Makatini</span>, <span class="hlFld-ContribAuthor ">Tricia  Naicker</span>, <span class="hlFld-ContribAuthor ">Thavendran  Govender</span>, <span class="hlFld-ContribAuthor ">Sooraj  Baijnath</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced brain penetration of pretomanid by intranasal administration of an oil-in-water nanoemulsion. </span><span class="cited-content_cbyCitation_journal-name">Nanomedicine</span><span> <strong>2018,</strong> <em>13 </em>
                                    (9)
                                     , 997-1008. <a href="https://doi.org/10.2217/nnm-2017-0365" title="DOI URL">https://doi.org/10.2217/nnm-2017-0365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/nnm-2017-0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fnnm-2017-0365%26sid%3Dliteratum%253Aachs%26jtitle%3DNanomedicine%26atitle%3DEnhanced%252Bbrain%252Bpenetration%252Bof%252Bpretomanid%252Bby%252Bintranasal%252Badministration%252Bof%252Ban%252Boil-in-water%252Bnanoemulsion%26aulast%3DShobo%26aufirst%3DAdeola%26date%3D2018%26volume%3D13%26issue%3D9%26spage%3D997%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlotta  Taddei</span>, <span class="hlFld-ContribAuthor ">Antony D.  Gee</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in [
              11
              C]carbon dioxide ([
              11
              C]CO
              2
              ) and [
              11
              C]carbon monoxide ([
              11
              C]CO) chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 237-251. <a href="https://doi.org/10.1002/jlcr.3596" title="DOI URL">https://doi.org/10.1002/jlcr.3596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3596%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DRecent%252Bprogress%252Bin%252B%25255B%252B11%252BC%25255Dcarbon%252Bdioxide%252B%252528%25255B%252B11%252BC%25255DCO%252B2%252B%252529%252Band%252B%25255B%252B11%252BC%25255Dcarbon%252Bmonoxide%252B%252528%25255B%252B11%252BC%25255DCO%252529%252Bchemistry%26aulast%3DTaddei%26aufirst%3DCarlotta%26date%3D2018%26date%3D2018%26volume%3D61%26issue%3D3%26spage%3D237%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip  Norcott</span>, <span class="hlFld-ContribAuthor ">Peter J.  Rayner</span>, <span class="hlFld-ContribAuthor ">Gary G. R.  Green</span>, <span class="hlFld-ContribAuthor ">Simon B.  Duckett</span>. </span><span class="cited-content_cbyCitation_article-title">Achieving High
              1
              H Nuclear Hyperpolarization Levels with Long Lifetimes in a Range of Tuberculosis Drug Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2017,</strong> <em>23 </em>
                                    (67)
                                     , 16990-16997. <a href="https://doi.org/10.1002/chem.201703278" title="DOI URL">https://doi.org/10.1002/chem.201703278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201703278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201703278%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DAchieving%252BHigh%252B1%252BH%252BNuclear%252BHyperpolarization%252BLevels%252Bwith%252BLong%252BLifetimes%252Bin%252Ba%252BRange%252Bof%252BTuberculosis%252BDrug%252BScaffolds%26aulast%3DNorcott%26aufirst%3DPhilip%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D67%26spage%3D16990%26epage%3D16997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David C.  Labaree</span>, <span class="hlFld-ContribAuthor ">Jim R.  Ropchan</span>, <span class="hlFld-ContribAuthor ">Nabeel  Nabulsi</span>, <span class="hlFld-ContribAuthor ">Yiyun  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">A modification to improve the reliability of [
              11
              C]CN
              −
              production in the GE radiochemistry system. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2017,</strong> <em>60 </em>
                                    (12)
                                     , 592-595. <a href="https://doi.org/10.1002/jlcr.3540" title="DOI URL">https://doi.org/10.1002/jlcr.3540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3540%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DA%252Bmodification%252Bto%252Bimprove%252Bthe%252Breliability%252Bof%252B%25255B%252B11%252BC%25255DCN%252B%2525E2%252588%252592%252Bproduction%252Bin%252Bthe%252BGE%252Bradiochemistry%252Bsystem%26aulast%3DLabaree%26aufirst%3DDavid%2BC.%26date%3D2017%26date%3D2017%26volume%3D60%26issue%3D12%26spage%3D592%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuradha  Rao</span>, <span class="hlFld-ContribAuthor ">Govindarajan  Mallarajapatna</span>, <span class="hlFld-ContribAuthor ">Sharanabasappa  Godehal</span>, <span class="hlFld-ContribAuthor ">Swarna  Shivakumar</span>. </span><span class="cited-content_cbyCitation_article-title">Isolated splenic tuberculosis detected only on FDG-PET. </span><span class="cited-content_cbyCitation_journal-name">BJR|case reports</span><span> <strong>2017,</strong> <em>3 </em>
                                    (3)
                                     , 20150238. <a href="https://doi.org/10.1259/bjrcr.20150238" title="DOI URL">https://doi.org/10.1259/bjrcr.20150238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1259/bjrcr.20150238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1259%2Fbjrcr.20150238%26sid%3Dliteratum%253Aachs%26jtitle%3DBJR%257Ccase%2520reports%26atitle%3DIsolated%252Bsplenic%252Btuberculosis%252Bdetected%252Bonly%252Bon%252BFDG-PET%26aulast%3DRao%26aufirst%3DAnuradha%26date%3D2017%26volume%3D3%26issue%3D3%26spage%3D20150238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jyotibon  Dutta</span>, <span class="hlFld-ContribAuthor ">Tricia  Naicker</span>, <span class="hlFld-ContribAuthor ">Thomas  Ebenhan</span>, <span class="hlFld-ContribAuthor ">Hendrik G.  Kruger</span>, <span class="hlFld-ContribAuthor ">Per I.  Arvidsson</span>, <span class="hlFld-ContribAuthor ">Thavendran  Govender</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approaches to radiochemical probes for imaging of bacterial infections. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>133 </em>, 287-308. <a href="https://doi.org/10.1016/j.ejmech.2017.03.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.03.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.03.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.03.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bapproaches%252Bto%252Bradiochemical%252Bprobes%252Bfor%252Bimaging%252Bof%252Bbacterial%252Binfections%26aulast%3DDutta%26aufirst%3DJyotibon%26date%3D2017%26volume%3D133%26spage%3D287%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael D.  Schump</span>, <span class="hlFld-ContribAuthor ">Douglas M.  Fox</span>, <span class="hlFld-ContribAuthor ">Carolyn R.  Bertozzi</span>, <span class="hlFld-ContribAuthor ">Lee W.  Riley</span>. </span><span class="cited-content_cbyCitation_article-title">Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2017,</strong> <em>61 </em>
                                    (3)
                                     <a href="https://doi.org/10.1128/AAC.01639-16" title="DOI URL">https://doi.org/10.1128/AAC.01639-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01639-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01639-16%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DSubcellular%252BPartitioning%252Band%252BIntramacrophage%252BSelectivity%252Bof%252BAntimicrobial%252BCompounds%252Bagainst%252BMycobacterium%252Btuberculosis%26aulast%3DSchump%26aufirst%3DMichael%2BD.%26date%3D2017%26volume%3D61%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Querellou</span>, <span class="hlFld-ContribAuthor ">P.  Robin</span>, <span class="hlFld-ContribAuthor ">R.  Abgral</span>, <span class="hlFld-ContribAuthor ">V.  Devauchelle</span>, <span class="hlFld-ContribAuthor ">C.  De Moreuil</span>, <span class="hlFld-ContribAuthor ">P.Y.  Salaun</span>, <span class="hlFld-ContribAuthor ">P.Y.  Le Roux</span>, <span class="hlFld-ContribAuthor ">A.  Le Duc-Pennec</span>. </span><span class="cited-content_cbyCitation_article-title">Review article: FDG-PET in inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Médecine Nucléaire</span><span> <strong>2017,</strong> <em>41 </em>
                                    (1)
                                     , 3-14. <a href="https://doi.org/10.1016/j.mednuc.2016.12.001" title="DOI URL">https://doi.org/10.1016/j.mednuc.2016.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mednuc.2016.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mednuc.2016.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DM%25C3%25A9decine%2520Nucl%25C3%25A9aire%26atitle%3DReview%252Barticle%25253A%252BFDG-PET%252Bin%252Binflammatory%252Bdiseases%26aulast%3DQuerellou%26aufirst%3DS.%26date%3D2017%26volume%3D41%26issue%3D1%26spage%3D3%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alvaro A.  Ordonez</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Bambarger</span>, <span class="hlFld-ContribAuthor ">Sanjay K.  Jain</span>, <span class="hlFld-ContribAuthor ">Edward A.  Weinstein</span>. </span><span class="cited-content_cbyCitation_article-title">Biodistribution and Pharmacokinetics of Antimicrobials. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 209-222. <a href="https://doi.org/10.1007/978-3-319-54592-9_10" title="DOI URL">https://doi.org/10.1007/978-3-319-54592-9_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-54592-9_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-54592-9_10%26sid%3Dliteratum%253Aachs%26atitle%3DBiodistribution%252Band%252BPharmacokinetics%252Bof%252BAntimicrobials%26aulast%3DOrdonez%26aufirst%3DAlvaro%2BA.%26date%3D2017%26date%3D2017%26spage%3D209%26epage%3D222%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DImaging%252BInfections%26aulast%3DJain%26aufirst%3DSanjay%2BK.%26date%3D2017%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Ebenhan</span>, <span class="hlFld-ContribAuthor ">Carl  Wagener</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Bambarger</span>, <span class="hlFld-ContribAuthor ">Alvin S.  Kalinda</span>, <span class="hlFld-ContribAuthor ">Jan Rijn  Zeevaart</span>. </span><span class="cited-content_cbyCitation_article-title">Radiochemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 77-131. <a href="https://doi.org/10.1007/978-3-319-54592-9_4" title="DOI URL">https://doi.org/10.1007/978-3-319-54592-9_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-54592-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-54592-9_4%26sid%3Dliteratum%253Aachs%26atitle%3DRadiochemistry%26aulast%3DEbenhan%26aufirst%3DThomas%26date%3D2017%26date%3D2017%26spage%3D77%26epage%3D131%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DImaging%252BInfections%26aulast%3DJain%26aufirst%3DSanjay%2BK.%26date%3D2017%26volume%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Kayla R.  Gogarty</span>, <span class="hlFld-ContribAuthor ">Fereidoon  Daryaee</span>, <span class="hlFld-ContribAuthor ">Peter J.  Tonge</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic and Pharmacodynamics Relationships. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 195-207. <a href="https://doi.org/10.1007/978-3-319-54592-9_9" title="DOI URL">https://doi.org/10.1007/978-3-319-54592-9_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-54592-9_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-54592-9_9%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacokinetic%252Band%252BPharmacodynamics%252BRelationships%26aulast%3DZhang%26aufirst%3DZhuo%26date%3D2017%26date%3D2017%26spage%3D195%26epage%3D207%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DImaging%252BInfections%26aulast%3DJain%26aufirst%3DSanjay%2BK.%26date%3D2017%26volume%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Molahlehi S.  Sonopo</span>, <span class="hlFld-ContribAuthor ">Kobus  Venter</span>, <span class="hlFld-ContribAuthor ">Susan  Winks</span>, <span class="hlFld-ContribAuthor ">Biljana  Marjanovic-Painter</span>, <span class="hlFld-ContribAuthor ">Garreth L.  Morgans</span>, <span class="hlFld-ContribAuthor ">Jan R.  Zeevaart</span>. </span><span class="cited-content_cbyCitation_article-title">Carbon-14 radiolabelling and tissue distribution evaluation of a potential anti-TB compound. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 264-269. <a href="https://doi.org/10.1002/jlcr.3391" title="DOI URL">https://doi.org/10.1002/jlcr.3391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3391%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DCarbon-14%252Bradiolabelling%252Band%252Btissue%252Bdistribution%252Bevaluation%252Bof%252Ba%252Bpotential%252Banti-TB%252Bcompound%26aulast%3DSonopo%26aufirst%3DMolahlehi%2BS.%26date%3D2016%26date%3D2016%26volume%3D59%26issue%3D7%26spage%3D264%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alfred O.  Ankrah</span>, <span class="hlFld-ContribAuthor ">Tjip S.  van der Werf</span>, <span class="hlFld-ContribAuthor ">Erik F. J.  de Vries</span>, <span class="hlFld-ContribAuthor ">Rudi A. J. O.  Dierckx</span>, <span class="hlFld-ContribAuthor ">Mike M.  Sathekge</span>, <span class="hlFld-ContribAuthor ">Andor W. J. M.  Glaudemans</span>. </span><span class="cited-content_cbyCitation_article-title">PET/CT imaging of Mycobacterium tuberculosis infection. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Imaging</span><span> <strong>2016,</strong> <em>4 </em>
                                    (2)
                                     , 131-144. <a href="https://doi.org/10.1007/s40336-016-0164-0" title="DOI URL">https://doi.org/10.1007/s40336-016-0164-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40336-016-0164-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40336-016-0164-0%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Imaging%26atitle%3DPET%25252FCT%252Bimaging%252Bof%252BMycobacterium%252Btuberculosis%252Binfection%26aulast%3DAnkrah%26aufirst%3DAlfred%2BO.%26date%3D2016%26date%3D2016%26volume%3D4%26issue%3D2%26spage%3D131%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adeola  Shobo</span>, <span class="hlFld-ContribAuthor ">Dominika  Bratkowska</span>, <span class="hlFld-ContribAuthor ">Sooraj  Baijnath</span>, <span class="hlFld-ContribAuthor ">Suhashni  Naiker</span>, <span class="hlFld-ContribAuthor ">Anou M.  Somboro</span>, <span class="hlFld-ContribAuthor ">Linda A.  Bester</span>, <span class="hlFld-ContribAuthor ">Sanil D.  Singh</span>, <span class="hlFld-ContribAuthor ">Tricia  Naicker</span>, <span class="hlFld-ContribAuthor ">Hendrik G.  Kruger</span>, <span class="hlFld-ContribAuthor ">Thavendran  Govender</span>. </span><span class="cited-content_cbyCitation_article-title">Tissue distribution of pretomanid in rat brain via mass spectrometry imaging. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2016,</strong> <em>46 </em>
                                    (3)
                                     , 247-252. <a href="https://doi.org/10.3109/00498254.2015.1067935" title="DOI URL">https://doi.org/10.3109/00498254.2015.1067935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/00498254.2015.1067935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F00498254.2015.1067935%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DTissue%252Bdistribution%252Bof%252Bpretomanid%252Bin%252Brat%252Bbrain%252Bvia%252Bmass%252Bspectrometry%252Bimaging%26aulast%3DShobo%26aufirst%3DAdeola%26date%3D2016%26date%3D2015%26volume%3D46%26issue%3D3%26spage%3D247%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin H.  Rotstein</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>, <span class="hlFld-ContribAuthor ">Michael S.  Placzek</span>, <span class="hlFld-ContribAuthor ">Jacob M.  Hooker</span>, <span class="hlFld-ContribAuthor ">Antony D.  Gee</span>, <span class="hlFld-ContribAuthor ">Frédéric  Dollé</span>, <span class="hlFld-ContribAuthor ">Alan A.  Wilson</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">11
              CO bonds made easily for positron emission tomography radiopharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2016,</strong> <em>45 </em>
                                    (17)
                                     , 4708-4726. <a href="https://doi.org/10.1039/C6CS00310A" title="DOI URL">https://doi.org/10.1039/C6CS00310A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6CS00310A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6CS00310A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3D11%252BC%2525EE%252580%252581O%252Bbonds%252Bmade%252Beasily%252Bfor%252Bpositron%252Bemission%252Btomography%252Bradiopharmaceuticals%26aulast%3DRotstein%26aufirst%3DBenjamin%2BH.%26date%3D2016%26date%3D2016%26volume%3D45%26issue%3D17%26spage%3D4708%26epage%3D4726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah R.  Rundell</span>, <span class="hlFld-ContribAuthor ">Zachary L.  Wagar</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Meints</span>, <span class="hlFld-ContribAuthor ">Claire D.  Olson</span>, <span class="hlFld-ContribAuthor ">Mara K.  O'Neill</span>, <span class="hlFld-ContribAuthor ">Brent F.  Piligian</span>, <span class="hlFld-ContribAuthor ">Anne W.  Poston</span>, <span class="hlFld-ContribAuthor ">Robin J.  Hood</span>, <span class="hlFld-ContribAuthor ">Peter J.  Woodruff</span>, <span class="hlFld-ContribAuthor ">Benjamin M.  Swarts</span>. </span><span class="cited-content_cbyCitation_article-title">Deoxyfluoro-
              d
              -trehalose (FDTre) analogues as potential PET probes for imaging mycobacterial infection. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (36)
                                     , 8598-8609. <a href="https://doi.org/10.1039/C6OB01734G" title="DOI URL">https://doi.org/10.1039/C6OB01734G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB01734G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB01734G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDeoxyfluoro-%252Bd%252B-trehalose%252B%252528FDTre%252529%252Banalogues%252Bas%252Bpotential%252BPET%252Bprobes%252Bfor%252Bimaging%252Bmycobacterial%252Binfection%26aulast%3DRundell%26aufirst%3DSarah%2BR.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D36%26spage%3D8598%26epage%3D8609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Yang  Lu</span>, <span class="hlFld-ContribAuthor ">Pan  Pan</span>, <span class="hlFld-ContribAuthor ">Jacob M.  Hooker</span>, <span class="hlFld-ContribAuthor ">Joanna S.  Fowler</span>, <span class="hlFld-ContribAuthor ">Peter J.  Tonge</span>. </span><span class="cited-content_cbyCitation_article-title">Radiolabelling and positron emission tomography of PT70, a time-dependent inhibitor of InhA, the Mycobacterium tuberculosis enoyl-ACP reductase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (21)
                                     , 4782-4786. <a href="https://doi.org/10.1016/j.bmcl.2015.07.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.07.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.07.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRadiolabelling%252Band%252Bpositron%252Bemission%252Btomography%252Bof%252BPT70%25252C%252Ba%252Btime-dependent%252Binhibitor%252Bof%252BInhA%25252C%252Bthe%252BMycobacterium%252Btuberculosis%252Benoyl-ACP%252Breductase%26aulast%3DWang%26aufirst%3DHui%26date%3D2015%26volume%3D25%26issue%3D21%26spage%3D4782%26epage%3D4786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marleen  van Oosten</span>, <span class="hlFld-ContribAuthor ">Markus  Hahn</span>, <span class="hlFld-ContribAuthor ">Lucia M.A.  Crane</span>, <span class="hlFld-ContribAuthor ">Rick G.  Pleijhuis</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Francis</span>, <span class="hlFld-ContribAuthor ">Jan Maarten  van Dijl</span>, <span class="hlFld-ContribAuthor ">Gooitzen M.  van Dam</span>, . </span><span class="cited-content_cbyCitation_article-title">Targeted imaging of bacterial infections: advances, hurdles and hopes. </span><span class="cited-content_cbyCitation_journal-name">FEMS Microbiology Reviews</span><span> <strong>2015,</strong> <em>39 </em>
                                    (6)
                                     , 892-916. <a href="https://doi.org/10.1093/femsre/fuv029" title="DOI URL">https://doi.org/10.1093/femsre/fuv029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/femsre/fuv029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ffemsre%2Ffuv029%26sid%3Dliteratum%253Aachs%26jtitle%3DFEMS%2520Microbiology%2520Reviews%26atitle%3DTargeted%252Bimaging%252Bof%252Bbacterial%252Binfections%25253A%252Badvances%25252C%252Bhurdles%252Band%252Bhopes%26aulast%3Dvan%2BOosten%26aufirst%3DMarleen%26date%3D2015%26date%3D2015%26volume%3D39%26issue%3D6%26spage%3D892%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent P.  DeMarco</span>, <span class="hlFld-ContribAuthor ">Alvaro A.  Ordonez</span>, <span class="hlFld-ContribAuthor ">Mariah  Klunk</span>, <span class="hlFld-ContribAuthor ">Brendan  Prideaux</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhuo</span>, <span class="hlFld-ContribAuthor ">Peter J.  Tonge</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Holt</span>, <span class="hlFld-ContribAuthor ">Carlton K. K.  Lee</span>, <span class="hlFld-ContribAuthor ">Edward A.  Weinstein</span>, <span class="hlFld-ContribAuthor ">Véronique  Dartois</span>, <span class="hlFld-ContribAuthor ">Kelly E.  Dooley</span>, <span class="hlFld-ContribAuthor ">Sanjay K.  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of [
              11
              C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2015,</strong> <em>59 </em>
                                    (9)
                                     , 5768-5774. <a href="https://doi.org/10.1128/AAC.01146-15" title="DOI URL">https://doi.org/10.1128/AAC.01146-15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01146-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01146-15%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DDetermination%252Bof%252B%25255B%252B11%252BC%25255DRifampin%252BPharmacokinetics%252Bwithin%252BMycobacterium%252Btuberculosis-Infected%252BMice%252Bby%252BUsing%252BDynamic%252BPositron%252BEmission%252BTomography%252BBioimaging%26aulast%3DDeMarco%26aufirst%3DVincent%2BP.%26date%3D2015%26date%3D2015%26volume%3D59%26issue%3D9%26spage%3D5768%26epage%3D5774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adeola  Shobo</span>, <span class="hlFld-ContribAuthor ">Dominika  Bratkowska</span>, <span class="hlFld-ContribAuthor ">Sooraj  Baijnath</span>, <span class="hlFld-ContribAuthor ">Suhashni  Naiker</span>, <span class="hlFld-ContribAuthor ">Linda A.  Bester</span>, <span class="hlFld-ContribAuthor ">Sanil D.  Singh</span>, <span class="hlFld-ContribAuthor ">Glenn Eamond Mitchell  Maguire</span>, <span class="hlFld-ContribAuthor ">Hendrik Gert  Kruger</span>, <span class="hlFld-ContribAuthor ">Thavendran  Govender</span>. </span><span class="cited-content_cbyCitation_article-title">Visualization of Time-Dependent Distribution of Rifampicin in Rat Brain Using MALDI MSI and Quantitative LCMS/MS. </span><span class="cited-content_cbyCitation_journal-name">ASSAY and Drug Development Technologies</span><span> <strong>2015,</strong> <em>13 </em>
                                    (5)
                                     , 277-284. <a href="https://doi.org/10.1089/adt.2015.634" title="DOI URL">https://doi.org/10.1089/adt.2015.634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/adt.2015.634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fadt.2015.634%26sid%3Dliteratum%253Aachs%26jtitle%3DASSAY%2520and%2520Drug%2520Development%2520Technologies%26atitle%3DVisualization%252Bof%252BTime-Dependent%252BDistribution%252Bof%252BRifampicin%252Bin%252BRat%252BBrain%252BUsing%252BMALDI%252BMSI%252Band%252BQuantitative%252BLCMS%25252FMS%26aulast%3DShobo%26aufirst%3DAdeola%26date%3D2015%26volume%3D13%26issue%3D5%26spage%3D277%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Molahlehi S.  Sonopo</span>, <span class="hlFld-ContribAuthor ">Kobus  Venter</span>, <span class="hlFld-ContribAuthor ">Grant  Boyle</span>, <span class="hlFld-ContribAuthor ">Susan  Winks</span>, <span class="hlFld-ContribAuthor ">Biljana  Marjanovic-Painter</span>, <span class="hlFld-ContribAuthor ">Jan R.  Zeevaart</span>. </span><span class="cited-content_cbyCitation_article-title">Carbon-14 radiolabeling and
              in vivo
              biodistribution of a potential anti-TB compound. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2015,</strong> <em>58 </em>
                                    (2)
                                     , 23-29. <a href="https://doi.org/10.1002/jlcr.3256" title="DOI URL">https://doi.org/10.1002/jlcr.3256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3256%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DCarbon-14%252Bradiolabeling%252Band%252Bin%252Bvivo%252Bbiodistribution%252Bof%252Ba%252Bpotential%252Banti-TB%252Bcompound%26aulast%3DSonopo%26aufirst%3DMolahlehi%2BS.%26date%3D2015%26date%3D2015%26volume%3D58%26issue%3D2%26spage%3D23%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas M.  Bocan</span>, <span class="hlFld-ContribAuthor ">Rekha G.  Panchal</span>, <span class="hlFld-ContribAuthor ">Sina  Bavari</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of In Vivo Imaging in the Evaluation of the Pathophysiology of Viral and Bacterial Infections and in Development of Countermeasures to BSL3/4 Pathogens. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2015,</strong> <em>17 </em>
                                    (1)
                                     , 4-17. <a href="https://doi.org/10.1007/s11307-014-0759-7" title="DOI URL">https://doi.org/10.1007/s11307-014-0759-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-014-0759-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-014-0759-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DApplications%252Bof%252BIn%252BVivo%252BImaging%252Bin%252Bthe%252BEvaluation%252Bof%252Bthe%252BPathophysiology%252Bof%252BViral%252Band%252BBacterial%252BInfections%252Band%252Bin%252BDevelopment%252Bof%252BCountermeasures%252Bto%252BBSL3%25252F4%252BPathogens%26aulast%3DBocan%26aufirst%3DThomas%2BM.%26date%3D2015%26date%3D2014%26volume%3D17%26issue%3D1%26spage%3D4%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Lu</span>, <span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Sung Won  Kim</span>, <span class="hlFld-ContribAuthor ">Jacob M.  Hooker</span>, <span class="hlFld-ContribAuthor ">Joanna S.  Fowler</span>, <span class="hlFld-ContribAuthor ">Peter J.  Tonge</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and biological evaluation of a novel enoyl-ACP reductase inhibitor for Staphylococcus aureus. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>88 </em>, 66-73. <a href="https://doi.org/10.1016/j.ejmech.2014.09.008" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRadiosynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bnovel%252Benoyl-ACP%252Breductase%252Binhibitor%252Bfor%252BStaphylococcus%252Baureus%26aulast%3DWang%26aufirst%3DHui%26date%3D2014%26volume%3D88%26spage%3D66%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel H.  Johnson</span>, <span class="hlFld-ContribAuthor ">Laura E.  Via</span>, <span class="hlFld-ContribAuthor ">Peter  Kim</span>, <span class="hlFld-ContribAuthor ">Dominick  Laddy</span>, <span class="hlFld-ContribAuthor ">Chuen-Yen  Lau</span>, <span class="hlFld-ContribAuthor ">Edward A.  Weinstein</span>, <span class="hlFld-ContribAuthor ">Sanjay  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Nuclear imaging: A powerful novel approach for tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2014,</strong> <em>41 </em>
                                    (10)
                                     , 777-784. <a href="https://doi.org/10.1016/j.nucmedbio.2014.08.005" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2014.08.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2014.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2014.08.005%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DNuclear%252Bimaging%25253A%252BA%252Bpowerful%252Bnovel%252Bapproach%252Bfor%252Btuberculosis%26aulast%3DJohnson%26aufirst%3DDaniel%2BH.%26date%3D2014%26volume%3D41%26issue%3D10%26spage%3D777%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Véronique  Dartois</span>. </span><span class="cited-content_cbyCitation_article-title">The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Microbiology</span><span> <strong>2014,</strong> <em>12 </em>
                                    (3)
                                     , 159-167. <a href="https://doi.org/10.1038/nrmicro3200" title="DOI URL">https://doi.org/10.1038/nrmicro3200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrmicro3200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrmicro3200%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Microbiology%26atitle%3DThe%252Bpath%252Bof%252Banti-tuberculosis%252Bdrugs%25253A%252Bfrom%252Bblood%252Bto%252Blesions%252Bto%252Bmycobacterial%252Bcells%26aulast%3DDartois%26aufirst%3DV%25C3%25A9ronique%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D3%26spage%3D159%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy T.  Ruckh</span>, <span class="hlFld-ContribAuthor ">Rachael A.  Oldinski</span>, <span class="hlFld-ContribAuthor ">Derek A.  Carroll</span>, <span class="hlFld-ContribAuthor ">Krasimira  Mikhova</span>, <span class="hlFld-ContribAuthor ">James D.  Bryers</span>, <span class="hlFld-ContribAuthor ">Ketul C.  Popat</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial effects of nanofiber poly(caprolactone) tissue scaffolds releasing rifampicin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Science: Materials in Medicine</span><span> <strong>2012,</strong> <em>23 </em>
                                    (6)
                                     , 1411-1420. <a href="https://doi.org/10.1007/s10856-012-4609-3" title="DOI URL">https://doi.org/10.1007/s10856-012-4609-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10856-012-4609-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10856-012-4609-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Science%253A%2520Materials%2520in%2520Medicine%26atitle%3DAntimicrobial%252Beffects%252Bof%252Bnanofiber%252Bpoly%252528caprolactone%252529%252Btissue%252Bscaffolds%252Breleasing%252Brifampicin%26aulast%3DRuckh%26aufirst%3DTimothy%2BT.%26date%3D2012%26date%3D2012%26volume%3D23%26issue%3D6%26spage%3D1411%26epage%3D1420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ou-Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Yi-Feng  Cheng</span>, <span class="hlFld-ContribAuthor ">Shi-Yan  Huang</span>, <span class="hlFld-ContribAuthor ">Ai-Min  Bai</span>, <span class="hlFld-ContribAuthor ">Yan-Jun  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the Binding of Rifampicin to Bovine Serum Albumin in Aqueous Solution. </span><span class="cited-content_cbyCitation_journal-name">Journal of Solution Chemistry</span><span> <strong>2011,</strong> <em>40 </em>
                                    (10)
                                     , 1711-1723. <a href="https://doi.org/10.1007/s10953-011-9747-6" title="DOI URL">https://doi.org/10.1007/s10953-011-9747-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10953-011-9747-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10953-011-9747-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Solution%2520Chemistry%26atitle%3DProbing%252Bthe%252BBinding%252Bof%252BRifampicin%252Bto%252BBovine%252BSerum%252BAlbumin%252Bin%252BAqueous%252BSolution%26aulast%3DYu%26aufirst%3DOu-Yang%26date%3D2011%26date%3D2011%26volume%3D40%26issue%3D10%26spage%3D1711%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Eckelman</span>. </span><span class="cited-content_cbyCitation_article-title">Changes: choosing a target?. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2011,</strong> <em>38 </em>
                                    (6)
                                     , 765-769. <a href="https://doi.org/10.1016/j.nucmedbio.2010.12.010" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2010.12.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2010.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2010.12.010%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DChanges%25253A%252Bchoosing%252Ba%252Btarget%25253F%26aulast%3DEckelman%26aufirst%3DWilliam%26date%3D2011%26volume%3D38%26issue%3D6%26spage%3D765%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip  Basu</span>, <span class="hlFld-ContribAuthor ">Abass  Alavi</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging role of FDG-PET for optimal response assessment in infectious diseases and disorders. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anti-infective Therapy</span><span> <strong>2011,</strong> <em>9 </em>
                                    (2)
                                     , 143-145. <a href="https://doi.org/10.1586/eri.10.167" title="DOI URL">https://doi.org/10.1586/eri.10.167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/eri.10.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2Feri.10.167%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anti-infective%2520Therapy%26atitle%3DEmerging%252Brole%252Bof%252BFDG-PET%252Bfor%252Boptimal%252Bresponse%252Bassessment%252Bin%252Binfectious%252Bdiseases%252Band%252Bdisorders%26aulast%3DBasu%26aufirst%3DSandip%26date%3D2011%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3D143%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Radiosynthesis of [<sup>11</sup>C]RIF</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Radiosynthesis of [<sup>11</sup>C]INH</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Radiosynthesis of [<sup>11</sup>C]PZA</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Blood−brain barrier penetration, brain tissue bioavailability, and TACs for [<sup>11</sup>C]PZA, [<sup>11</sup>C]INH, and [<sup>11</sup>C]RIF. (a) TACs generated from the image acquired after iv administration of each drug in baboons by manually drawing the ROIs. (b) Whole-brain regions of interest were used to generate TACs for each labeled drug. The resulting curves were integrated as a function of time to produce AUC plots. (c) Dose corrected coronal images summed over frames 24−35 (15−90 min). The NIH color scale was used to represent relative radioactivity concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. TACs for [<sup>11</sup>C]RIF in the (a) heart, lungs, liver, kidneys, and (b) gallbladder. Peripheral organ distribution following torso PET imaging of [<sup>11</sup>C]RIF administered iv to anesthetized baboons. TACs were generated from the image acquired after iv administration of each drug in baboons by manually drawing the ROIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. TACs for [<sup>11</sup>C]INH in the heart, lungs, liver, and kidneys. Peripheral organ distribution following torso PET imaging of [<sup>11</sup>C]INH administered iv to anesthetized baboons. TACs were generated from the image acquired after iv administration of each drug in baboons by manually drawing the ROIs. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/medium/jm-2009-01858n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. TACs for [<sup>11</sup>C]PZA in the heart, lungs, liver, and kidneys. Peripheral organ distribution following torso PET imaging of [<sup>11</sup>C]PZA administered iv to anesthetized baboons. TACs were generated from the image acquired after iv administration of each drug in baboons by manually drawing the ROIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901858n/production/images/large/jm-2009-01858n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901858n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Muller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dela Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derendorf, H.</span><span> </span><span class="NLM_article-title">Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1441</span><span class="NLM_x">–</span> <span class="NLM_lpage">1453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1441-1453&author=M.+Mullerauthor=A.+dela+Penaauthor=H.+Derendorf&title=Issues+in+pharmacokinetics+and+pharmacodynamics+of+anti-infective+agents%3A+distribution+in+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DM.%26aulast%3Ddela%2BPena%26aufirst%3DA.%26aulast%3DDerendorf%26aufirst%3DH.%26atitle%3DIssues%2520in%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520anti-infective%2520agents%253A%2520distribution%2520in%2520tissue%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1441%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Langer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M.</span><span> </span><span class="NLM_article-title">Methods to assess tissue-specific distribution and metabolism of drugs</span> <span class="citation_source-journal">Curr. Drug. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.2174%2F1389200043335379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=15578942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWhurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=463-481&author=O.+Langerauthor=M.+Muller&title=Methods+to+assess+tissue-specific+distribution+and+metabolism+of+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Methods to assess tissue-specific distribution and metabolism of drugs</span></div><div class="casAuthors">Langer, Oliver; Mueller, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">463-481</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Most drugs exert their effects not within the blood plasma compartment, but in defined target tissues into which drugs have to distribute from the central compartment.  Unfortunately, a complete and lasting equilibration between blood and tissue cannot always be taken for granted.  Drug distribution processes may be characterized by a high intertissue- and intersubject variability and target site drug levels may substantially differ from corresponding plasma levels.  Suboptimal target site concns. may have important clin. implications, as it is a potential explanation for therapeutic failures.  Therefore, detn. of drug tissue penetration plays an important role in clin. drug development.  In recent years, the assessment of tissue concns. after administration of very low, sub-pharmacol. drug amts. (microdosing) has attracted major interest in early clin. drug development, which calls for the availability of highly sensitive anal. methods.  The present article will review the most important techniques that are currently available for studying drug disposition in humans.  These can be classified as semi-invasive (microdialysis, MD) and non-invasive (positron emission tomog., PET, and magnetic resonance spectroscopy, MRS).  The authors will discuss individual strengths and shortcomings of each method and provide some recent examples with particular focus on antiinfective and anticancer drugs.  Whereas MD and MRS also lend themselves to the assessment of tissue-specific drug metab., PET usually does not provide metabolic information.  For some drugs, such as the anticancer agents 5-fluorouracil and capecitabine, measurement of drug metabolites is particularly important as these represent the therapeutically active species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn1J5qD2c-IbVg90H21EOLACvtfcHk0lhNqRuG07t82w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWhurnK&md5=ba1643d5a090ba7ecd0a7947c856cb82</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F1389200043335379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200043335379%26sid%3Dliteratum%253Aachs%26aulast%3DLanger%26aufirst%3DO.%26aulast%3DMuller%26aufirst%3DM.%26atitle%3DMethods%2520to%2520assess%2520tissue-specific%2520distribution%2520and%2520metabolism%2520of%2520drugs%26jtitle%3DCurr.%2520Drug.%2520Metab.%26date%3D2004%26volume%3D5%26spage%3D463%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Fischman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alpert, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, R. H.</span><span> </span><span class="NLM_article-title">The role of positron emission tomography in pharmacokinetic analysis</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">956</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.3109%2F03602539709002238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=9421680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK1cXhtlGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1997&pages=923-956&author=A.+J.+Fischmanauthor=N.+M.+Alpertauthor=J.+W.+Babichauthor=R.+H.+Rubin&title=The+role+of+positron+emission+tomography+in+pharmacokinetic+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of positron emission tomography in pharmacokinetic analysis</span></div><div class="casAuthors">Fischman, Alan J.; Alpert, Nathaniel M.; Babich, John W.; Rubin, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">923-956</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review with 77 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk-4bEzSDZH7Vg90H21EOLACvtfcHk0lhNqRuG07t82w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtlGkug%253D%253D&md5=275fffcf5e05b5c6e46d0bc84499c31e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3109%2F03602539709002238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602539709002238%26sid%3Dliteratum%253Aachs%26aulast%3DFischman%26aufirst%3DA.%2BJ.%26aulast%3DAlpert%26aufirst%3DN.%2BM.%26aulast%3DBabich%26aufirst%3DJ.%2BW.%26aulast%3DRubin%26aufirst%3DR.%2BH.%26atitle%3DThe%2520role%2520of%2520positron%2520emission%2520tomography%2520in%2520pharmacokinetic%2520analysis%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D1997%26volume%3D29%26spage%3D923%26epage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bloom, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. J.</span><span> </span><span class="NLM_article-title">Tuberculosis: commentary on a reemergent killer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1992&pages=1055-1064&author=B.+R.+Bloomauthor=C.+J.+Murray&title=Tuberculosis%3A+commentary+on+a+reemergent+killer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBloom%26aufirst%3DB.%2BR.%26aulast%3DMurray%26aufirst%3DC.%2BJ.%26atitle%3DTuberculosis%253A%2520commentary%2520on%2520a%2520reemergent%2520killer%26jtitle%3DScience%26date%3D1992%26volume%3D257%26spage%3D1055%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kochi, A.</span><span> </span><span class="NLM_article-title">The global tuberculosis situation and the new control strategy of the World Health Organization</span> <span class="citation_source-journal">Tubercle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1016%2F0041-3879%2891%2990017-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=1882440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADyaK3Mzlt1ylsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1991&pages=1-6&author=A.+Kochi&title=The+global+tuberculosis+situation+and+the+new+control+strategy+of+the+World+Health+Organization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The global tuberculosis situation and the new control strategy of the World Health Organization</span></div><div class="casAuthors">Kochi A</div><div class="citationInfo"><span class="NLM_cas:title">Tubercle</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>
        ISSN:<span class="NLM_cas:issn">0041-3879</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQA5m2VZZuC4VvAgqb2vdc5fW6udTcc2eY7agszzINlu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3Mzlt1ylsA%253D%253D&md5=664a0be98ad235e8898256d65b8f788a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0041-3879%2891%2990017-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0041-3879%252891%252990017-M%26sid%3Dliteratum%253Aachs%26aulast%3DKochi%26aufirst%3DA.%26atitle%3DThe%2520global%2520tuberculosis%2520situation%2520and%2520the%2520new%2520control%2520strategy%2520of%2520the%2520World%2520Health%2520Organization%26jtitle%3DTubercle%26date%3D1991%26volume%3D72%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rattan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, N.</span><span> </span><span class="NLM_article-title">Multidrug-resistant <i>Mycobacterium tuberculosis</i>: molecular perspectives</span> <span class="citation_source-journal">Emerg. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.3201%2Feid0402.980207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=9621190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK1cXjvVemt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=195-209&author=A.+Rattanauthor=A.+Kaliaauthor=N.+Ahmad&title=Multidrug-resistant+Mycobacterium+tuberculosis%3A+molecular+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives</span></div><div class="casAuthors">Rattan, Ashok; Kalia, Awdhesh; Ahmad, Nishat</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Infectious Diseases</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-209</span>CODEN:
                <span class="NLM_cas:coden">EIDIFA</span>;
        ISSN:<span class="NLM_cas:issn">1080-6040</span>.
    
            (<span class="NLM_cas:orgname">National Center for Infectious Diseases, Centers for Disease Control and Prevention</span>)
        </div><div class="casAbstract">A review with 121 refs.  Multidrug-resistant strains of Mycobacterium tuberculosis seriously threaten tuberculosis (TB) control and prevention efforts.  Mol. studies of the mechanism of action of antitubercular drugs have elucidated the genetic basis of drug resistance in M. tuberculosis.  Drug resistance in M. tuberculosis is attributed primarily to the accumulation of mutations in the drug target genes; these mutations lead either to an altered target (e.g., RNA polymerase and catalase-peroxidase in rifampicin and isoniazid resistance, resp.) or to a change in titrn. of the drug (e.g., InhA in isoniazid resistance).  Development of specific mechanism-based inhibitors and techniques to rapidly detect multidrug resistance will require further studies addressing the drug and drug-target interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0AqTkDe_vyLVg90H21EOLACvtfcHk0lgPkGTNuLlGHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvVemt7s%253D&md5=9f849fcf4a974028f9b8286a3bb98616</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3201%2Feid0402.980207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid0402.980207%26sid%3Dliteratum%253Aachs%26aulast%3DRattan%26aufirst%3DA.%26aulast%3DKalia%26aufirst%3DA.%26aulast%3DAhmad%26aufirst%3DN.%26atitle%3DMultidrug-resistant%2520Mycobacterium%2520tuberculosis%253A%2520molecular%2520perspectives%26jtitle%3DEmerg.%2520Infect.%2520Dis.%26date%3D1998%26volume%3D4%26spage%3D195%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Bass, J. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farer, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopewell, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruben, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snider, D. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, G.</span><span> </span><span class="NLM_article-title">Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8173779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADyaK2c3ivVSrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=1994&pages=1359-1374&author=J.+B.+Bassauthor=L.+S.+Farerauthor=P.+C.+Hopewellauthor=R.+O%27Brienauthor=R.+F.+Jacobsauthor=F.+Rubenauthor=D.+E.+Sniderauthor=G.+Thornton&title=Treatment+of+tuberculosis+and+tuberculosis+infection+in+adults+and+children.+American+Thoracic+Society+and+The+Centers+for+Disease+Control+and+Prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention</span></div><div class="casAuthors">Bass J B Jr; Farer L S; Hopewell P C; O'Brien R; Jacobs R F; Ruben F; Snider D E Jr; Thornton G</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1359-74</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Treatment of Tuberculosis. 1.  A 6-mo regimen consisting of isoniazid, rifampin, and pyrazinamide given for 2 mo followed by isoniazid and rifampin for 4 mo is the preferred treatment for patients with fully susceptible organisms who adhere to treatment.  Ethambutol (or streptomycin in children too young to be monitored for visual acuity) should be included in the initial regimen until the results of drug susceptibility studies are available, unless there is little possibility of drug resistance (i.e., there is less than 4% primary resistance to isoniazid in the community, and the patient has had no previous treatment with antituberculosis medications, is not from a country with a high prevalence of drug resistance, and has no known exposure to a drug-resistant case).  This four-drug, 6-mo regimen is effective even when the infecting organism is resistant to INH.  This recommendation applies to both HIV-infected and uninfected persons.  However, in the presence of HIV infection it is critically important to assess the clinical and bacteriologic response.  If there is evidence of a slow or suboptimal response, therapy should be prolonged as judged on a case by case basis. 2.  Alternatively, a 9-mo regimen of isoniazid and rifampin is acceptable for persons who cannot or should not take pyrazinamide.  Ethambutol (or streptomycin in children too young to be monitored for visual acuity) should also be included until the results of drug susceptibility studies are available, unless there is little possibility of drug resistance (see Section 1 above).  If INH resistance is demonstrated, rifampin and ethambutol should be continued for a minimum of 12 mo. 3.  Consideration should be given to treating all patients with directly observed therapy (DOT). 4.  Multiple-drug-resistant tuberculosis (i.e., resistance to at least isoniazid and rifampin) presents difficult treatment problems.  Treatment must be individualized and based on susceptibility studies.  In such cases, consultation with an expert in tuberculosis is recommended. 5.  Children should be managed in essentially the same ways as adults using appropriately adjusted doses of the drugs.  This document addresses specific important differences between the management of adults and children. 6.  Extrapulmonary tuberculosis should be managed according to the principles and with the drug regimens outlined for pulmonary tuberculosis, except for children who have miliary tuberculosis, bone/joint tuberculosis, or tuberculous meningitis who should receive a minimum of 12 mo of therapy.(ABSTRACT TRUNCATED AT 400 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0l93nkFZ-q1Zoq0fPSOTvfW6udTcc2eY7agszzINlu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3ivVSrsQ%253D%253D&md5=087f7c9125678f52f8d2d83d09c34fd4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBass%26aufirst%3DJ.%2BB.%26aulast%3DFarer%26aufirst%3DL.%2BS.%26aulast%3DHopewell%26aufirst%3DP.%2BC.%26aulast%3DO%2527Brien%26aufirst%3DR.%26aulast%3DJacobs%26aufirst%3DR.%2BF.%26aulast%3DRuben%26aufirst%3DF.%26aulast%3DSnider%26aufirst%3DD.%2BE.%26aulast%3DThornton%26aufirst%3DG.%26atitle%3DTreatment%2520of%2520tuberculosis%2520and%2520tuberculosis%2520infection%2520in%2520adults%2520and%2520children.%2520American%2520Thoracic%2520Society%2520and%2520The%2520Centers%2520for%2520Disease%2520Control%2520and%2520Prevention%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D1994%26volume%3D149%26spage%3D1359%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">American Thoracic Society</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Medical Section of the American Lung Association: Treatment of tuberculosis and tuberculosis infection in adults and children</span>.  <span class="citation_source-journal">Am. Rev. Respir. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span>− <span class="NLM_lpage">363</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=3527010" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1986&pages=355-363&author=American+Thoracic+Society&title=Medical+Section+of+the+American+Lung+Association%3A+Treatment+of+tuberculosis+and+tuberculosis+infection+in+adults+and+children"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DMedical%2520Section%2520of%2520the%2520American%2520Lung%2520Association%253A%2520Treatment%2520of%2520tuberculosis%2520and%2520tuberculosis%2520infection%2520in%2520adults%2520and%2520children%26jtitle%3DAm.%2520Rev.%2520Respir.%2520Dis.%26date%3D1986%26volume%3D134%26spage%3D355%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Thwaites, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemingway, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innes, J.</span><span> </span><span class="NLM_article-title">British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children</span> <span class="citation_source-journal">J. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1016%2Fj.jinf.2009.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=19643501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADC%252BD1Mnhslygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2009&pages=167-187&author=G.+Thwaitesauthor=M.+Fisherauthor=C.+Hemingwayauthor=G.+Scottauthor=T.+Solomonauthor=J.+Innes&title=British+Infection+Society+guidelines+for+the+diagnosis+and+treatment+of+tuberculosis+of+the+central+nervous+system+in+adults+and+children"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children</span></div><div class="casAuthors">Thwaites Guy; Fisher Martin; Hemingway Cheryl; Scott Geoff; Solomon Tom; Innes John</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infection</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SUMMARY AND KEY RECOMMENDATIONS: The aim of these guidelines is to describe a practical but evidence-based approach to the diagnosis and treatment of central nervous system tuberculosis in children and adults.  We have presented guidance on tuberculous meningitis (TBM), intra-cerebral tuberculoma without meningitis, and tuberculosis affecting the spinal cord.  Our key recommendations are as follows: 1.  TBM is a medical emergency.  Treatment delay is strongly associated with death and empirical anti-tuberculosis therapy should be started promptly in all patients in whom the diagnosis of TBM is suspected.  Do not wait for microbiological or molecular diagnostic confirmation. 2.  The diagnosis of TBM is best made with lumbar puncture and examination of the cerebrospinal fluid (CSF).  Suspect TBM if there is a CSF leucocytosis (predominantly lymphocytes), the CSF protein is raised, and the CSF:plasma glucose is <50%.  The diagnostic yield of CSF microscopy and culture for Mycobacterium tuberculosis increases with the volume of CSF submitted; repeat the lumbar puncture if the diagnosis remains uncertain. 3.  Imaging is essential for the diagnosis of cerebral tuberculoma and tuberculosis involving the spinal cord, although the radiological appearances do not confirm the diagnosis.  A tissue diagnosis (by histopathology and mycobacterial culture) should be attempted whenever possible, either by biopsy of the lesion itself, or through diagnostic sampling from extra-neural sites of disease e.g. lung, gastric fluid, lymph nodes, liver, bone marrow. 4.  Treatment for all forms of CNS tuberculosis should consist of 4 drugs (isoniazid, rifampicin, pyrazinamide, ethambutol) for 2 months followed by 2 drugs (isoniazid, rifampicin) for at least 10 months.  Adjunctive corticosteroids (either dexamethasone or prednisolone) should be given to all patients with TBM, regardless of disease severity. 5.  Children with CNS tuberculosis should ideally be managed by a paediatrician with familiarity and expertise in paediatric tuberculosis or otherwise with input from a paediatric infectious diseases unit.  The Children's HIV Association of UK and Ireland (CHIVA) provide further guidance on the management of HIV-infected children (www.chiva.org.uk). 6.  All patients with suspected or proven tuberculosis should be offered testing for HIV infection.  The principles of CNS tuberculosis diagnosis and treatment are the same for HIV infected and uninfected individuals, although HIV infection broadens the differential diagnosis and anti-retroviral treatment complicates management.  Tuberculosis in HIV infected patients should be managed either within specialist units by physicians with expertise in both HIV and tuberculosis, or in a combined approach between HIV and tuberculosis experts.  The co-administration of anti-retroviral and anti-tuberculosis drugs should follow guidance issued by the British HIV association (www.bhiva.org).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdAsg5jWJ-Tf9pSBfyDvp7fW6udTcc2eZp78pFMv_1vrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mnhslygug%253D%253D&md5=562be8ce340708f97e1fb7768a59f7b6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jinf.2009.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinf.2009.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DThwaites%26aufirst%3DG.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DHemingway%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DG.%26aulast%3DSolomon%26aufirst%3DT.%26aulast%3DInnes%26aufirst%3DJ.%26atitle%3DBritish%2520Infection%2520Society%2520guidelines%2520for%2520the%2520diagnosis%2520and%2520treatment%2520of%2520tuberculosis%2520of%2520the%2520central%2520nervous%2520system%2520in%2520adults%2520and%2520children%26jtitle%3DJ.%2520Infect.%26date%3D2009%26volume%3D59%26spage%3D167%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Thwaites, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. H.</span><span> </span><span class="NLM_article-title">Tuberculous meningitis: many questions, too few answers</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=15721826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252Fpt1Cntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=160-170&author=G.+E.+Thwaitesauthor=T.+H.+Tran&title=Tuberculous+meningitis%3A+many+questions%2C+too+few+answers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculous meningitis: many questions, too few answers</span></div><div class="casAuthors">Thwaites Guy E; Tran Tinh Hien</div><div class="citationInfo"><span class="NLM_cas:title">Lancet neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">160-70</span>
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    </div><div class="casAbstract">Tuberculous meningitis (TM) is difficult to diagnose and treat; clinical features are non-specific, conventional bacteriology is widely regarded as insensitive, and assessment of newer diagnostic methods is not complete.  Treatment includes four drugs, which were developed more than 30 years ago, and prevents death or disability in less than half of patients.  Mycobacterium tuberculosis resistant to these drugs threatens a return to the prechemotherapeutic era in which all patients with TM died.  Research findings suggest that adjunctive treatment with corticosteroids improve survival but probably do not prevent severe disability, although how or why is not known.  There are many important unanswered questions about the pathophysiology, diagnosis, and treatment of TM.  Here we review the available evidence to answer some of these questions, particularly those on the diagnosis and treatment of TM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRcTUVBfA8UlsNIRw0GKUoEfW6udTcc2eZp78pFMv_1vrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252Fpt1Cntw%253D%253D&md5=1089377020ed93b3a602bda7cbb625a2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThwaites%26aufirst%3DG.%2BE.%26aulast%3DTran%26aufirst%3DT.%2BH.%26atitle%3DTuberculous%2520meningitis%253A%2520many%2520questions%252C%2520too%2520few%2520answers%26jtitle%3DLancet%2520Neurol.%26date%3D2005%26volume%3D4%26spage%3D160%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Nau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorgel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prange, H. W.</span><span> </span><span class="NLM_article-title">Pharmacokinetic optimization of the treatment of bacterial central nervous system infections</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.2165%2F00003088-199835030-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=9784935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK1cXmsFOqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1998&pages=223-246&author=R.+Nauauthor=F.+Sorgelauthor=H.+W.+Prange&title=Pharmacokinetic+optimization+of+the+treatment+of+bacterial+central+nervous+system+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic optimization of the treatment of bacterial central nervous system infections</span></div><div class="casAuthors">Nau, Roland; Sorgel, Fritz; Prange, Hilmar W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-246</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 141 refs. Central nervous system (CNS) infections caused by bacteria with reduced sensitivity to antibacterials are an increasing worldwide challenge.  In successfully treating these infections several conditions should be considered. Antibacterials do not distribute homogeneously in the central nervous compartments [cerebrospinal fluid (CSF), extracellular space of the nervous tissue, intracellular space of the neurons, glial cells and leukocytes].  Even within the CSF, after i.v. administration, a ventriculolumbar concn. gradient is often obsd.  Valid parameters of drug entry into the CSF are the CSF/serum concn. ratio at steady state and the CSF/serum ratio of the area under the concn.-time curves (AUCCSF/AUCs).  Frequently, the elimination half-life (t1/2β) in the CSF is longer than the t1/2β in serum.  For most antibacterials, lipophilicity, mol. wt. and serum protein binding det. the drug entry into the CSF and brain tissue.  With an intact blood-CSF and blood-brain barrier, the entry of hydrophilic antibacterials (β-lactam antibacterials, glycopeptides) into the CNS compartments is poor and increases during meningeal inflammation.  More lipophilic compds. [metronidazole, quinolones, rifampicin (rifampin) and chloramphenicol] are less dependent on the function of the blood-CSF and blood-brain barrier.  Detn. of the minimal inhibitory concns. (MIC) of the causative organism is necessary for optimization of treatment.  For rapid sterilization of the CSF, drug concns. of ≥10-fold the MIC are required.  The min. CSF concn./MIC ratio ensuring successful therapy is unknown.  Strategies to achieve optimum antibacterial concns. in the presence of minor disturbances of the blood-CSF and blood-brain barrier include the increased use of low-toxicity antibacterials (e.g., β-lactam antibiotics), the use of moderately lipophilic compds., and the combination of i.v. and intraventricular administration.  Antibacterials which do not interfere with bacterial cell wall synthesis delay and/or decrease the liberation of proinflammatory bacterial products, delay or inhibit tumor necrosis factor release, and may reduce brain edema in exptl. meningitis.  Conclusive evidence of the redn. of neuronal damage by this approach, however, is lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoujxLLsN4K0bVg90H21EOLACvtfcHk0liRRl5Te-O2_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsFOqsrk%253D&md5=4caa1f73dbb2af3f000c290f391bf334</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2165%2F00003088-199835030-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199835030-00005%26sid%3Dliteratum%253Aachs%26aulast%3DNau%26aufirst%3DR.%26aulast%3DSorgel%26aufirst%3DF.%26aulast%3DPrange%26aufirst%3DH.%2BW.%26atitle%3DPharmacokinetic%2520optimization%2520of%2520the%2520treatment%2520of%2520bacterial%2520central%2520nervous%2520system%2520infections%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1998%26volume%3D35%26spage%3D223%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kniess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rode, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuest, F.</span><span> </span><span class="NLM_article-title">Practical experiences with the synthesis of [<sup>11</sup>C]CH<sub>3</sub>I through gas phase iodination reaction using a TRACERlabFX<sub>C</sub> synthesis module</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1016%2Fj.apradiso.2007.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=17683943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisl2jurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2008&pages=482-488&author=T.+Kniessauthor=K.+Rodeauthor=F.+Wuest&title=Practical+experiences+with+the+synthesis+of+%5B11C%5DCH3I+through+gas+phase+iodination+reaction+using+a+TRACERlabFXC+synthesis+module"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Practical experiences with the synthesis of [11C]CH3I through gas phase iodination reaction using a TRACERlabFXC synthesis module</span></div><div class="casAuthors">Kniess, Torsten; Rode, Katrin; Wuest, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">482-488</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The results of [11C]CH3I synthesis through hydrogen gas redn. of [11C]CO2 on different nickel catalysts (HARSHAW-nickel, SHIMALITE-nickel, nickel on silica/alumina, nickel nanosize 99.99%) followed by gas phase iodination using a TRACERlab FXC synthesis unit are reported.  Further reaction parameters such as furnace temps., flow rate of hydrogen gas and redn. time were optimized.  It was found that redn. of [11C]CO2 proceeded in 28-83% yield depending on the nickel catalyst and temp.  The gas phase iodination (methane conversion) gave 31-62% of [11C]CH3I depending on temp. and amt. of iodine in the iodine furnace. [11C]CH3I was used for heteroatom methylation reactions exemplified by a piperazine and a phenol.  The specific activity of the 11C-labeled products and was detd. after HPLC purifn. and solid-phase extn.  Compds. and were obtained in 8-14% radiochem. yield (decay-cor., based upon trapped [11C]CH4) within 30 min.  The specific activity was detd. to be in the range of 20-30 GBq/μmol at the end-of-synthesis.  Nickel catalyst nanosize was found to be superior compared with other Ni catalysts tested.  The relatively low specific activity may be mainly due to carbon contaminations originating from the long copper tubing (500 m) between the cyclotron and the radiochem. facility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFrj_rSyu5ybVg90H21EOLACvtfcHk0liRRl5Te-O2_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisl2jurg%253D&md5=bfa6dacc534a9da92ab6e8c9969f0e7c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2007.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2007.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DKniess%26aufirst%3DT.%26aulast%3DRode%26aufirst%3DK.%26aulast%3DWuest%26aufirst%3DF.%26atitle%3DPractical%2520experiences%2520with%2520the%2520synthesis%2520of%2520%255B11C%255DCH3I%2520through%2520gas%2520phase%2520iodination%2520reaction%2520using%2520a%2520TRACERlabFXC%2520synthesis%2520module%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2008%26volume%3D66%26spage%3D482%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Andersson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstroem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laanstroem, B.</span><span> </span><span class="NLM_article-title">Synthesis of <sup>11</sup>C-labelled benzamide compounds as potential tracers for poly(ADP-ribose) synthetase</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1016%2F0969-8043%2894%2990251-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8038764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK2cXlvF2ks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=707-714&author=I.+Anderssonauthor=M.+Bergstroemauthor=B.+Laanstroem&title=Synthesis+of+11C-labelled+benzamide+compounds+as+potential+tracers+for+poly%28ADP-ribose%29+synthetase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 11C-labeled benzamide compounds as potential tracers for poly(ADP-ribose) synthetase</span></div><div class="casAuthors">Andersson, Ivonne; Bergstroem, Mats; Laanstroem, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">707-14</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0883-2889</span>.
    </div><div class="casAbstract">Poly(ADP-ribose) synthetase catalyzes the synthesis of poly(ADP-ribose) from NAD+, thereby releasing the DNA from histones to a transcriptionally and reparationally active form.  To investigate if in vivo and in vitro studies of this enzyme are feasible to perform with PET, the poly(ADP-ribose) synthetase inhibitors benzamide, 3-aminobenzamide, 3-methoxybenzamide and nicotinamide were labeled with carbon-11 in the amide group.  Starting with the corresponding arom. halides and hydrogen [11C]cyanide, the substituted [11C]benzohitriles were prepd. using a palladium promoted reaction.  Conversion of the nitriles to [carboxy-11C]amides was achieved by reaction with sodium percarbonate.  A one-pot procedure for synthesis of the 11C-labeled arom. amides was developed.  The total synthesis time including reversed-phase HPLC purifn. was 25-35 min.  Decay-cor. radiochem. yield was 40-70% and the radiochem. purity >99%.  The specific radioactivity was in the order of 2-3 Ci/μmol.  Initial distribution and kinetic studies were performed in monkey using the tracer substance injected as a rapid bolus.  These studies demonstrated that the blood-clearance was fast for [carboxy-11C]nicotinamide but considerably slower for 3-amino[carboxy-11C]benzamide and 3-methoxy[carboxy-11C]benzamide.  The brain uptake was low for substances except 3-methoxy[carboxy-11C]benzamide which initially had a high brain uptake, followed by a rapid washout.  The 11C-labeled nicotinamide demonstrated a rapid fixation with high uptake values in the liver, kidney and lymph nodes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgyJnh3qqEb7Vg90H21EOLACvtfcHk0lg74UWDJe-Ynw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvF2ks7o%253D&md5=65baa59048ce59955fabdfd6c6c575d1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F0969-8043%2894%2990251-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8043%252894%252990251-8%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DI.%26aulast%3DBergstroem%26aufirst%3DM.%26aulast%3DLaanstroem%26aufirst%3DB.%26atitle%3DSynthesis%2520of%252011C-labelled%2520benzamide%2520compounds%2520as%2520potential%2520tracers%2520for%2520poly%2528ADP-ribose%2529%2520synthetase%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D1994%26volume%3D45%26spage%3D707%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Milic, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opsenica, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnadevic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solaja, B. A.</span><span> </span><span class="NLM_article-title">NaY zeolite: A useful catalyst for nitrile hydrolysis</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=118-126&author=D.+R.+Milicauthor=D.+M.+Opsenicaauthor=B.+Adnadevicauthor=B.+A.+Solaja&title=NaY+zeolite%3A+A+useful+catalyst+for+nitrile+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilic%26aufirst%3DD.%2BR.%26aulast%3DOpsenica%26aufirst%3DD.%2BM.%26aulast%3DAdnadevic%26aufirst%3DB.%26aulast%3DSolaja%26aufirst%3DB.%2BA.%26atitle%3DNaY%2520zeolite%253A%2520A%2520useful%2520catalyst%2520for%2520nitrile%2520hydrolysis%26jtitle%3DMolecules%26date%3D2000%26volume%3D5%26spage%3D118%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Elias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, W. F.</span><span> </span><span class="NLM_article-title">Hydrazine determination in sludge samples by high-performance liquid chromatography</span> <span class="citation_source-journal">J. Sep. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1002%2Fjssc.200500380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=16544889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1KnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=460-464&author=G.+Eliasauthor=W.+F.+Bauer&title=Hydrazine+determination+in+sludge+samples+by+high-performance+liquid+chromatography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrazine determination in sludge samples by high-performance liquid chromatography</span></div><div class="casAuthors">Elias, Gracy; Bauer, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Separation Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">460-464</span>CODEN:
                <span class="NLM_cas:coden">JSSCCJ</span>;
        ISSN:<span class="NLM_cas:issn">1615-9306</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A relatively simple and cost-effective method using HPLC with UV detection was developed to detect and quantify hydrazine in sludge samples.  The method was developed primarily for sludge samples, but it can also be applicable to soil and other environmental samples.  The hydrazines in the matrixes were derivatized to hydrazones with benzaldehyde.  The hydrazones were sepd. using HPLC with an RP C-18 column in an isocratic mode with MeOH-H2O (95:5 vol./vol.) and detected with UV detection at 313 nm.  The detection limit (25 μL injection) for the method is 0.02 μg/mL of hydrazine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6MFJs_8YxX7Vg90H21EOLACvtfcHk0lg74UWDJe-Ynw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1KnsLk%253D&md5=41deed0322cf3b5a8cb8e5b95cbf7635</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjssc.200500380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjssc.200500380%26sid%3Dliteratum%253Aachs%26aulast%3DElias%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DW.%2BF.%26atitle%3DHydrazine%2520determination%2520in%2520sludge%2520samples%2520by%2520high-performance%2520liquid%2520chromatography%26jtitle%3DJ.%2520Sep.%2520Sci.%26date%3D2006%26volume%3D29%26spage%3D460%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Woo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K.</span><span> </span><span class="NLM_article-title">In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and α-1-acid glycoprotein</span> <span class="citation_source-journal">Clin. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1016%2F0009-9120%2895%2902024-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8601328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK28Xis1Krurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1996&pages=175-177&author=J.+Wooauthor=W.+Cheungauthor=R.+Chanauthor=H.+S.+Chanauthor=A.+Chengauthor=K.+Chan&title=In+vitro+protein+binding+characteristics+of+isoniazid%2C+rifampicin%2C+and+pyrazinamide+to+whole+plasma%2C+albumin%2C+and+%CE%B1-1-acid+glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and α-1-acid glycoprotein</span></div><div class="casAuthors">Woo, J.; Cheung, W.; Chan, R.; Chan, H.S.; Cheng, A.; Chan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-7</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In this study, the authors examd. the degree of binding of isoniazid, rifampicin, and pyrazinamide to plasma, albumin and α-1-glycoprotein, and the effect of variations in protein concn. on the degree of binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSy4n49k3rRLVg90H21EOLACvtfcHk0lg74UWDJe-Ynw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xis1Krurk%253D&md5=98b1a5bcfd24635d324366d23046fdbd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2F0009-9120%2895%2902024-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-9120%252895%252902024-1%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DH.%2BS.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DK.%26atitle%3DIn%2520vitro%2520protein%2520binding%2520characteristics%2520of%2520isoniazid%252C%2520rifampicin%252C%2520and%2520pyrazinamide%2520to%2520whole%2520plasma%252C%2520albumin%252C%2520and%2520%25CE%25B1-1-acid%2520glycoprotein%26jtitle%3DClin.%2520Biochem.%26date%3D1996%26volume%3D29%26spage%3D175%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Nguyen, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillarme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudaz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veuthey, J. L.</span><span> </span><span class="NLM_article-title">Validation of an ultra-fast UPLC-UV method for the separation of antituberculosis tablets</span> <span class="citation_source-journal">J. Sep. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1050</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1002%2Fjssc.200700537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=18306434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVKhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=1050-1056&author=D.+T.+Nguyenauthor=D.+Guillarmeauthor=S.+Rudazauthor=J.+L.+Veuthey&title=Validation+of+an+ultra-fast+UPLC-UV+method+for+the+separation+of+antituberculosis+tablets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of an ultra-fast UPLC-UV method for the separation of antituberculosis tablets</span></div><div class="casAuthors">Nguyen, Dao T.-T.; Guillarme, Davy; Rudaz, Serge; Veuthey, Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Separation Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">1050-1056</span>CODEN:
                <span class="NLM_cas:coden">JSSCCJ</span>;
        ISSN:<span class="NLM_cas:issn">1615-9306</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A simple method using ultra performance LC (UPLC) coupled with UV detection was developed and validated for the detn. of antituberculosis drugs in combined dosage form, i.e. isoniazid (ISN), pyrazinamide (PYR), and rifampicin (RIF).  Drugs were sepd. on a short column (2.1 mm × 50 mm) packed with 1.7 μm particles, using an elution gradient procedure.  At 30°C, < 2 min was necessary for the complete sepn. of the 3 antituberculosis drugs, while the original USP method was performed in 15 min.  Further improvements were obtained with the combination of UPLC and high temp. (≤ 90°C), namely HT-UPLC, which allows the application of higher mobile phase flow rates.  Therefore, the sepn. of ISN, PYR, and RIF was performed in < 1 min.  After validation (selectivity, trueness, precision, and accuracy), both methods (UPLC and HT-UPLC) have proven suitable for the routine quality control anal. of antituberculosis drugs in combined dosage form.  Addnl., a large no. of samples per day can be analyzed due to the short anal. times.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTBoSNMvpqLLVg90H21EOLACvtfcHk0ljjmJtDrtRc8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVKhs7s%253D&md5=c89b5767697d10a8c03571d6a17219f1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fjssc.200700537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjssc.200700537%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DD.%2BT.%26aulast%3DGuillarme%26aufirst%3DD.%26aulast%3DRudaz%26aufirst%3DS.%26aulast%3DVeuthey%26aufirst%3DJ.%2BL.%26atitle%3DValidation%2520of%2520an%2520ultra-fast%2520UPLC-UV%2520method%2520for%2520the%2520separation%2520of%2520antituberculosis%2520tablets%26jtitle%3DJ.%2520Sep.%2520Sci.%26date%3D2008%26volume%3D31%26spage%3D1050%26epage%3D1056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Nau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prange, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolenda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seydel, J. K.</span><span> </span><span class="NLM_article-title">Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1093%2Fjac%2F29.6.719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=1506352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADyaK38znt1GntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1992&pages=719-724&author=R.+Nauauthor=H.+W.+Prangeauthor=S.+Menckauthor=H.+Kolendaauthor=K.+Visserauthor=J.+K.+Seydel&title=Penetration+of+rifampicin+into+the+cerebrospinal+fluid+of+adults+with+uninflamed+meninges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges</span></div><div class="casAuthors">Nau R; Prange H W; Menck S; Kolenda H; Visser K; Seydel J K</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of antimicrobial chemotherapy</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-24</span>
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">The penetration of rifampicin into CSF was studied in seven patients who had undergone external ventriculostomy for occlusive hydrocephalus without major disturbance of the blood-CSF barrier.  After the first dose of rifampicin 600 mg i.v. over 3 h, blood and CSF concentrations were determined serially by HPLC.  Peak CSF concentrations obtained 0-8 h (median = 1 h) after the end of the infusion ranged from 0.57 to 1.24 mg/L (median = 0.73 mg/L).  Elimination from CSF was slower than from serum (T1/2 beta CSF: 9.1-21.0 h (median = 14.5 h, n = 5); T1/2 beta serum: 2.2-5.8 h (median = 3.6 h, n = 7)).  Based on the ratios of the areas under the concentration-time curves in CSF and serum, the overall penetration of rifampicin into CSF was 0.13-0.42 (median = 0.22).  These results demonstrate effective CSF penetration and favourable pharmacokinetics of rifampicin in the absence of meningeal inflammation.  They support the use of rifampicin as part of a combination therapy not only for tuberculosis of the central nervous system (CNS), but also for staphylococcal and listerial infections of the CNS in which there may be little meningeal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlfIHswCXjJUEksK8CslK8fW6udTcc2eZqeCcOFLcu3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38znt1GntA%253D%253D&md5=8fd53d2446185536fd0f0cd0f05d18f6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F29.6.719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F29.6.719%26sid%3Dliteratum%253Aachs%26aulast%3DNau%26aufirst%3DR.%26aulast%3DPrange%26aufirst%3DH.%2BW.%26aulast%3DMenck%26aufirst%3DS.%26aulast%3DKolenda%26aufirst%3DH.%26aulast%3DVisser%26aufirst%3DK.%26aulast%3DSeydel%26aufirst%3DJ.%2BK.%26atitle%3DPenetration%2520of%2520rifampicin%2520into%2520the%2520cerebrospinal%2520fluid%2520of%2520adults%2520with%2520uninflamed%2520meninges%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1992%26volume%3D29%26spage%3D719%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">McDougall, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grahame-Smith, D. G.</span><span> </span><span class="NLM_article-title">Penetration of C<sup>14</sup>-labelled rifampicin into primate peripheral nerve</span> <span class="citation_source-journal">Experientia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1069</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1975&pages=1068-1069&author=A.+C.+McDougallauthor=J.+A.+Roseauthor=D.+G.+Grahame-Smith&title=Penetration+of+C14-labelled+rifampicin+into+primate+peripheral+nerve"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcDougall%26aufirst%3DA.%2BC.%26aulast%3DRose%26aufirst%3DJ.%2BA.%26aulast%3DGrahame-Smith%26aufirst%3DD.%2BG.%26atitle%3DPenetration%2520of%2520C14-labelled%2520rifampicin%2520into%2520primate%2520peripheral%2520nerve%26jtitle%3DExperientia%26date%3D1975%26volume%3D31%26spage%3D1068%26epage%3D1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Mindermann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landolt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajacic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratzl, O.</span><span> </span><span class="NLM_article-title">Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">737</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1093%2Fjac%2F31.5.731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8335500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK3sXks1agur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1993&pages=731-737&author=T.+Mindermannauthor=H.+Landoltauthor=W.+Zimmerliauthor=Z.+Rajacicauthor=O.+Gratzl&title=Penetration+of+rifampicin+into+the+brain+tissue+and+cerebral+extracellular+space+of+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats</span></div><div class="casAuthors">Mindermann, Thomas; Landolt, Hans; Zimmerli, Werner; Rajacic, Zarko; Gratzl, Otmar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">731-7</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">Rifampicin is used to treat neurosurgical shunt infections because of its excellent in-vitro activity against staphylococci and its adequate penetration into the CSF.  However, nothing is known about rifampicin concns. in the cerebral extracellular space (CES).  The authors measured the penetration of rifampicin into the CES of anesthetized rats by microdialysis using low-flow and equil. methods.  Depending on the method, rifampicin concns. in the CES were 0.3-1% of the serum concn. or 3-8% of brain tissue concn., resp.  These exptl. data in animals suggest that the recommended dose of rifampicin in man might be inadequate for treatment of some brain infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIHLQcpKx2z7Vg90H21EOLACvtfcHk0ljjmJtDrtRc8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1agur8%253D&md5=2edbcc2307384e527e5f5c2c7952bab9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F31.5.731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F31.5.731%26sid%3Dliteratum%253Aachs%26aulast%3DMindermann%26aufirst%3DT.%26aulast%3DLandolt%26aufirst%3DH.%26aulast%3DZimmerli%26aufirst%3DW.%26aulast%3DRajacic%26aufirst%3DZ.%26aulast%3DGratzl%26aufirst%3DO.%26atitle%3DPenetration%2520of%2520rifampicin%2520into%2520the%2520brain%2520tissue%2520and%2520cerebral%2520extracellular%2520space%2520of%2520rats%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1993%26volume%3D31%26spage%3D731%26epage%3D737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mindermann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratzl, O.</span><span> </span><span class="NLM_article-title">Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2626</span><span class="NLM_x">–</span> <span class="NLM_lpage">2629</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=2626-2629&author=T.+Mindermannauthor=W.+Zimmerliauthor=O.+Gratzl&title=Rifampin+concentrations+in+various+compartments+of+the+human+brain%3A+a+novel+method+for+determining+drug+levels+in+the+cerebral+extracellular+space"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMindermann%26aufirst%3DT.%26aulast%3DZimmerli%26aufirst%3DW.%26aulast%3DGratzl%26aufirst%3DO.%26atitle%3DRifampin%2520concentrations%2520in%2520various%2520compartments%2520of%2520the%2520human%2520brain%253A%2520a%2520novel%2520method%2520for%2520determining%2520drug%2520levels%2520in%2520the%2520cerebral%2520extracellular%2520space%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1998%26volume%3D42%26spage%3D2626%26epage%3D2629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Barclay, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Roy, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthei, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, L. J.</span><span> </span><span class="NLM_article-title">Distribution and excretion of radioactive isoniazid in tuberculous patients</span> <span class="citation_source-journal">J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">1384</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=13034481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaG3sXkvVOhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1953&pages=1384-1388&author=W.+R.+Barclayauthor=R.+H.+Ebertauthor=G.+V.+Le+Royauthor=R.+W.+Mantheiauthor=L.+J.+Roth&title=Distribution+and+excretion+of+radioactive+isoniazid+in+tuberculous+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and excretion of radioactive isoniazid in tuberculous patients</span></div><div class="casAuthors">Barclay, W. R.; Ebert, R. H.; LeRoy, G. V.; Manthei, R. W.; Roth, L. J.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1384-8</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    </div><div class="casAbstract">C14-Isoniazid (isonicotinic acid hydrazide) was used to study the distribution and excretion of this bacteriostatic agent in tuberculous patients.  Peak levels were reached in blood and plasma within 1 hr. after intramuscular injection and fell rapidly during the next 8 hrs., but detectable amts. were still present 3-7 days after a single injection.  The drug is freely diffusible into tissues, and the highest concns. were found in lung and skin.  The drug diffuses freely into dense caseous lesions in both lung and lymph nodes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog8Vax7fsyGbVg90H21EOLACvtfcHk0lgLdUOkDQcn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXkvVOhsQ%253D%253D&md5=2739c78a0a683c250b6ce8f57d5145ec</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarclay%26aufirst%3DW.%2BR.%26aulast%3DEbert%26aufirst%3DR.%2BH.%26aulast%3DLe%2BRoy%26aufirst%3DG.%2BV.%26aulast%3DManthei%26aufirst%3DR.%2BW.%26aulast%3DRoth%26aufirst%3DL.%2BJ.%26atitle%3DDistribution%2520and%2520excretion%2520of%2520radioactive%2520isoniazid%2520in%2520tuberculous%2520patients%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D1953%26volume%3D151%26spage%3D1384%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Barling, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkon, J. B.</span><span> </span><span class="NLM_article-title">The penetration of antibiotics into cerebrospinal fluid and brain tissue</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1093%2Fjac%2F4.3.203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=353023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaE1cXkslSlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1978&pages=203-227&author=R.+W.+Barlingauthor=J.+B.+Selkon&title=The+penetration+of+antibiotics+into+cerebrospinal+fluid+and+brain+tissue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The penetration of antibiotics into cerebrospinal fluid and brain tissue</span></div><div class="casAuthors">Barling, R. W. A.; Selkon, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-27</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">A review with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTqbQ0NuAeA7Vg90H21EOLACvtfcHk0lgLdUOkDQcn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXkslSlsrc%253D&md5=52ba0b85f9be881a6a38c702368cda47</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F4.3.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F4.3.203%26sid%3Dliteratum%253Aachs%26aulast%3DBarling%26aufirst%3DR.%2BW.%26aulast%3DSelkon%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520penetration%2520of%2520antibiotics%2520into%2520cerebrospinal%2520fluid%2520and%2520brain%2520tissue%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1978%26volume%3D4%26spage%3D203%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Rouse, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. L.</span><span> </span><span class="NLM_article-title">Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2472</span><span class="NLM_x">–</span> <span class="NLM_lpage">2477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1995&pages=2472-2477&author=D.+A.+Rouseauthor=Z.+Liauthor=G.+H.+Baiauthor=S.+L.+Morris&title=Characterization+of+the+katG+and+inhA+genes+of+isoniazid-resistant+clinical+isolates+of+Mycobacterium+tuberculosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRouse%26aufirst%3DD.%2BA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBai%26aufirst%3DG.%2BH.%26aulast%3DMorris%26aufirst%3DS.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520katG%2520and%2520inhA%2520genes%2520of%2520isoniazid-resistant%2520clinical%2520isolates%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1995%26volume%3D39%26spage%3D2472%26epage%3D2477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Roth, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthel, R. W.</span><span> </span><span class="NLM_article-title">The distribution of C<sup>14</sup> labeled isonicotinic acid hydrazide in normal mice</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">566</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=13027371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaG3sXhs1Khsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1952&pages=566-569&author=L.+J.+Rothauthor=R.+W.+Manthel&title=The+distribution+of+C14+labeled+isonicotinic+acid+hydrazide+in+normal+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The distribution of carbon14-labeled isonicotinic acid hydrazide in normal mice</span></div><div class="casAuthors">Roth, L. J.; Manthei, R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">566-9</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    </div><div class="casAbstract">After subcutaneous injection of carboxyl C14-labeled isonicotinic hydrazide (I) in mice the drug is localized chiefly in the liver, skin, lungs, brain, and kidneys.  The lung tissue contains considerable amts. of activity after the blood level has fallen to trace amts.  Both I and its major metabolite isonicotinic acid are found in the brain tissue.  The skin may serve as an important storage depot for I.  Excretion of I is chiefly in the urine.  Less than 1% is converted to CO2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaPydx34E7CbVg90H21EOLACvtfcHk0lgLdUOkDQcn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXhs1Khsg%253D%253D&md5=496407f5c3c55db733a095450f47c0c5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DL.%2BJ.%26aulast%3DManthel%26aufirst%3DR.%2BW.%26atitle%3DThe%2520distribution%2520of%2520C14%2520labeled%2520isonicotinic%2520acid%2520hydrazide%2520in%2520normal%2520mice%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1952%26volume%3D81%26spage%3D566%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Barlow, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoolar, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, L. J.</span><span> </span><span class="NLM_article-title">Distribution of carbon-14 labeled isoniazid in brain</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">820</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1957&pages=820-824&author=C.+F.+Barlowauthor=J.+C.+Schoolarauthor=L.+J.+Roth&title=Distribution+of+carbon-14+labeled+isoniazid+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarlow%26aufirst%3DC.%2BF.%26aulast%3DSchoolar%26aufirst%3DJ.%2BC.%26aulast%3DRoth%26aufirst%3DL.%2BJ.%26atitle%3DDistribution%2520of%2520carbon-14%2520labeled%2520isoniazid%2520in%2520brain%26jtitle%3DNeurology%26date%3D1957%26volume%3D7%26spage%3D820%26epage%3D824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Schoolar, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlow, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, L. J.</span><span> </span><span class="NLM_article-title">Autoradiography of carbon-14 labeled isoniazid in brain</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=13297797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaG28XksF2jsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1956&pages=347-349&author=J.+C.+Schoolarauthor=C.+F.+Barlowauthor=L.+J.+Roth&title=Autoradiography+of+carbon-14+labeled+isoniazid+in+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Autoradiography of carbon-14 labeled isoniazid in brain</span></div><div class="casAuthors">Schoolar, Joseph C.; Barlow, Charles F.; Roth, Lloyd J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">347-9</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    </div><div class="casAbstract">Gross autoradiograms of cat brain slices contg. C14-labeled isoniazid, together with supportive data from radioactive assay, are presented to show the differential localization of isoniazid in brain tissues.  The technique is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk40ZUvucL17Vg90H21EOLACvtfcHk0lhpmOFHEn-qXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG28XksF2jsw%253D%253D&md5=4b3df642f7e90cb94ff2f08d85a3031d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoolar%26aufirst%3DJ.%2BC.%26aulast%3DBarlow%26aufirst%3DC.%2BF.%26aulast%3DRoth%26aufirst%3DL.%2BJ.%26atitle%3DAutoradiography%2520of%2520carbon-14%2520labeled%2520isoniazid%2520in%2520brain%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1956%26volume%3D91%26spage%3D347%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ellard, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, B. W.</span><span> </span><span class="NLM_article-title">Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis</span> <span class="citation_source-journal">Am. Rev. Respir. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1164%2Fajrccm%2F148.3.650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8368635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADyaK3sznvVWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1993&pages=650-655&author=G.+A.+Ellardauthor=M.+J.+Humphriesauthor=B.+W.+Allen&title=Cerebrospinal+fluid+drug+concentrations+and+the+treatment+of+tuberculous+meningitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis</span></div><div class="casAuthors">Ellard G A; Humphries M J; Allen B W</div><div class="citationInfo"><span class="NLM_cas:title">The American review of respiratory disease</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">650-5</span>
        ISSN:<span class="NLM_cas:issn">0003-0805</span>.
    </div><div class="casAbstract">Tuberculous meningitis is a very serious form of tuberculosis.  In the absence of randomized controlled trials of alternative treatment regimens, its management depends on employing potent drugs that penetrate well into the cerebrospinal fluid (CSF).  The penetration of isoniazid, rifampin, and streptomycin into the CSF of 27 Chinese patients was studied using fluorimetric and microbiologic procedures.  Isoniazid rapidly diffused into the CSF, peak concentrations in excess of 3 mg/L, or over 30 times its minimal inhibitory concentration (MIC) against Mycobacterium tuberculosis being attained within 4 hr.  In contrast, rifampin and streptomycin penetrated very slowly across the meninges, and CSF levels only slightly in excess of their MICs against M. tuberculosis were achieved.  The penetration of the drugs into the CSF correlated poorly with differences in their partitioning between octanol/water and cyclohexane/water but could be predicted using a simple model based on their renal clearance rates and plasma protein binding.  It is recommended that patients with tuberculous meningitis should be treated for at least 9 months with a combination of isoniazid, rifampin, and pyrazinamide, which may be supplemented in the first 2 mo with streptomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfiYpMTPePUNNTrvPZP1IpfW6udTcc2ebst_UBMYVnmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3sznvVWquw%253D%253D&md5=4705021b0d042ac346c3384bda1f6035</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1164%2Fajrccm%2F148.3.650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm%252F148.3.650%26sid%3Dliteratum%253Aachs%26aulast%3DEllard%26aufirst%3DG.%2BA.%26aulast%3DHumphries%26aufirst%3DM.%2BJ.%26aulast%3DAllen%26aufirst%3DB.%2BW.%26atitle%3DCerebrospinal%2520fluid%2520drug%2520concentrations%2520and%2520the%2520treatment%2520of%2520tuberculous%2520meningitis%26jtitle%3DAm.%2520Rev.%2520Respir.%2520Dis.%26date%3D1993%26volume%3D148%26spage%3D650%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Forgan-Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellard, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, D. A.</span><span> </span><span class="NLM_article-title">Pyrazinamide and other drugs in tuberculous meningitis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1973&pages=374&author=R.+Forgan-Smithauthor=G.+A.+Ellardauthor=D.+Newtonauthor=D.+A.+Mitchison&title=Pyrazinamide+and+other+drugs+in+tuberculous+meningitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForgan-Smith%26aufirst%3DR.%26aulast%3DEllard%26aufirst%3DG.%2BA.%26aulast%3DNewton%26aufirst%3DD.%26aulast%3DMitchison%26aufirst%3DD.%2BA.%26atitle%3DPyrazinamide%2520and%2520other%2520drugs%2520in%2520tuberculous%2520meningitis%26jtitle%3DLancet%26date%3D1973%26volume%3D2%26spage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Wu, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, H.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, T.-H.</span><span> </span><span class="NLM_article-title">Determination and pharmacokinetic profile of pyrazinamide in rat blood, brain and bile using microdialysis coupled with high-performance liquid chromatography and verified by tandem mass spectrometry</span> <span class="citation_source-journal">Anal. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">522</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=522&publication_year=2004&pages=231-239&author=J.-W.+Wuauthor=H.-H.+Shihauthor=S.-C.+Wangauthor=T.-H.+Tsai&title=Determination+and+pharmacokinetic+profile+of+pyrazinamide+in+rat+blood%2C+brain+and+bile+using+microdialysis+coupled+with+high-performance+liquid+chromatography+and+verified+by+tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-W.%26aulast%3DShih%26aufirst%3DH.-H.%26aulast%3DWang%26aufirst%3DS.-C.%26aulast%3DTsai%26aufirst%3DT.-H.%26atitle%3DDetermination%2520and%2520pharmacokinetic%2520profile%2520of%2520pyrazinamide%2520in%2520rat%2520blood%252C%2520brain%2520and%2520bile%2520using%2520microdialysis%2520coupled%2520with%2520high-performance%2520liquid%2520chromatography%2520and%2520verified%2520by%2520tandem%2520mass%2520spectrometry%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2004%26volume%3D522%26spage%3D231%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Nitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virgilio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricolo, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuliano, A.</span><span> </span><span class="NLM_article-title">Pharmacokinetic study of intravenous rifampicin</span> <span class="citation_source-journal">Chemotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1977&pages=1-6&author=V.+Nittiauthor=R.+Virgilioauthor=M.+R.+Patricoloauthor=A.+Iuliano&title=Pharmacokinetic+study+of+intravenous+rifampicin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNitti%26aufirst%3DV.%26aulast%3DVirgilio%26aufirst%3DR.%26aulast%3DPatricolo%26aufirst%3DM.%2BR.%26aulast%3DIuliano%26aufirst%3DA.%26atitle%3DPharmacokinetic%2520study%2520of%2520intravenous%2520rifampicin%26jtitle%3DChemotherapy%26date%3D1977%26volume%3D23%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Furesz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallanza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mapelli, E.</span><span> </span><span class="NLM_article-title">Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=5631581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaF2sXkvV2ms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1967&pages=534-537&author=S.+Fureszauthor=R.+Scottiauthor=R.+Pallanzaauthor=E.+Mapelli&title=Rifampicin%3A+a+new+rifamycin.+3.+Absorption%2C+distribution%2C+and+elimination+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Rifamycins.  LIII.  Rifampicin.  A new rifamycin.  3.  Absorption, distribution, and elimination in man</span></div><div class="casAuthors">Furesz, S.; Scotti, R.; Pallanza, Rosa; Mapelli, E.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">534-7</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">cf. preceding abstrs.  Rifampicin (I) was well absorbed by humans after oral administration, therapeutically active concns. being maintained in the blood for 8 hrs. after administration of 150 mg.  When the dose was increased to 450 mg., serum I was detected for 24 hrs., and with 900 mg. I, blood levels were very high and long lasting.  Elimination of I was slow and took place mainly via the bile, although bactericidal concns. were present in the urine.  The new antibiotic had a high distribution vol. (1.619 ml./g. after a 25-mg. dose), and direct detn. of the antibiotic in the different organs confirmed that I diffused well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzSTAjqSdWIbVg90H21EOLACvtfcHk0lhgloCgD7lZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXkvV2ms7c%253D&md5=27fa6079567ab3f60deec5ded972ce19</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuresz%26aufirst%3DS.%26aulast%3DScotti%26aufirst%3DR.%26aulast%3DPallanza%26aufirst%3DR.%26aulast%3DMapelli%26aufirst%3DE.%26atitle%3DRifampicin%253A%2520a%2520new%2520rifamycin.%25203.%2520Absorption%252C%2520distribution%252C%2520and%2520elimination%2520in%2520man%26jtitle%3DArzneim.%2520Forsch.%26date%3D1967%26volume%3D17%26spage%3D534%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Boman, G.</span><span> </span><span class="NLM_article-title">Tissue distribution of <sup>14</sup>C-rifampicin II. Accumulation in melanin-containing structures</span> <span class="citation_source-journal">Acta Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1111%2Fj.1600-0773.1975.tb00794.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=1173525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaE2MXkt1ahs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1975&pages=267-283&author=G.+Boman&title=Tissue+distribution+of+14C-rifampicin+II.+Accumulation+in+melanin-containing+structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution of carbon-14-labeled-rifampicin.  II.  Accumulation in melanin-containing structures</span></div><div class="casAuthors">Boman, Gunnar</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica et Toxicologica</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-83</span>CODEN:
                <span class="NLM_cas:coden">APTOA6</span>;
        ISSN:<span class="NLM_cas:issn">0001-6683</span>.
    </div><div class="casAbstract">The tissue distribution of 14Crifampicin [13292-46-1] was investigated by whole body autoradiog. in brown mice surviving up to 30 days after a single i.v. injection.  In contrast to the findings in albino mice a long-term retention was obsd. in the uveal tract, the inner ear and the skin.  Similar results were obtained in pigmented rats.  Sections of organs from a human fetus incubated in 14C-rifampicin showed selective accumulation in the pigment epithelium of the eye.  Quant. detns. of radioactivity were performed of the blood, liver, lung, kidney and eye of mice up to 4 days after a single i.v. injection of 14C-rifampicin.  A 15-fold difference was found between the pigmented and the albino eye after 4 days.  The findings were interpreted as evidence for a melanin affinity of rifampicin and discussed in relation to its possible ocular and otol. side effects, which seem to be mostly unverified and very infrequent even during long-term therapy.  However, the accumulation of transplacentally transferred drug in the eye and the inner ear provides a further reason for restricting its use during pregnancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNwGb65N0n5rVg90H21EOLACvtfcHk0lhgloCgD7lZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXkt1ahs74%253D&md5=b45ba0e1bc4cdb77ef963c0191f6ea8d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1975.tb00794.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1975.tb00794.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoman%26aufirst%3DG.%26atitle%3DTissue%2520distribution%2520of%252014C-rifampicin%2520II.%2520Accumulation%2520in%2520melanin-containing%2520structures%26jtitle%3DActa%2520Pharmacol.%2520Toxicol.%26date%3D1975%26volume%3D36%26spage%3D267%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Verma, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span> </span><span class="NLM_article-title">Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3195</span><span class="NLM_x">–</span> <span class="NLM_lpage">3201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3195-3201&author=R.+K.+Vermaauthor=J.+Kaurauthor=K.+Kumarauthor=A.+B.+Yadavauthor=A.+Misra&title=Intracellular+time+course%2C+pharmacokinetics%2C+and+biodistribution+of+isoniazid+and+rifabutin+following+pulmonary+delivery+of+inhalable+microparticles+to+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DR.%2BK.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DYadav%26aufirst%3DA.%2BB.%26aulast%3DMisra%26aufirst%3DA.%26atitle%3DIntracellular%2520time%2520course%252C%2520pharmacokinetics%252C%2520and%2520biodistribution%2520of%2520isoniazid%2520and%2520rifabutin%2520following%2520pulmonary%2520delivery%2520of%2520inhalable%2520microparticles%2520to%2520mice%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3195%26epage%3D3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Roohi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mushtaq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jehangir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, S. A.</span><span> </span><span class="NLM_article-title">Direct labeling of isoniazid with technetium-99m for diagnosis of tuberculosis</span> <span class="citation_source-journal">Radiochim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1524%2Fract.2006.94.3.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslOmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=147-152&author=S.+Roohiauthor=A.+Mushtaqauthor=M.+Jehangirauthor=S.+A.+Malik&title=Direct+labeling+of+isoniazid+with+technetium-99m+for+diagnosis+of+tuberculosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Direct labeling of isoniazid with technetium-99m for diagnosis of tuberculosis</span></div><div class="casAuthors">Roohi, Samina; Mushtaq, A.; Jehangir, M.; Malik, Salman A.</div><div class="citationInfo"><span class="NLM_cas:title">Radiochimica Acta</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">147-152</span>CODEN:
                <span class="NLM_cas:coden">RAACAP</span>;
        ISSN:<span class="NLM_cas:issn">0033-8230</span>.
    
            (<span class="NLM_cas:orgname">Oldenbourg Wissenschaftsverlag GmbH</span>)
        </div><div class="casAbstract">Isonicotinic acid hydrazide (isoniazid) is one of the most effective agents in tuberculosis therapy.  Hence it was chosen as ligand for 99mTc labeling and imaging in the developed animal model with a gamma camera.  Direct labeling of isoniazid with technetium-99m was studied.  Factors affecting the radiolabeling efficiency such as amt. of reducing agent, pH and time of the reaction were studied.  Biodistribution of the labeled compd. was performed in Sprague-Dawley rats.  The localization kinetics of the radiolabeled complex was also studied in the developed animal model by injecting 100-125 MBq 99mTc-isoniazid i.v. in the ear of rabbit and the images were taken with a gamma camera.  Optimum conditions gave > 98% labeling efficiency of 99mTc-isoniazid.  Biodistribution studies in rats revealed that the max. uptake was in kidneys (15%, 8% and 2.5% at 0.5, 4 and 24 h, resp.), indicating renal excretion of the 99mTc-isoniazid.  High accumulation was obtained in liver (10%, 11% and 4% at 0.5, 4 and 24 h, resp.) and significant radioactivity was also seen in the intestines (8%, 6% and 1% at 0.5, 4 and 24 h, resp.), indicating hepatobiliary excretion of the complex.  Less than 2% uptake in stomach until 24 h confirmed good in vivo stability of the complex.  99mTc-isoniazid initially accumulated in infective lesions of S. aureus in rabbits due to hyper-vascularity, but because of its non specificity for S. aureus the residency of 99mTc-isoniazid was low and it showed rapid wash out from the lesion, whereas residency of tubercular lesion was high and it remained in the tubercular lesion in the delayed images also.  The results suggest that 99mTc-isoniazid is a specific agent for localization of tubercular lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_IVkud-n2yLVg90H21EOLACvtfcHk0lhgloCgD7lZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslOmurw%253D&md5=b83c120dc91c97b9185793a0a6c42483</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1524%2Fract.2006.94.3.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1524%252Fract.2006.94.3.147%26sid%3Dliteratum%253Aachs%26aulast%3DRoohi%26aufirst%3DS.%26aulast%3DMushtaq%26aufirst%3DA.%26aulast%3DJehangir%26aufirst%3DM.%26aulast%3DMalik%26aufirst%3DS.%2BA.%26atitle%3DDirect%2520labeling%2520of%2520isoniazid%2520with%2520technetium-99m%2520for%2520diagnosis%2520of%2520tuberculosis%26jtitle%3DRadiochim.%2520Acta%26date%3D2006%26volume%3D94%26spage%3D147%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Stottmeier, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beam, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubica, G. P.</span><span> </span><span class="NLM_article-title">The absorption and excretion of pyrazinamide. I. Preliminary study in laboratory animals and in man</span> <span class="citation_source-journal">Am. Rev. Respir. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=5657154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADyaF1c3os1OmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1968&pages=70-74&author=K.+D.+Stottmeierauthor=R.+E.+Beamauthor=G.+P.+Kubica&title=The+absorption+and+excretion+of+pyrazinamide.+I.+Preliminary+study+in+laboratory+animals+and+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The absorption and excretion of pyrazinamide. I. Preliminary study in laboratory animals and in man</span></div><div class="casAuthors">Stottmeier K D; Beam R E; Kubica G P</div><div class="citationInfo"><span class="NLM_cas:title">The American review of respiratory disease</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-4</span>
        ISSN:<span class="NLM_cas:issn">0003-0805</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQskxNTbfL5CFm8bhe6roZYfW6udTcc2eabl36vGdtF6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF1c3os1OmsA%253D%253D&md5=d97eb5604f6e151d045719f1ea224a50</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStottmeier%26aufirst%3DK.%2BD.%26aulast%3DBeam%26aufirst%3DR.%2BE.%26aulast%3DKubica%26aufirst%3DG.%2BP.%26atitle%3DThe%2520absorption%2520and%2520excretion%2520of%2520pyrazinamide.%2520I.%2520Preliminary%2520study%2520in%2520laboratory%2520animals%2520and%2520in%2520man%26jtitle%3DAm.%2520Rev.%2520Respir.%2520Dis.%26date%3D1968%26volume%3D98%26spage%3D70%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Peloquin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaresko, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keung, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulpitt, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelliffe, R. W.</span><span> </span><span class="NLM_article-title">Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2670</span><span class="NLM_x">–</span> <span class="NLM_lpage">2679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1997&pages=2670-2679&author=C.+A.+Peloquinauthor=G.+S.+Jareskoauthor=C.+L.+Yongauthor=A.+C.+Keungauthor=A.+E.+Bulpittauthor=R.+W.+Jelliffe&title=Population+pharmacokinetic+modeling+of+isoniazid%2C+rifampin%2C+and+pyrazinamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeloquin%26aufirst%3DC.%2BA.%26aulast%3DJaresko%26aufirst%3DG.%2BS.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DKeung%26aufirst%3DA.%2BC.%26aulast%3DBulpitt%26aufirst%3DA.%2BE.%26aulast%3DJelliffe%26aufirst%3DR.%2BW.%26atitle%3DPopulation%2520pharmacokinetic%2520modeling%2520of%2520isoniazid%252C%2520rifampin%252C%2520and%2520pyrazinamide%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1997%26volume%3D41%26spage%3D2670%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Lacroix, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nouveau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyonnaud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duwoos, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafont, O.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1989&pages=395-400&author=C.+Lacroixauthor=T.+P.+Hoangauthor=J.+Nouveauauthor=C.+Guyonnaudauthor=G.+Laineauthor=H.+Duwoosauthor=O.+Lafont&title=Pharmacokinetics+of+pyrazinamide+and+its+metabolites+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLacroix%26aufirst%3DC.%26aulast%3DHoang%26aufirst%3DT.%2BP.%26aulast%3DNouveau%26aufirst%3DJ.%26aulast%3DGuyonnaud%26aufirst%3DC.%26aulast%3DLaine%26aufirst%3DG.%26aulast%3DDuwoos%26aufirst%3DH.%26aulast%3DLafont%26aufirst%3DO.%26atitle%3DPharmacokinetics%2520of%2520pyrazinamide%2520and%2520its%2520metabolites%2520in%2520healthy%2520subjects%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1989%26volume%3D36%26spage%3D395%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heym, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S.</span><span> </span><span class="NLM_article-title">The catalase-peroxidase gene and isoniazid resistance of <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1992&pages=591-593&author=Y.+Zhangauthor=B.+Heymauthor=B.+Allenauthor=D.+Youngauthor=S.+Cole&title=The+catalase-peroxidase+gene+and+isoniazid+resistance+of+Mycobacterium+tuberculosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHeym%26aufirst%3DB.%26aulast%3DAllen%26aufirst%3DB.%26aulast%3DYoung%26aufirst%3DD.%26aulast%3DCole%26aufirst%3DS.%26atitle%3DThe%2520catalase-peroxidase%2520gene%2520and%2520isoniazid%2520resistance%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D591%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Blanchard, J. S.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of drug resistance in <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1146%2Fannurev.bi.65.070196.001243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=8811179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADyaK28XktFamtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1996&pages=215-239&author=J.+S.+Blanchard&title=Molecular+mechanisms+of+drug+resistance+in+Mycobacterium+tuberculosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of drug resistance in Mycobacterium tuberculosis</span></div><div class="casAuthors">Blanchard, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">215-239</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 127 refs.  In spite of forty years of effective chemotherapy for tuberculosis, the mol. mechanisms of antibacterial compds. in Mycobacterium tuberculosis have only recently been revealed.  Broad spectrum antibacterials, including streptomycin, rifampicin, and fluoroquinolones, have been demonstrated to act on the same targets in M. tuberculosis as they do in Escherichia coli.  Resistance to these agents results from single mutagenic events that lead to amino acid substitutions in their target proteins.  The mechanisms of action of the unique antitubercular drugs, including isoniazid, ethambutol, and pyrazinamide, have also recently been defined.  Resistance to isoniazid can be caused either by mutations in the katG-encoded catalase-peroxidase, the enzyme responsible for drug activation, or by the mol. target, the inhA-encoded long chain enoyl-ACP reductase.  Ethambutol appears to block specifically the biosynthesis of the arabinogalactan component of the mycobacterial cell envelope, and pyrazinamide has no known target.  With the resurgence of tuberculosis and the appearance of strains which are multiply resistant to the above compds., present tuberculosis chemotherapies are threatened.  New approaches to the treatment of multidrug-resistant tuberculosis are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBC4hQKmc42rVg90H21EOLACvtfcHk0liwgMs8OI50eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktFamtLw%253D&md5=8154424e4e4d3c06a4388d561eb9adae</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bi.65.070196.001243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bi.65.070196.001243%26sid%3Dliteratum%253Aachs%26aulast%3DBlanchard%26aufirst%3DJ.%2BS.%26atitle%3DMolecular%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520Mycobacterium%2520tuberculosis%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1996%26volume%3D65%26spage%3D215%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Rawat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonge, P. J.</span><span> </span><span class="NLM_article-title">The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the <i>Mycobacterium tuberculosis</i> enoyl reductase: adduct affinity and drug resistance</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">13881</span><span class="NLM_x">–</span> <span class="NLM_lpage">13886</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1073%2Fpnas.2235848100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=14623976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFGisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13881-13886&author=R.+Rawatauthor=A.+Whittyauthor=P.+J.+Tonge&title=The+isoniazid-NAD+adduct+is+a+slow%2C+tight-binding+inhibitor+of+InhA%2C+the+Mycobacterium+tuberculosis+enoyl+reductase%3A+adduct+affinity+and+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance</span></div><div class="casAuthors">Rawat, Richa; Whitty, Adrian; Tonge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13881-13886</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Isoniazid (INH), a frontline antitubercular drug, inhibits InhA, the enoyl reductase from Mycobacterium tuberculosis, by forming a covalent adduct with the NAD cofactor.  Here, we report that the INH-NAD adduct is a slow, tight-binding competitive inhibitor of InhA.  Demonstration that the adduct binds to WT InhA by a two-step enzyme inhibition mechanism, with initial weak binding (K-1 = 16 ± 11 nM) followed by slow conversion to a final inhibited complex (EI*) with overall Ki = 0.75 ± 0.08 nM, reconciles existing contradictory values for the inhibitory potency of INH-NAD for InhA.  The first order rate const. for conversion of the initial EI complex to EI* (k2 = 0.13 ± 0.01 min-1) is similar to the max. rate const. obsd. for InhA inhibition in reaction mixts. contg. InhA, INH, NADH, and the INH-activating enzyme KatG (catalase/peroxidase from M. tuberculosis), consistent with an inhibition mechanism in which the adduct forms in soln. rather than on the enzyme.  Importantly, three mutations that correlate with INH resistance, 121V, 147T, and S94A, have little impact on the inhibition consts.  Thus, drug resistance does not result simply from a redn. in affinity of INH-NAD for pure InhA.  Instead, we hypothesize that protein-protein interactions within the type II dissocd. fatty acid biosynthesis pathway (FASII) complex are crit. to the mechanism of INH action.  Finally, for M161V, an InhA mutation that correlates with resistance to the common biocide triclosan in Mycobacterium smegmatis, binding to form the initial EI complex is significantly weakened, explaining why this mutant inactivates more slowly than WT InhA when incubated with INH, NADH, and KatG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ASTFMC3T_rVg90H21EOLACvtfcHk0liwgMs8OI50eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFGisLo%253D&md5=dbacbee13fb8ab6c677df78554ae1fdf</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2235848100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2235848100%26sid%3Dliteratum%253Aachs%26aulast%3DRawat%26aufirst%3DR.%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520isoniazid-NAD%2520adduct%2520is%2520a%2520slow%252C%2520tight-binding%2520inhibitor%2520of%2520InhA%252C%2520the%2520Mycobacterium%2520tuberculosis%2520enoyl%2520reductase%253A%2520adduct%2520affinity%2520and%2520drug%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D13881%26epage%3D13886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Yarbrough, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. W.</span><span> </span><span class="NLM_article-title">Molecular mechanism of the rifampicin−RNA polymerase interaction</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2669</span><span class="NLM_x">–</span> <span class="NLM_lpage">2676</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00657a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1976&pages=2669-2676&author=L.+R.+Yarbroughauthor=F.+Y.+Wuauthor=C.+W.+Wu&title=Molecular+mechanism+of+the+rifampicin%E2%88%92RNA+polymerase+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi00657a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00657a029%26sid%3Dliteratum%253Aachs%26aulast%3DYarbrough%26aufirst%3DL.%2BR.%26aulast%3DWu%26aufirst%3DF.%2BY.%26aulast%3DWu%26aufirst%3DC.%2BW.%26atitle%3DMolecular%2520mechanism%2520of%2520the%2520rifampicin%25E2%2588%2592RNA%2520polymerase%2520interaction%26jtitle%3DBiochemistry%26date%3D1976%26volume%3D15%26spage%3D2669%26epage%3D2676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1624</span><span class="NLM_x">–</span> <span class="NLM_lpage">1630</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1624-1630&author=J.+Maoauthor=Y.+Wangauthor=B.+Wanauthor=A.+P.+Kozikowskiauthor=S.+G.+Franzblau&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+mefloquine-based+ligands+as+novel+antituberculosis+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520mefloquine-based%2520ligands%2520as%2520novel%2520antituberculosis%2520agents%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1624%26epage%3D1630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Glamkowski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitano, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, D. L.</span><span> </span><span class="NLM_article-title">Synthesis of 3-(4-acylaminopiperazin-1-ylalkyl)indoles as potential antihypertensive agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1489</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00221a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=1485-1489&author=E.+J.+Glamkowskiauthor=P.+A.+Reitanoauthor=D.+L.+Woodward&title=Synthesis+of+3-%284-acylaminopiperazin-1-ylalkyl%29indoles+as+potential+antihypertensive+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm00221a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00221a024%26sid%3Dliteratum%253Aachs%26aulast%3DGlamkowski%26aufirst%3DE.%2BJ.%26aulast%3DReitano%26aufirst%3DP.%2BA.%26aulast%3DWoodward%26aufirst%3DD.%2BL.%26atitle%3DSynthesis%2520of%25203-%25284-acylaminopiperazin-1-ylalkyl%2529indoles%2520as%2520potential%2520antihypertensive%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D1485%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Loening, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. S.</span><span> </span><span class="NLM_article-title">AMIDE: a free software tool for multimodality medical image analysis</span> <span class="citation_source-journal">Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm901858n&amp;key=10.1162%2F153535003322556877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm901858n&amp;key=14649056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm901858n&amp;key=1%3ACAS%3A280%3ADC%252BD3srmtF2jsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=131-137&author=A.+M.+Loeningauthor=S.+S.+Gambhir&title=AMIDE%3A+a+free+software+tool+for+multimodality+medical+image+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">AMIDE: a free software tool for multimodality medical image analysis</span></div><div class="casAuthors">Loening Andreas Markus; Gambhir Sanjiv Sam</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-7</span>
        ISSN:<span class="NLM_cas:issn">1535-3508</span>.
    </div><div class="casAbstract">Amide's a Medical Image Data Examiner (AMIDE) has been developed as a user-friendly, open-source software tool for displaying and analyzing multimodality volumetric medical images.  Central to the package's abilities to simultaneously display multiple data sets (e.g., PET, CT, MRI) and regions of interest is the on-demand data reslicing implemented within the program.  Data sets can be freely shifted, rotated, viewed, and analyzed with the program automatically handling interpolation as needed from the original data.  Validation has been performed by comparing the output of AMIDE with that of several existing software packages.  AMIDE runs on UNIX, Macintosh OS X, and Microsoft Windows platforms, and it is freely available with source code under the terms of the GNU General Public License.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcToCSSNUtq4wiCEBeYuoi7AfW6udTcc2ebhXTlpNSD_Qbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srmtF2jsw%253D%253D&md5=edf65edb4cc1fd4160544df7138b66c0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1162%2F153535003322556877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1162%252F153535003322556877%26sid%3Dliteratum%253Aachs%26aulast%3DLoening%26aufirst%3DA.%2BM.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26atitle%3DAMIDE%253A%2520a%2520free%2520software%2520tool%2520for%2520multimodality%2520medical%2520image%2520analysis%26jtitle%3DMol.%2520Imaging%26date%3D2003%26volume%3D2%26spage%3D131%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901858n&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-7%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm901858n%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901858n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679abe56180b2390","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
